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Abstract 
 
 
Objectives This thesis aimed to explore psychological factors associated with 
walking behaviour in patients with Peripheral Arterial Disease, within the framework 
of Leventhal et al’s (1998) Common-sense Model of Self-regulation of Health and 
Illness. The objective was to identify psychological factors which could be modified to 
increase walking behaviour in these patients. 
Method  A series of three studies were conducted to achieve these aims. The 
first study was an exploratory qualitative study, to explore the illness and treatment 
beliefs and walking behaviour of patients with intermittent claudication. The second 
study was a cross-sectional postal questionnaire to a cohort of patients with 
intermittent claudication, which tested the influence of the psychological factors 
identified in the qualitative study, in a larger sample. The final study was a randomised 
controlled trial of a brief psychological intervention designed to modify the illness and 
walking beliefs of patients with intermittent claudication, in order to increase walking 
behaviour. 
Results  Beliefs about intermittent claudication, and beliefs about walking 
were both found to be associated with walking behaviour in the qualitative study. The 
results from the cross-sectional postal questionnaire confirmed this relationship – 
taken as a set, illness and walking beliefs accurately predicted adherence to minimum 
walking levels for 93.4% of the sample. The brief psychological intervention 
successfully modified illness and treatment beliefs and increased walking behaviour in 
patients newly diagnosed with intermittent claudication. 
 
ix 
 
Conclusion This thesis highlights the importance of illness and walking beliefs to 
the walking behaviour of patients with intermittent claudication. The thesis has added 
to the body of knowledge about intermittent claudication, and the findings of this 
thesis have implications for the treatment of patients with intermittent claudication 
within the health service. Theoretical and clinical implications of this research are 
discussed. 
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Overview 
This chapter aims to give an introduction to Peripheral Arterial Disease (PAD), 
highlighting the causes and consequences of the disease, and considering the 
treatments that are currently available. PAD has behavioural risk factors, and 
treatment of PAD involves health behaviour change, therefore application of 
psychological theory to increase understanding of PAD may enhance the current 
treatment of patients with PAD. The potential contribution of the Common-Sense 
Model of Self-Regulation to our understanding and treatment of PAD will therefore be 
considered. 
 
Peripheral Arterial Disease 
Peripheral Arterial Disease is caused by atherosclerosis in the leg arteries, which leads 
to a reduction in blood supply to the lower limbs. Atherosclerosis is the build-up of 
fatty plaque on the wall of an artery which causes the artery wall to thicken. Over 
time, atherosclerotic plaque may rupture into the lumen of the artery, causing 
stenosis (narrowing) of the artery. This narrowing reduces the volume of blood which 
can flow through the artery. Narrowing of the arteries which supply blood to the legs 
or arms is known as Peripheral Arterial Disease (PAD).  
 
Risk factors for atherosclerosis and PAD include hypercholesterolemia (high 
cholesterol levels), diabetes, hypertension (high blood pressure), smoking, obesity, 
and older age (Murabito et al, 2002). In a study of middle-aged adults in the US, 
Murabito et al (2002) found that there was a 2.6 fold increase in the prevalence of 
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PAD for each 10 year increment in age, and hypertension and smoking were each 
found to double the odds of PAD. 
 
The symptoms of PAD are commonly classified using the Fontaine stages as described 
by Rutherford et al (1997) - Fontaine Stage I is classified as asymptomatic disease, 
Fontaine Stage II is classified as intermittent claudication, Fontaine Stage III is 
classified as ischemic rest pain, and Fontaine Stage IV is classified as tissue loss.  
 
Fontaine Stage I, asymptomatic disease, is thought to be the most prevalent stage of 
PAD; however, it is rarely diagnosed as there are no symptoms. Fowkes et al (1991) 
analysed the prevalence of both asymptomatic and symptomatic PAD in a large 
general population-based sample of 55 to 74 year olds in the Edinburgh Artery Study 
and found that 24.6% of the sample had asymptomatic PAD causing a major 
impairment to blood flow. In the US-based PAD Awareness, Risk and Treatment: New 
Resources for Survival (PARTNERS) programme, Hirsch et al (2001) studied a large 
group of patients aged 70 years or older, or aged 50 to 69 but with a history of 
cigarette smoking or diabetes, and found clinical evidence of PAD but no, or atypical 
leg symptoms in 41.8% of the sample - this increased prevalence is probably due to 
the increased number of risk factors for PAD present in the sample. 
 
Fontaine Stage II, intermittent claudication (IC), is leg pain when walking, which 
relieves immediately upon resting. The pain can take the form of cramping pain, 
discomfort, weakness or a heavy feeling and can occur in the hip, buttock, thigh, calf 
or foot (Rutherford et al, 1997). IC tends to occur more quickly if walking up an incline, 
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up stairs or at a faster pace. Claudication pain is thought to be a result of a build up of 
lactic acid in the muscle due to anaerobic metabolism. As the muscle has to work 
harder during exercise, the reduced blood flow through the narrowed artery does not 
deliver enough oxygen for aerobic metabolism, and so lactic acid is produced in the 
muscle, causing the claudication pain (Tan, de Cossart & Edwards, 2000). The pain is 
relieved within 1 or 2 minutes of rest, as the lactic acid dissipates.  
 
A number of large scale population studies have attempted to measure prevalence of 
IC within the population. Fowkes et al (1991) found that 4.5% of 55 to 74 year olds 
who participated in the Edinburgh Artery Study had IC, this figure rose at 5 year 
follow-up to 7.1% of the sample (Leng et al, 1996). While in a US study of PAD, Criqui 
et al (1985) found a 3.1% prevalence of IC among participants under age 60, rising to 
5.4% prevalence in 60 to 69 year olds, and 7.7% prevalence in the over-70s. Similar 
rates of IC were found in a Dutch study with 4.7% of 45 to 54 year olds, 6.9% of 55 to 
64 year olds and 9% of 65 to 74 year olds being found to have IC (Stoffers, Rinkens, 
Kester, Kaiser & Knottnerus, 1996). Hirsch et al (2001) found a 4.9% prevalence of 
classic claudication symptoms in the PARTNERS programme. The incidence of PAD is 
thought to be increasing, due to an ageing population (Golomb, Dang & Criqui, 2006) 
and increasing levels of obesity and diabetes in the population (Sumner, Eid, Parks, 
Edris & Reed, 2007). 
 
Stage III and IV PAD are less prevalent in the population. Stage III PAD, critical limb 
ischemia is characterised by resting leg pain. Prevalence has been found to be around 
0.25% of 40 to 69 year olds (Jensen, Vatten &Mhyre, 2006). Stage IV PAD, the 
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presence of non-healing ulcers on the foot or leg, and tissue loss, is thought to occur 
in approximately 25% of patients with critical limb ischemia (Jensen et al, 2006). In the 
5 year follow-up of the Edinburgh Artery Study, Leng et al (1996) found 1.4% of the 
sample originally diagnosed with IC went on to develop leg ulceration. The risk of a 
patient with IC developing critical limb ischemia and requiring amputation is estimated 
to be less than 1% a year (Burns, Gough & Bradbury, 2003). 
 
Atherosclerotic build-up of plaque on the walls of arteries is not confined to the legs; 
therefore a diagnosis of PAD is an indicator of generalised atherosclerosis in other 
parts of the body. Patients diagnosed with PAD are at increased risk of cardiovascular 
co-morbidity and mortality. Caro, Miglicciao-Walle, Ishak & Proskorovsky (2005) 
analysed a large Canadian database of patients with PAD, diagnosed through the 
health service, and found that subsequent to a diagnosis of PAD, angina, myocardial 
infarction and stroke each occurred in approximately 10% of the PAD population. 
33.2% of PAD patients died, mainly from cardiovascular events, within 5 years of 
diagnosis of PAD (Caro et al, 2005). By comparing the PAD database, with databases 
for stroke and myocardial infarction patients, Caro et al (2005) found that the PAD 
mortality rate is lower than for that for stroke patients (41.8% mortality rate within 5 
years of stroke), but higher than the mortality rate for patients suffering a myocardial 
infarction (26.6% mortality rate within 5 years of myocardial infarction). In the 5 year 
follow-up of the Edinburgh Artery Study, Leng et al (1996) found that 9.1% of patients 
who had PAD at baseline, went on to have a myocardial infarction, compared to 6.7% 
of participants who had no PAD at baseline. Rates of angina (7.2% vs. 5.3%) and stroke 
(4.5% vs. 2.8%) were also higher for participants with PAD at baseline than those with 
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no PAD at baseline. Mortality in the Edinburgh Artery Study was higher for 
participants with PAD at baseline (18.9%), than for participants with no PAD at 
baseline (10%); approximately 53% of the deaths among participants with PAD were 
cardiovascular, although there was also a high incidence of non-cardiovascular death 
in this group, mainly due to bronchogenic neoplasms, possibly due to the high levels 
of cigarette smoking in the PAD group (Leng et al, 1996). The difference in mortality 
rates between the Canadian study and the Scottish study is probably due to sampling 
methods, as the Canadian study used a database of patients diagnosed within the 
healthcare services, who probably therefore had more severe, symptomatic disease. 
The Scottish sample was population-based, with a large proportion of participants 
with asymptomatic and therefore less severe PAD. Many patients with asymptomatic 
PAD remain un-diagnosed, however when a diagnosis of PAD is made, it should be 
seen as an important early warning sign of future cardiovascular problems, and should 
trigger measures to reduce the risk of death and vascular co-morbidity (Cassar, 2006).  
 
Golomb et al (2006) have suggested that in addition to atherosclerosis causing 
increased risk of co-morbidity and mortality among people with PAD, PAD may itself 
be causally involved in increasing the risk of cardiac and cerebrovascular disease. A 
possible mechanism for this may be that symptomatic PAD reduces walking behaviour, 
which is itself protective against cardiovascular problems due to its effect on insulin 
resistance, hypertension and dyslipidemia (Golomb et al, 2006). 
 
As well as having an increased risk of co-morbidity and mortality, patients with IC have 
been found to have poorer quality of life than age and sex matched controls due to 
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pain, restricted mobility, and reduced energy (Breek, Hamming, De Vries, Aquarius & 
Van Berge Henegouwen, 2001). Barletta et al (1996) used the McMaster Health Index 
to investigate quality of life and found that patients with IC had significantly lower 
scores on the global, physical function, emotional function and social function 
domains than controls. Dumville, Lee, Smith & Fowkes (2004) analysed quality of life 
data from the Edinburgh Artery Study, measured using the SF-36, and found patients 
with IC had significantly worse scores in all domains except social functioning and 
mental health, compared to participants with asymptomatic PAD or no PAD. The mean 
physical component score of the SF-36 for the IC participants in this study was 39, 
worse than the US population physical component scores for arthritis (US score = 43), 
cancer (US score = 45), chronic lung disease (US score = 42), but better than angina 
(US score = 36) and congestive heart failure (US score = 31) (Dumville et al, 2004). This 
comparison of SF-36 physical component scores indicates that IC has similarly serious 
physical consequences as these other major diseases. 
 
Hunt, McKenna & Pope (1982) and Khaira, Hanger & Shearman (1996) used the 
Nottingham Health Profile to examine the quality of life of patients with IC, compared 
to healthy older adults. Participants with IC in both studies reported significantly 
worse energy levels, pain levels, sleep, emotional reactions and physical mobility than 
controls. Hunt et al (1982) reported that 37.8% of PAD participants reported that their 
health problems affected their ability to do jobs around the home, 32.2% reported 
that PAD affected their social life, 68% reported that PAD affected their hobbies, and 
30.3% reported that PAD affected their holidays. These results show that PAD impacts 
on all aspects of patients’ lives. 
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Severity of PAD has been found to only partially predict health-related quality of life 
(Breek et al, 2001; Breek, Hamming, De Vries, Van Berge Henegouwen & Van Heck, 
2002; Chetter, Dolan, Spark, Scott & Kester, 1997), indicating that factors other than 
pain and functional limitation may also play a part in the quality of life of patients with 
PAD. Poorer quality of life in patients with PAD has also been associated with a greater 
number of co-morbidities, in particular stroke (Breek et al, 2002; Cook & Galland, 
1997); greater body mass index (Muller-Buhl, Engeser, Klimm & Wiesemann, 2003); 
and older age (Izquierdo-Porrera et al, 2005). 
 
PAD has also been associated with depression. Waldstein et al (2003) found that 
participants with IC (mean BDI=8, SD=8.0) scored significantly higher than both age-
matched healthy controls (mean BDI=3.7, SD=3.3), and patients with hypertension 
(mean BDI=4.8, SD=4.5) on the Beck Depression Inventory; and had comparable 
depression scores to patients who had had a stroke (mean BDI=8.4, SD=7.0). Arseven, 
Guralnik, O’Brien, Liu & McDermott (2001) examined the association between PAD 
and depression, and found that participants with PAD reported depression twice as 
often as non-PAD participants. Participants with more severe PAD had a significantly 
greater number of depressive symptoms. Greater walking ability, in terms of distance 
the participant could walk in 6 minutes, was significantly associated with lower 
depression scores among participants with PAD. This relationship between walking 
ability and depression may be bi-directional, as impaired physical ability is a risk factor 
for depression (Turner & Noh, 1988) and older adults with depression are at increased 
risk of physical decline (Pennix, Guralnik & Ferrucci, 1998). 
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Finally, PAD has been shown to affect cognitive function, due to generalised 
atherosclerosis. Waldstein et al (2003) found that IC patients performed significantly 
worse than healthy controls, and patients with hypertension, but better than stroke 
patients, on a range of cognitive tests measuring nonverbal memory, concentration, 
executive function, perceptuo-motor speed and manual dexterity; these results were 
independent of age, education and depression scores. Waldstein et al (2003) 
concluded that these results suggest than cognitive impairment becomes steadily 
worse with increasing levels of cardiovascular disease. The cognitive deficits of 
patients with IC may affect their ability to follow complicated treatment instructions, 
for example detailed advice about how and when to exercise.        
 
Treatment 
Patients with PAD have been described as ‘a high risk, but neglected, disease 
population’ (Tomson & Lip, 2005), because the disease is thought to be both under-
detected and under-treated. A number of reviews of PAD have been critical of the way 
PAD is currently under-diagnosed in primary care, and of the less intensive 
management of risk factors of patients with PAD compared with patients with other 
cardiovascular diseases (e.g. Golomb et al, 2006; Khan, Cleanthis, Smout, Flather & 
Stansby, 2005; Tomson & Lip, 2005).  
 
There are reliable, non-invasive methods for diagnosing PAD including measuring the 
Ankle Brachial Pressure Index (ABPI), which is the ratio of systolic blood pressure in 
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the legs to systolic blood pressure in the arms. An ABPI of less than 0.9 is taken as an 
indication of the presence of PAD, with lower ABPI indicating more severe disease 
(Fowkes et al, 1992). Golomb et al (2006) suggested that assessment of ABPI should 
take place as part of a general assessment of cardiovascular risk in primary care. 
However, in the PARTNERS programme, Hirsch et al (2001) found that primary care 
doctors are often not aware that their patients have PAD. Savader, Porter, Ehrman & 
Haikal (2001) assessed patient compliance with physician recommendations following 
screening for PAD in a community hospital. Patients could either self-refer for 
screening or be referred by physicians. Of the 205 patients who attended screening, 
48 (23%) were found to be at high or moderate risk of developing PAD, with 77% of 
the moderate to high risk group reporting symptoms of IC. However, at seven month 
follow-up, 31 (70%) of those patients at high or moderate risk of developing PAD had 
not complied with advice to seek out care from a vascular specialist after the 
screening. Savader et al (2001) suggest this may be due, at least in part, to lack of 
insurance, however, the low compliance with recommendations may also be due to an 
inability to remember verbal instructions, poor understanding of written instructions, 
and a poor attitude to self-care (Savader et al, 2001).  
 
Several studies have shown that once a diagnosis of PAD has been made, 
atherosclerotic risk factors are not managed as intensively as they are in patients who 
have coronary artery disease (e.g. Hirsch et al, 2001; McDermott, Mehta, Ahn & 
Greenland, 1997). McDermott et al (1997) found that patients with coronary artery 
disease were more likely to be taking aspirin or warfarin than patients with PAD; 
patients with coronary artery disease and high cholesterol levels were significantly 
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more likely to have their cholesterol treated than patients with high cholesterol levels 
and PAD; and significantly more coronary artery disease patients were likely to 
exercise regularly, or recall their physician’s instructions to exercise than patients with 
PAD.  
 
Cassar (2006) proposed that treatment of PAD should target two fronts – firstly aiming 
to reduce cardiovascular risk factors, and secondly aiming to improve the symptoms of 
the disease. Cardiovascular risk factor reduction includes smoking cessation, diabetes 
control, weight loss, exercise, and drug therapy to lower cholesterol and blood 
pressure (Cassar, 2006). Treatment to improve the symptoms of PAD includes drug 
therapy, exercise, percutaneous transluminal angioplasty and bypass surgery (Cassar, 
2006).  
 
Smoking cessation 
Smoking is a major risk factor for the development of atherosclerosis, and severity of 
PAD is related to the amount smoked (Fowkes et al, 1992). Amputation rate and 
mortality rates are higher among patients with PAD who continue to smoke than non-
smokers (Khan et al, 2005). Graft failure rate after bypass surgery for PAD has also 
been found to be significantly higher for smokers than non-smokers (Giswold et al, 
2003). Smoking cessation slows the rate of development of further atherosclerosis and 
reduces the risk of mortality from cardiovascular causes (Cassar, 2006).The Scottish 
Intercollegiate Guidelines Network (SIGN, 2006, p.3) recommends that patients with 
PAD ‘should be actively discouraged from smoking’. 
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Clarke & Aish (2002) surveyed smokers with PAD about their beliefs about the 
consequences of continuing to smoke, and found that 34% of the sample believed 
smoking was unlikely to cause the development of further circulatory problems, 57.6% 
believed continuing smoking was unlikely to increase the risk of amputation, and 
38.8% felt health risks and health problems would not be reduced by quitting smoking. 
A survey of Dutch PAD patients’ awareness of vascular risk factors found 48% were not 
aware of the risk of smoking, and half the sample who had been smokers at diagnosis 
of PAD continued to smoke after diagnosis (Willigendael et al, 2004). In a similar 
survey in the US, Bloom, Stevick & Lennon (1990) found that only 44% of PAD patients 
who were active smokers considered PAD to be smoking related. In a study of PAD 
patients in New Zealand, Muthu, Chu, Le Heron, Roake & Lewis (2007) found that 81% 
of patients were aware that smoking was a risk factor for PAD, but despite this 33% of 
patients continued to smoke. 
 
Parry, Thomson & Fowkes (2002) conducted a qualitative study with older smokers 
with arterial disease to explore how smoking behaviour is influenced by social context. 
Parry et al (2002) found that participants who were debilitated by disease and had 
reduced social contact used smoking as a coping strategy to keep occupied and pass 
the time; and that as social support was a crucial factor in smoking cessation, the 
isolated smokers therefore received little encouragement and support to quit, and in 
fact had few constraints on their smoking behaviour.   
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These studies have highlighted the lack of awareness of smoking as a risk factor 
among patients with PAD, and the need for interventions beyond giving advice alone, 
to help patients with PAD to stop smoking. 
 
Exercise 
Exercise is thought to be beneficial to patients with PAD, both to reduce 
cardiovascular risk factors and to reduce symptoms of PAD (Khan et al, 2005). There is 
a lack of experimental evidence in PAD research as to whether patients with PAD who 
take part in exercise interventions live longer than patients with PAD who do not 
receive exercise interventions. However, evidence from observational research 
suggests that PAD patients in the highest quartile of daily physical activity levels at 
baseline have significantly reduced mortality and cardiovascular morbidity compared 
with PAD patients in the lowest levels quartile of physical activity levels at baseline, 
and that this effect is independent of confounding variables (Garg et al, 2006; 
Gardner, Montgomery & Parker, 2008). In addition, evidence from coronary artery 
research shows better survival rates for patients who exercise, with a Cochrane review 
finding a 27% reduction in all cause mortality for patients with heart disease who had 
taken part in exercise interventions (Jolliffe et al, 2001). 
 
Walking benefits patients with PAD as it reduces blood pressure, improves the lipid 
profile of the blood, and encourages development of a collateral blood supply 
(Eberhardt, 2002). Exercise training has also been found to improve oxidative 
capability in patients with IC by increasing mitochondrial function in the muscles - this 
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reduces the reliance on anaerobic metabolism, which reduces the production of lactic 
acid and therefore reduces muscle pain (Tan et al, 2000). 
 
A review by Spronk, Bosch, den Hoed & Hunink (2005) investigated quality of life after 
exercise training for patients with IC and found significant improvement in the 
physical functioning and bodily pain domains of the SF-36 at 3 month follow-up (mean 
change, 8 and 10, respectively). A review comparing the efficacy of generic and 
disease-specific quality of life measures in assessing change in quality of life after 
exercise-based interventions for IC (Guidon & McGee, 2010) concluded that while 
generic quality of life measures like the SF-36 do detect quality of life changes in 
physical functioning domains, disease-specific measures are more sensitive to change 
in quality of life following both supervised and unsupervised exercise programmes. In 
two studies which used both generic and disease-specific quality of life measures for 
unsupervised exercise programmes (Cheetham et al, 2004; Imfeld et al, 2006), the SF-
36 showed minimal changes in quality of life while the disease-specific measures 
showed clear improvements in quality of life.     
 
In a Cochrane review of exercise for intermittent claudication, Leng, Fowler & Ernst 
(2000) found significant improvements in walking distance following exercise therapy, 
the most effective exercise regimens involving walking to near-maximal pain, three 
times a week. The studies reviewed by Leng et al (2000) used treadmill based walking 
outcomes, measuring maximal walking distance until the participant had to stop 
walking due to leg pain. Overall, a 150% improvement was found in maximal walking 
distance for participants who received some form of exercise therapy. However, trials 
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with several different types of exercise therapy were included in this review, ranging 
from advice alone to supervised exercise programmes.  
 
Leng et al (2000) called for further research to determine the degree of supervision 
required in an exercise programme, and how long changes in exercise could be 
expected to last following participation in an exercise programme. 
 
A further Cochrane review (Bendermacher, Willigendael, Teijink & Prins, 2006) 
compared supervised exercise therapy with non-supervised exercise therapy for 
patients with IC, again using treadmill based walking outcomes. Supervised exercise 
programmes mainly consisted of 3 exercise sessions a week for 12 weeks, each session 
lasting for half an hour. Bendermacher et al (2006) found that supervised exercise 
programmes had a significantly greater improvement in maximal walking distance 
compared to non-supervised programmes, with an approximately 150m better 
improvement in the supervised walking groups at 3 months. Although this is not a 
large improvement in maximal walking distance, it is believed to be clinically 
significant because of the low walking capability of patients with IC (Bendermacher et 
al, 2006). Only two of the included trials repeated outcomes at 12 months, however, 
the effect was maintained in both these trials. Mechanisms by which supervised 
exercise programmes achieve improved maximal walking distance compared to non-
supervised programmes may include the higher level of intensity of exercise in 
supervised programmes leading to improved physical condition of the patient, and the 
added motivation and encouragement given to the patient in a supervised 
programme.  
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Although there is a clear improvement in walking capability as a result of supervised 
exercise programmes, there are a number of questions about these programmes 
which have not been addressed in the research to date, including what proportion of 
patients attend programmes when provided by the health service, how acceptable 
patients find supervised exercise programmes, and what the drop-out rate is from 
supervised programmes. Gelin et al (2001) found that 32.8% of patients assigned to a 
supervised exercise group were either unwilling or unable to complete the 
programme over a 1 year period, most dropping out after attending only a small 
number of classes. In a Dutch study of exercise behaviour and attitudes towards 
exercise of patients with IC, Bartelink, Stoffers, Biesheuvel & Hoes (2004) found that 
only a few participants were in favour of treatment which involved walking on a 
treadmill, or having regular appointments with a physiotherapist. Finally, although 
supervised exercise programmes have been shown to increase walking capability in 
patients with IC, there is no evidence that these programmes lead to long-term 
behaviour change outside the gym. In a small-sample study of a 12 month supervised 
exercise programme for patients with IC, Crowther et al (2008) also measured physical 
activity by pedometer at baseline and 1 year follow-up and found that although 
walking performance had improved significantly over time, there was no significant 
increase in daily steps from baseline to follow-up, indicating that supervised exercise 
programmes may not change day-to-day behaviour.   
 
At present in the UK, supervised exercise programmes for patients with IC are 
relatively uncommon, therefore exercise for claudication is usually promoted by 
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advice alone. In a recent survey of UK vascular surgeons, Shalhoub, Hamish & Davies 
(2009) found that only 24% of responders had access to supervised exercise 
programmes for patients with IC. Of those who did have access to supervised exercise 
programmes, 46% referred less than half of their IC patients to supervised exercise, 
because of patient co-morbidities, geographical constraints and patients being in work 
when the programme was running. 72% of responding surgeons who did not have 
access to supervised exercise programmes for patients with IC believed they did not 
have access to a supervised programme because of lack of resources. 63% of 
responding surgeons who did not have access to supervised exercise programmes 
gave advice to patients to walk, and 34% gave a leaflet about walking to patients.  
 
Stewart & Lamont (2007) indicated a number of reasons why advice alone may not be 
appropriate for patients with IC, including patients’ loss of confidence/self-efficacy in 
their ability to walk, their embarrassment at having to stop and rest, and their 
concerns that pain may be an indication that walking is harmful to them. In a 
qualitative study of barriers for walking in individuals with IC, Galea, Bray & Martin-
Ginis (2008) found that there were personal, activity-related and environmental 
barriers to walking. Personal barriers included uncertainty about the benefits of 
walking, and concerns about the potential harm caused by leg pain; activity-related 
barriers included the need for frequent breaks due to leg pain when walking; and 
environmental barriers included stairs, hills and not having an appropriate place to 
stop for a rest (Galea et al, 2008).    
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The Scottish Intercollegiate Guidelines Network (SIGN, 2006, p.17) recommends that 
patients with PAD ‘should be encouraged to exercise’. However, it is unclear whether 
patients with PAD realise the benefits of walking, or that insufficient physical activity is 
a risk factor for further cardiovascular health problems, for example, Willigendael et al 
(2004) found that only 23% of PAD patients recognised scarce physical exercise as a 
PAD risk factor, and only 48% of PAD patients felt that exercise was a measure they 
could undertake to improve the symptoms of PAD. Bartelink et al (2004) found that 
while 70% of Dutch patients with IC reported that they had received advice to walk, 
the content of the advice was generally not specific, and those who did walk did not 
tend to do so at optimum intensity or optimum frequency.  
 
There is some evidence that patients with PAD do not undertake the same level of 
exercise as older adults without PAD. McDermott et al (2002) used accelerometers 
over 7 days to compare the two groups, and found that participants with PAD had 
significantly lower physical activity levels (Mean = 783.8kcal/day, SD=426.2) than 
those without PAD (Mean =1109.0kcal/day, SD =640.1). Gardner, Montgomery, Scott, 
Afaq & Blevins (2007) compared daily walking activity between participants with and 
without IC, and found that participants with IC took significantly fewer daily strides (IC 
= 3149 strides/day +/- 1556; no IC = 4230 strides/day +/- 1708), spent significantly less 
time walking (IC=264 mins, SD=109; no IC=312 mins, SD=96), and took significantly 
fewer strides at a moderate and high pace than age and sex matched participants 
without IC. Two previous studies have measured the walking behaviour of patients 
with IC by waist-mounted pedometer, Nasr, McCarthy, Walker & Horrocks (2002) 
found that patients with IC walked a median of 5728 steps/day (interquartile range 
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4037-7956); Crowther et al (2007) found patients with IC walked a mean 4156.1 
steps/day (SD=572.6). Tudor-Locke, Washington & Harte (2009) compared the median 
steps/day measured by waist-mounted pedometer, for patients with a range of 
chronic illnesses. The median steps/day for patients with IC, based on the Nasr et al 
(2002) and Crowther et al (2007) studies is 4942.05 steps/day. This is a greater 
number of daily steps than that found for patients with chronic obstructive lung 
disease (median = 2237 steps/day), patients receiving dialysis (median = 3448 
steps/day), and patients with arthritis (median = 4086 steps/day) and is similar to the 
daily walking activity of patients who have received a joint replacement (median = 
4892 steps/day) (Tudor-Locke et al, 2009). However, in a review of several studies 
measuring daily walking activity by waist-mounted pedometer, Tudor-Locke & Myers 
(2001) found that healthy older adults walk between 6,000 and 8,500 steps/day, 
indicating that patients with IC generally walk less than healthy older adults.         
 
Galea & Bray (2006) used the Theory of Planned Behaviour (TPB) to model walking 
behaviour in patients with IC, and found that while attitudes, subjective norms and 
perceived behavioural control explained 67% of the variance in intention to walk for 
half an hour, three times a week, there was no correlation between walking intentions 
and walking behaviour. This indicates that there may be other factors which over-ride 
intention and influence walking behaviour in patients with IC. Investigation of beliefs 
about walking and beliefs about the disease may shed light on modifiable constructs 
which could be targeted in an intervention to increase walking in patients with PAD.      
 
CHAPTER ONE 
 
20 
 
Endovascular and vascular intervention 
Both endovascular and vascular intervention can be performed to improve the 
symptoms of PAD. Endovascular intervention involves the use of balloon angioplasty 
and stent implantation to improve blood flow. These procedures are minimally 
invasive, and involve a balloon tipped catheter being inserted into the artery and 
guided to the narrowing, the balloon is then inflated to open the artery, and in the 
case of stenting, a small tube is placed into the artery to hold it open. Success of 
endovascular intervention depends on both the size and location of the narrowing of 
the artery, and on the number of lesions in the artery (Norgren et al, 2007). In a 
review of the success of angioplasty procedures, Wilson, Gelfand, Jimenez & Gordon 
(2006) found primary patency (lack of obstruction) rates of 71.1% for angioplasty plus 
stenting, and 58.3% for angioplasty alone. This means that a considerable number of 
patients who receive angioplasty will need to receive repeat treatments, to treat re-
obstruction of the artery, which increases risk for the patient, and costs for the health 
service.  
 
While endovascular intervention has been found to improve symptoms of PAD in the 
short term, it does not reduce cardiovascular risk, and studies have failed to show a 
significant long-term benefit of angioplasty over exercise training for patients with IC 
(e.g. Perkins, Collin, Creasy, Fletcher & Morris, 1996; Whyman et al, 1997). Only two 
studies have been carried out comparing the long-term outcomes of angioplasty and 
exercise for patients with IC. In Oxford, Creasy, McMillan, F;etcher, Collin & Morris 
(1990) randomly assigned patients to receive either angioplasty, or to attend a 
supervised exercise programme for 6 months. There was a significant increase in 
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distance to claudication and a non-significant increase in maximal walking distance in 
the angioplasty group at 3 months, but then a decline to just above baseline measure 
at 6, 9 and 12 months. In contrast, distance to claudication and maximal walking 
distance increased steadily at each time point in the exercise group, with significant 
increases at 6, 9, 12 and 15 months. In a six year follow-up of this study, Perkins et al 
(1996) found that distance to claudication, and maximum walking distance were 
significantly longer in the exercise therapy group than in the angioplasty group. In 
Edinburgh, Whyman et al (1996) found an initial advantage at 6 month follow-up of 
angioplasty over advice to exercise in terms of distance to claudication, maximum 
walking distance, ABPI and pain rating. However, this advantage was lost at 2 year 
follow-up, with no significant difference between the two groups on any of the 
outcome measures, representing a worsening of scores in the angioplasty group over 
time, and an improvement over time in the advice to exercise group. More recent 
research has compared supervised exercise therapy alone, and angioplasty alone, with 
a combined treatment of exercise and angioplasty and found significant improvement 
in claudication distance and maximal walking distance at 3 month follow-up in each of 
the three groups, with best outcomes in the combined therapy group (Mazari et al, 
2010). The authors concluded that a supervised exercise programme should be the 
primary treatment for patients with IC, due to lower costs and lower risk to the 
patient. However, as noted, supervised exercise programmes are not readily available 
in the NHS and may not change walking behaviour in the long-term. 
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Quality of life has been found to improve following angioplasty. Spronk et al (2005) 
reviewed quality of life after angioplasty for patients with IC and found a significant 
improvement in the physical role functioning and general health domains of the SF-36.  
 
SIGN (2006, p.18) guidelines state ‘endovascular and surgical intervention are not 
recommended for the majority of patients with intermittent claudication.’ However, 
rates of angioplasty to treat the symptoms of claudication have dramatically increased 
in recent years as angioplasty has become more widely available (Vogel, Su, Symons & 
Flum, 2007). 
 
Vascular surgical intervention tends to be considered for patients with IC when the 
patient experiences severe disability, or when the patient has a narrowing which is not 
suitable for angioplasty. Surgical intervention for IC involves either bypass surgery, the 
insertion of a healthy blood vessel to bypass the narrowed artery; or endarterectomy, 
removal of plaque from the diseased artery. Surgery is a more invasive option for 
symptom management than either exercise therapy or angioplasty, carrying a greater 
risk of serious complication (Campbell & Birchley, 2010). However, Campbell & 
Birchley (2010) argue that surgery is the only treatment option which can restore 
walking ability to normal levels in patients with PAD. Although surgery can be used to 
treat patients with IC, it is more commonly used in treatment of patients with more 
severe PAD (critical limb ischemia).  
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Psychosocial factors and PAD 
A small number of qualitative studies have investigated patient and family experiences 
of coping with PAD. Crosby, Ventura, Frainier & Wu (1993) asked 115 patients with 
PAD open-ended questions about their concerns about the disease. The majority of 
concerns related to leg pain, being unable to walk, and fears about having a foot or leg 
amputated. Only 2 participants stated a concern about a general deterioration in their 
health. This highlights that patients with PAD may have erroneous beliefs about the 
consequences of PAD, seeing amputation as a more likely consequence of PAD than 
the risk to their general health. This lack of understanding of the consequences of PAD 
has also been identified in a qualitative study by Leavitt (1990), who interviewed 
patients with PAD who had received vascular surgery and their family members. 
Leavitt (1990) found that family members and the patients themselves had insufficient 
knowledge of the disease, of the serious consequences of the disease, or of the 
importance of lifestyle change. Treat-Jacobsen et al (2002) interviewed 38 PAD 
patients with a wide range of disease severity and found a poor understanding of the 
causes of PAD, and a poor understanding of which behaviours to change to improve 
health, or of how to make the changes. Treat-Jacobsen et al (2002) noted some 
participants had a feeling of lack of control over the progression of PAD, and found 
that those participants with a greater sense of control tended to also be the 
participants who knew more about the disease. Gibson & Kenrick (1998) interviewed 
patients who had received surgery for PAD and found that patients were unclear 
about the causes of PAD, tending to attribute disease to external causes or to chance, 
rather than seeing the disease as having been caused primarily by their own 
behaviour. 
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Leavitt (1990) found that patients with PAD and their families tended to think of PAD 
as an acute rather than chronic condition, and believed that surgery could repair or 
cure the disease. Gibson & Kenrick (1998) also noted this belief by PAD patients that 
surgery is a cure for PAD, with patients viewing PAD as an acute illness. Leavitt (1990) 
hypothesised that this belief that PAD was curable led to patients not taking 
responsibility to change lifestyle factors to limit disease progression. 
 
A number of these qualitative studies have also highlighted the emotional burden of 
having PAD, with patients describing loss of independence (Treat-Jacobsen et al, 2002; 
Wann-Hansson, Hallberg, Klevsgard & Andersson, 2005), loss of identity and 
limitations in social functioning (Treat-Jacobsen et al, 2002) leading to feelings of 
social isolation (Treat-Jacobsen et al, 2002; Wann-Hansson et al, 2005; Gibson & 
Kenrick, 1998). Patients described feelings of powerlessness in relation to how they 
could affect the course of the illness (Wann-Hansson et al, 2005; Gibson & Kenrick, 
1998), and had unrealistic expectations about treatment (Leavitt, 1990; Gibson & 
Kenrick, 1998). Instead of actively changing health behaviours to reduce the impact of 
the illness on their lives, patients described maladaptive coping strategies of 
reorientation – reducing physical activities, walking distance and walking speed; or 
resignation – giving up physical activities (Treat-Jacobsen et al, 2002; Wann-Hansson 
et al, 2005; Gibson & Kenrick, 1998). 
 
There are some methodological limitations with these studies which mean the results 
are not necessarily generalisable, for example, small sample size (Gibson & Kenrick, 
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1998), patients with different levels of severity of PAD included in the study as a 
homogenous group (Gibson & Kenrick, 1998; Wann-Hansson et al, 2005; Crosby et al, 
1993; Leavitt, 1990; Treat-Jacobsen et al, 2002), and patients at different stages of 
treatment included in the study as a homogenous group (Treat-Jacobsen et al, 2002; 
Crosby et al, 1993). 
 
That said, these qualitative studies have raised issues about PAD patients’ erroneous 
beliefs about the causes of the disease, the consequences of the disease, whether the 
disease is acute or chronic, and whether the disease is curable or controllable, which 
may be related to how patients cope with their illness, and whether they choose to 
change their health behaviours. These illness beliefs are considered in Leventhal, 
Leventhal & Contrada’s (1998) Common-sense Model of Self-regulation of Health and 
Illness which focuses on mechanisms underlying how patients make decisions about 
how to self-manage their health.   
 
Common-sense model of self-regulation of health and illness 
Leventhal et al’s (1998) Common-sense model of self-regulation of health and illness 
(CSM) is a three stage perceptual-cognitive model which proposes that when 
individuals experience a health threat or illness (perceptual stage) their subsequent 
coping behaviour (response stage) is influenced by their cognitive and emotional 
representations of the illness, their cognitive representation of their coping actions, 
and their representation of themselves. This process is dynamic, with the individual 
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evaluating (appraisal stage) how their actions affect their goals, and adjusting their 
representations and coping actions in light of changes in physiological signals. 
 
Representations are common-sense definitions or schemas which the individual 
develops through past experience and through social interaction, and which function 
at both a concrete (symptom based) and abstract (disease label) level (Leventhal et al, 
1998).  
 
Illness representations are thought to contain information about the identity of the 
illness, both in terms of the label of the illness, and its symptoms; the temporal 
features of the illness, both subjective and objective; the imagined and real 
consequences of the illness; the causes of the illness; and beliefs about whether the 
illness can be cured or controlled (Leventhal et al, 1998). The model proposes that the 
content of these representations determines the cognitive and behavioural actions 
which the individual will take to cope with the illness and also the goals which the 
individual is trying to achieve.  
 
Leventhal et al (1998) argue that the bi-level nature of illness representations can lead 
to the individual making poor decisions about treatment efficacy. For example, in the 
case of IC (symptom) and PAD (illness label), claudication pain is a relatively poor 
indicator of the extent of the underlying atherosclerotic disease, and treating the 
symptom will not treat the disease, however, many patients believe they have an 
acute illness that can be treated by surgery (Leavitt, 1990; Gibson & Kenrick, 1998). 
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Leventhal, Breland, Mora & Leventhal (2010) propose that representations of coping 
actions or treatments will also influence the self-regulation process and can be 
characterised using the same framework as illness representations. Actions have an 
identity (e.g. the name of the action), time lines (e.g. the length of time the behaviour 
will take to achieve the goal, and when and for how long the behaviour has to be 
carried out), consequences (e.g. outcome expectations about the consequences of the 
behaviour; judgement about the risk of performing the action), causes (e.g. the 
mechanism by which the coping action will work) and control (e.g. whether the action 
will cure or control symptoms or the underlying disease; the individual’s beliefs about 
their ability to carry out the behaviour).  
 
Horne & Weinman (2002) studied the role of illness representations and treatment 
beliefs in adherence to asthma medication, and found that illness representations 
influenced adherence both directly, and indirectly, via treatment beliefs. The Beliefs 
About Medicines Questionnaire (BMQ) (Horne, Hankins & Weinman, 1999) was 
developed to assess treatment beliefs – specifically beliefs about the necessity of 
medication, and concerns about taking medication. The BMQ contains items which 
can be classified within the five illness representation labels e.g. ‘My medicines are a 
mystery to me’ could be classified as a treatment representation about how taking 
medication works to treat illness (causal mechanism); ‘My medicines protect me from 
becoming worse’ could be classified as a control treatment representation.   
 
The CSM has been widely used to understand how individuals think about illness and 
how this relates to coping behaviour across a wide range of chronic diseases including 
CHAPTER ONE 
 
28 
 
myocardial infarction (e.g. Weinman, Petrie, Sharpe & Walker, 2000), chronic fatigue 
syndrome (Moss-Morris, Petrie & Weinman, 1996), rheumatoid arthritis, chronic 
obstructive pulmonary disease and psoriasis (Scharloo et al, 1998). Petrie, Weinman, 
Sharpe & Buckley (1996) found that behaviour after myocardial infarction in terms of 
attendance at rehabilitation clinic, return to work and disability was significantly 
predicted by the content of illness representations. In a later randomised controlled 
trial, Petrie, Cameron, Ellis, Buick & Weinman (2002) tested an intervention to modify 
illness representations and found significant, positive changes in illness 
representations in the intervention group, and an impact on behaviour in relation to 
significantly faster return to work rate in the intervention group than the control 
group. 
 
Leventhal et al (2010) argues that for an intervention to change health behaviour 
based on the CSM to be successful, the interventionist must understand the patient’s 
treatment representations, their illness representations and the coherence of the 
treatment representations with the illness representation, in terms of the patient’s 
understanding of the causal link between their representation of the illness and their 
representation of how the treatment will cure or control the illness. 
 
Other models from health psychology have been used to understand walking 
behaviour in patients with IC, for example Pochstein & Wegner (2010) used Schwarzer 
et al’s (2003) Health Action Process Approach (HAPA), and Galea & Bray (2006) used 
Ajzen’s (1985) Theory of Planned Behaviour (TPB) to explore psychological 
determinants of walking behaviour in people with IC. However, Galea & Bray (2006) 
CHAPTER ONE 
 
29 
 
found that while attitudes, subjective norms and perceived behavioural control 
explained 67% of the variance in intention to walk; intention and perceived 
behavioural control only explained 8% of the variance in walking behaviour, and 
intention made no significant contribution to the model of walking behaviour in 
patients with IC. Galea & Bray (2006) suggest that the pain experienced when walking 
may over-ride good intentions to walk, indicating that the TPB may not take enough 
factors into account to determine walking behaviour in this particular population. 
Further, Armitage & Conner (2000) argue that motivational models, of which the TPB 
is one, do not provide adequate explanation of how intention leads to behaviour. The 
TPB is a static model, designed to predict behaviour at one point in time, and may 
therefore not be the best model to understand the ongoing process of day-to-day 
walking behaviour in patients with IC, where experience of pain on previous days, and 
beliefs about illness and walking may all also influence walking behaviour. 
 
Pochstein & Wegner (2010) used the HAPA to design an intervention to change 
walking in patients with IC. The HAPA is a two-stage model of behaviour change - in 
the motivational stage the individual forms an intention to perform a behaviour; and 
in the volitional stage, the individual turns intention to action through planning 
(Schwarzer et al, 2003). Pochstein & Wegner (2010) found that IC patients with high 
intentions to walk, who received a volitional intervention which involved action and 
coping planning, had a significant increase in walking behaviour over time compared 
to a control group. However, Armitage & Conner (2000) argue that while the HAPA 
provides a useful extension to motivational models of behaviour with the addition of 
the volitional stage, the HAPA is vague about how volitional components change 
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behaviour, and about how volitional components should be measured. Further, 
Leventhal & Mora (2008) argue that the HAPA is a descriptive model useful for 
predicting behaviour, but which does not identify health and illness factors which 
affect behavioural outcomes. Leventhal & Mora (2008) suggest that somatic and 
functional changes are critical factors in the self-regulation of health behaviour, which 
are not accounted for in the HAPA. A dynamic model, like the CSM, which takes 
somatic experience into account in explaining behaviour, may be more appropriate as 
the basis for designing an intervention to change walking in patients with IC. 
   
Summary 
PAD is a relatively common chronic disease in older adults which affects both physical 
and social functioning. PAD is an indication of widespread arterial disease, and people 
with PAD are at increased risk of heart attack and stroke. Behaviour change, both in 
terms of quitting smoking, and increasing walking can have positive effects on future 
health and on symptoms of PAD. However, there is evidence that patients with PAD 
do not tend to change their health behaviours, possibly as a result of their beliefs 
about the illness.  
 
The relationship between beliefs about PAD and subsequent health behaviour will be 
explored in this thesis, within the framework of the CSM.   
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RATIONALE AND GENERAL AIMS 
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Overview 
This chapter outlines the aims and overall structure of this thesis. In order to present 
the aims in context, the population and behaviour targeted by the research, the 
theoretical basis underpinning the research, the scope of this thesis, and the 
framework within which this thesis has been developed will be discussed.  
 
Patient population 
This thesis will focus on patients with Stage II PAD (intermittent claudication). Patients 
with IC are the largest diagnosed group of people with PAD, and for most patients 
with IC, conservative treatment including behavioural risk factor management is the 
recommended first line of treatment. Patients with IC face additional barriers to 
walking compared to other older adults due to walking related pain, and this warrants 
the design of psychological interventions specifically for this patient group.  
 
Behaviour 
Patients with IC are routinely recommended to lose weight, stop smoking and increase 
their exercise (Cassar, 2006). Particular barriers to exercise have been identified for 
patients with PAD (Stewart & Lamont, 2007; Galea et al, 2008). There is evidence that 
patients with IC carry out less daily exercise than older adults without PAD 
(McDermott et al, 2002). However, several studies have demonstrated that increasing 
walking is particularly important in reducing symptoms of IC (e.g. Leng et al, 2000), 
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and may reduce cardiovascular risk (Khan et al, 2005). This thesis will therefore focus 
on walking behaviour of patients with IC. 
 
Theoretical basis 
The findings from several qualitative studies into the experience and behaviour of 
patients with IC (Gibson & Kenrick, 1998; Wann-Hansson et al, 2005; Crosby et al, 
1993; Leavitt, 1990; Treat-Jacobsen et al, 2002) suggest that both beliefs about PAD 
and beliefs about treatment influence the walking behaviour of patients with IC. 
Leventhal et al’s (1998) Common-sense model of self-regulation of health and illness 
(CSM) is a dynamic model which considers both the role of illness representations and 
treatment representations in an individual’s coping actions (see Figure 2.1). The CSM 
focuses on both cognitive and emotional aspects of illness, and therefore provides a 
consideration of how pain and anxiety may influence behaviour.  
 
 
 
 
 
 
 
 
 
Figure 2.1 The Common-sense model of self-regulation of health and illness 
Adapted from Horne (2003) 
Illness representation: 
Identity, Cause, Timeline, 
Control, Consequences 
Health threat 
or symptom  
Treatment representation: 
Identity, Cause, Timeline, 
Control, Consequences 
Emotional response to 
illness/symptom 
Emotional response to 
treatment 
Action Plan 
Action Plan 
Appraisal 
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The CSM is a self-regulatory model, and therefore is built on the underlying 
assumption that individuals, (i) are actively engaged in solving health problems, 
consciously selecting coping actions to deal with health threats, and capable of 
changing their illness and treatment representations in light of new evidence; (ii) that 
any coping actions used to solve a problem will be used in context; and (iii) that 
attention and effort will be expended on the threat which is perceived to be most 
urgent, and are limited by resources available to the individual (Leventhal et al, 1998). 
A critical component of the CSM is the individual’s appraisal of how the effects of 
treatment (in the case of IC this could be walking) relate to the individual’s experience 
and understanding of the disease, and whether treatment brings them closer to their 
goals (Leventhal et al, 2010).  
 
The CSM differs from social-cognition models of health behaviour change such as the 
Health Belief Model (Rosenstock, 1974), Protection-Motivation Theory (Rogers, 1983) 
and the Theory of Planned Behaviour (Ajzen, 1985), because it is a dynamic model, 
which allows for beliefs and behaviour to change within the self-regulatory 
framework. Social-cognition models tend to treat behaviour change as a static event 
focusing on the decision or commitment to change behaviour rather than on the long-
term process of behaviour change (de Ridder & de Wit, 2006). In social cognition 
models, the motivation or intention to perform a behaviour change is viewed as being 
sufficient to predict successful behaviour change, and most models fail to consider 
either the difference between intention to change behaviour and real behaviour 
change, or the factors which may be associated with maintaining changed behaviour. 
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Unlike social cognition models, the CSM focuses on setting both immediate and longer 
term goals (Leventhal & Mora, 2008), and how both the cognitive and the emotional 
aspects of illness influence behaviour towards achieving those goals (Leventhal, 
Weinman, Leventhal & Phillips, 2008).  
 
Leventhal et al’s (1998) CSM therefore provides the underlying theoretical framework 
for this thesis. 
 
Scope of the thesis 
Little work has been conducted into IC from a psychological perspective. Most studies 
into IC to date have focused on either prevalence of PAD, suitable medical or surgical 
treatment of stages of the disease, or have been small-sample qualitative studies of 
the experience of living with PAD, with small and heterogeneous samples. Therefore, 
this thesis will explore psychological factors associated with walking behaviour in 
patients with IC (Chapters 3 & 5), and will include a pilot brief psychological 
intervention to modify these psychological factors to increase walking (Chapter 6). 
Because this thesis includes an intervention, the MRC framework for developing and 
evaluating complex interventions (Craig et al, 2008) will be used as a guide to the 
structure of this thesis.   
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MRC framework for developing and evaluating complex interventions 
The MRC has recently published new guidance on developing and evaluating complex 
interventions in order to guide the choice of appropriate methods in health research 
(Craig et al, 2008). The guidance focuses on methodological design to identify whether 
interventions are effective and how the intervention works. The framework suggests 
that the development of a complex intervention should involve a number of phases 
(see Figure 2.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 MRC Framework – Key phases of the development and evaluation process 
(Craig et al, 2008) 
 
A complex intervention is one which has several interacting components. The CSM 
proposes that illness representations, treatment representations, and emotional 
representations interact to influence coping actions, therefore an intervention to 
change behaviour using the CSM as a theoretical base, would be a complex 
Feasibility/piloting 
1. Testing procedures 
2. Estimating 
recruitment/retention 
3. Determining sample size 
Implementation 
1. Dissemination 
2. Surveillance and monitoring 
3. Long term follow-up 
Evaluation 
1. Assessing effectiveness 
2. Understanding change process 
3. Assessing cost effectiveness 
Development 
1. 1. Identifying the evidence base 
2. 2. Identifying/developing theory 
3. 3. Modelling process and outcomes 
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intervention. This thesis will carry out the steps in the Development and 
Feasibility/Piloting phases of the MRC Framework to design an intervention to change 
walking behaviour in patients with IC.  
 
 
General aims    
The overarching aim of this thesis is to identify modifiable psychological constructs 
which play a part in influencing the walking behaviour of patients with IC. To this end, 
an initial, exploratory study was carried out to understand the walking behaviour of 
patients with IC, and their illness and treatment representations (Chapter 3). Bowling 
(2002) notes that qualitative research can be used inductively to develop and refine 
hypotheses. As little research has been conducted into psychological factors 
associated with walking in patient with IC, qualitative methods have been used in 
Chapter 3. 
 
Chapter 4 describes the design of the measures used in the subsequent two empirical 
chapters, along with the process followed to design the brief psychological 
intervention. 
 
Chapter 5 describes a cross-sectional study designed to model key psychological 
constructs with walking behaviour in a cohort of IC patients. These psychological 
constructs were identified in the qualitative study (Chapter 3) and appropriate 
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measures were chosen and designed (Chapter 4) to test these constructs within a 
larger, representative sample of patients with IC. 
 
Chapter 6 presents the results from the pilot intervention to modify illness and 
treatment representations in order to change walking behaviour in a sample of 
patients newly diagnosed with IC. The results of this study will enable the process and 
outcomes of the pilot behaviour change intervention to be modelled, which will 
provide information for the Evaluation and Implementation phases of future work to 
increase walking in patients with IC.  
Summary 
This thesis presents a series of studies, based on the Development and 
Feasibility/Piloting phases of the MRC Framework (marked in Bold in Figure 2.2), 
which aim to identify and modify psychological constructs which influence walking 
behaviour in patients with IC. 
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PSYCHOLOGICAL FACTORS ASSOCIATED WITH WALKING IN 
PATIENTS WITH INTERMITTENT CLAUDICATION – A 
QUALITATIVE STUDY 
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Abstract 
Background: 
Patients with intermittent claudication (IC) are recommended to increase their 
walking levels, as walking has been found to reduce symptoms of claudication, and 
may improve overall cardiovascular health. The Common Sense Model (CSM, 
Leventhal et al, 1998) proposes that behaviour will be influenced by the patient’s 
illness and treatment representations. However, little is known about the illness or 
treatment representations, or the walking behaviour of patients with IC. 
Method: 
Semi-structured interviews were conducted with 20 participants who had previously 
received a vascular intervention for IC. Transcripts were analysed using a Framework 
Approach. Interviews explored participants’ illness and treatment representations, 
based on the CSM, and their health behaviour. 
Results: 
Participants described a high level of symptoms in their legs, despite having received 
vascular intervention. They viewed their illness as an acute condition, and controlled 
symptoms by avoiding walking and slowing their pace. Participants were to some 
extent unaware of the causes of the disease, and were unaware of their increased risk 
of future cardiovascular health problems.  
Conclusion: 
The findings highlight that patients with IC have dysfunctional representations about 
their illness and about walking, which may influence their behaviour. These 
representations could be addressed in a psychological intervention to increase walking 
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behaviour in patients with IC.
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Introduction 
As outlined in Chapter 2, this thesis focuses on psychological factors associated with 
walking in patients with IC, and is based within the framework of the CSM. No 
research has previously been conducted to study the illness or treatment 
representations of patients with IC, and little is known about their walking behaviour. 
 
In NHS Forth Valley, the NHS board where the research for this thesis was conducted, 
the majority (approximately 56%) of patients receive either angioplasty or surgery, 
usually within 6 months of diagnosis with IC. Surgery and angioplasty are performed 
for symptom management and aim to improve quality of life, but do not reduce the 
risk of future cardiovascular events due to atherosclerosis. The decision about what 
kind of treatment to offer is made by the Vascular Consultant after reviewing 
ultrasound charts of the artery, and is based on the size and location of the narrowing 
of the artery, and the general health of the patient. In NHS Forth Valley, patients with 
IC are advised to ‘stop smoking and start walking’, however detailed advice is not 
routinely given to patients about the recommended intensity or frequency of walking, 
or about the benefits of walking to IC or to general health. Patients who receive 
angioplasty or surgery are reviewed periodically in outpatient clinics following their 
surgery, however the focus of the clinics is on checking that the wound has healed and 
that the blood pressure in the affected leg has increased, rather than on the patient’s 
walking behaviour, or on how IC affects their life. In a qualitative study of PAD patient-
physician communication, Collins et al (2006) found that patient-physician 
communication about exercise was an important factor in whether or not patients 
with PAD exercised, and that it was common for patients to feel they did not 
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understand the disease, or the benefits of walking to the disease, due to poor patient-
physician communication.  
 
Two qualitative studies have explored the effect of PAD on life after vascular 
intervention. Wann-Hansson, Hallberg, Klevsgard & Andersson (2008) interviewed 
fourteen patients with PAD, 6 months and 2.5 years after revascularisation, about 
their long-term experiences of living with PAD. These interviews revealed that while 
patients experienced less pain, and were able to sleep better after revascularisation, 
they still experienced symptoms of PAD, struggled to come to terms with the fact that 
they had a chronic disease, and had slowed down and changed their behaviour to 
cope with the restrictions in their daily lives. Wann-Hansson et al (2008) concluded 
that providing information and education to patients with PAD could increase 
knowledge about PAD, promote self-management and prevent unhealthy behaviour 
choices. Gibson & Kenrick (1998) interviewed nine patients who had received bypass 
surgery within the previous 18 months. They found that patients had unrealistic 
expectations of surgery, and thought of themselves as having an acute illness which 
could be cured with surgery. Gibson & Kenrick (1998) also found that participants had 
adapted to their illness by slowing down and restricting their activities, and concluded 
that further research was needed to investigate the potential for patients with PAD to 
become more involved in self-managed care activities. 
 
These studies have highlighted that patients with PAD still have leg symptoms and 
restricted activity after revascularisation, and that in coping with these restrictions 
choose to slow down and reduce activity levels. While slowing down and reducing 
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activity levels helps the patient to experience less leg pain symptoms, the opposite 
behaviour, increasing speed and activity levels, is recommended for patients with IC – 
both to reduce symptoms and to improve cardiovascular health.  
 
Although interesting, these studies involved relatively small heterogeneous samples of 
patients with both IC and critical limb ischemia, which means conclusions drawn from 
these studies about the experience and behaviours of patients with PAD may not be 
generalisable. In addition, the focus of the studies was on the experience of life after 
revascularisation, not on health behaviour or on psychological factors which might 
influence health behaviour.  
 
Patients’ beliefs about IC and its treatment are likely to vary according to their stage in 
the overall process from diagnosis to post-treatment, therefore it is important to 
recruit a homogeneous group of patients into the present study, who are all at a 
similar point in the treatment of IC. In NHS Forth Valley, patients are diagnosed with IC 
by a Vascular Assessment Nurse, and are then seen at an outpatient clinic by a 
Vascular Surgeon who agrees treatment with the patient, and places the patient on a 
waiting list. This study focuses on patients who have already received either 
angioplasty or surgery to treat IC, because the majority of patients diagnosed with IC 
in NHS Forth Valley go on to receive vascular intervention fairly quickly after diagnosis. 
The rate of patients being diagnosed with IC in NHS Forth Valley is around 2 patients 
per week, therefore a pragmatic decision was made to recruit patients after, rather 
than before vascular intervention to meet the overall time constraints of the PhD. An 
added benefit of recruiting patients after revascularisation is that they are able to take 
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a long-term view of their illness and treatment, and how their behaviour and beliefs 
have changed over time.  
 
 The main objective of this study is therefore to explore the health behaviours and 
illness and treatment representations of patients with IC after they have received 
vascular intervention. 
     
Research Questions 
This study is exploratory, in that little is known about the illness beliefs or health 
behaviours of patients with IC. The research questions are therefore: 
1. What are the illness representations of patients with IC? 
2. What are the treatment representations of patients with IC? 
3. What is the health behaviour of patients with IC? 
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Method 
Design 
A qualitative approach was taken to exploring these research questions, in order to 
gain a deep understanding of the cognitive representations of patients with IC. Semi-
structured, one to one interviews were conducted with participants in their own 
homes. Interview transcripts were analysed using Framework Analysis based on initial 
themes taken from the CSM. 
 
Participants 
20 consecutive patients who met the study inclusion criteria were recruited from NHS 
Forth Valley Vascular Outpatient Clinics. Inclusion criteria included a diagnosis of IC, 
and revascularisation surgery or angioplasty between 6 months and 2 years previous 
to recruitment. Potential participants were excluded from the study if they were 
unable to speak English, had a psychiatric illness or were known to be taking part in 
other studies. 25 patients who met the inclusion criteria were invited to participate in 
the study, of these, 3 patients did not want to participate, and 2 patients failed to 
attend the scheduled interviews. The remaining 20 patients took part in the study. 
Sample size was determined by data saturation, recruitment ended when no new 
themes emerged from the interviews, and information gathered confirmed themes 
already identified from previous interviews. 
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Participants were aged between 58 and 81 years with a mean age of 70.9 years 
(SD=6.6). All except one of the participants were retired. Eleven males and 9 females 
participated in the study. Five participants were current smokers, 3 had never smoked, 
and 12 had given up smoking (range 3 months to 35 years since quitting), the mean 
time since quitting was 9 years (sd = 10 years). Demographic characteristics of the 
participants in this study are shown in Table 3.1. 
 
Table 3.1   Demographic characteristics of the participants (n=20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Procedure 
Participants were recruited from the Vascular Outpatient Clinic at Stirling Royal 
Infirmary, NHS Forth Valley. Consecutive patients attending the clinic for review of 
their IC following angioplasty or bypass surgery were approached by the researcher 
(MC). Patients were given a Participant Information Sheet and a brief verbal 
description of the study, and were then asked if they would be willing to receive a 
Demographics n % 
Living Arrangements  
Living alone   12 60 
Living with relative  8 40 
Risk factors 
Diabetes 5 25 
Smoker 
Yes  5 25 
Never  3 15 
Given Up  12 60 
Co morbidities  
Heart Disease  9 45 
Stroke   3 15 
Vascular Interventions  
Bypass graft   12 60 
Angioplasty  8 40 
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telephone call in two days to confirm whether they would participate in the study. No 
patients refused to consider taking part in the study, or to give the researcher their 
phone number. Of the 25 patients who were called, 3 declined to take part in the 
study at that point; reasons given were because they felt they had nothing to say 
(n=2), and there had been a death in the family (n=1). The remaining 22 patients 
agreed to participate in the study, and a suitable time was agreed for the researcher 
to interview the participants in their own home. Of the 22 interviews which were 
scheduled, 2 participants failed to answer their door when the researcher arrived at 
their house, therefore 20 interviews were conducted. 
  
Consent was taken prior to the interview commencing. All interviews were taped. The 
interviews were semi-structured, with the researcher having some set questions 
which were always asked (see Table 3.2), to ensure areas of interest were covered in 
the interview. The opening question was “I understand you have been having 
circulation problems. Can you tell me all about what has happened with your legs?” 
Probing questions were used to explore participants’ behaviour and beliefs about their 
health. Interviews lasted from forty-five minutes to two hours. The researcher ended 
the interview by undertaking to send participants a summary of key findings once 
analysis was completed, and asking participants to review this and give feedback on 
the analysis. All interviews were transcribed verbatim and their accuracy checked 
against the original tapes. 
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Table 3.2  Set questions asked in each interview 
 
Analysis 
The interview transcripts were analysed using framework analysis (Ritchie & Spencer, 
1994), concurrent with data collection. Framework analysis is both a deductive and 
inductive form of thematic analysis, in that initial themes are pre-set based on the 
research questions, and further themes develop from the interviews with participants 
(Rabiee, 2004).  This approach was used as the research questions in this study 
specified particular themes which were being sought in the interviews e.g. the illness 
representations and treatment representations of patients with IC. Framework 
Analysis provides systematic and visible stages to the analysis process. The key stages 
of Framework Analysis are as follows (Pope, Ziebland & Mays, 2000): 
 Familiarisation – with the data e.g. by listening to audio tapes of the interviews 
and re-reading transcripts; 
 Identification of a Thematic Framework – both deductively and inductively, by 
identifying a-priori themes from the research questions, and recurring themes 
which emerge from the data, and creating an index of themes; 
 Indexing – applying the thematic framework systematically to all the 
interviews, identifying and labelling all instances of each theme; 
What are your current symptoms? 
What do you think caused your current condition? 
What do you think will happen to your health in the future? 
Have you changed any of your health behaviours since the operation? 
How do you control your condition? 
How has your life been influenced by having intermittent claudication? 
Can you tell me about the treatment you’ve had for intermittent claudication? 
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 Charting – rearranging the data to create a chart of each theme, with 
summaries of the views and experiences of participants under each theme 
heading; 
 Mapping and Interpretation – using the charts to describe the themes, and find 
associations between themes to explain the findings. This step is influenced by 
the research questions and the themes which have emerged from the 
interviews. 
 
The thematic framework used in this study was initially based on illness and treatment 
representations and health behaviour. However, other issues emerged during the 
‘familiarisation’ and ‘identification of a thematic framework’ stages which were 
incorporated into the thematic framework. Therefore, the thematic framework was 
developed and refined on an ongoing basis as more data was collected. 
 
Indexing was carried out by applying the thematic framework to the data - this was 
done manually by going through each transcript and highlighting sections of text 
relevant to each theme. The data was then charted by theme. The mapping and 
interpretation stage of analysis was guided by Rabiee’s (2004) criteria for interpreting 
coded data, namely considering the words used and their meaning, the context of 
comments made by participants, the frequency and extensiveness of comments, the 
intensity of comments, checking internal consistency of comments between 
participants, and considering the specificity of responses. 
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Reliability and validity 
A number of strategies have been outlined to increase the rigour of qualitative 
healthcare research, in order to ensure that the findings drawn from qualitative 
research are valid and relevant (e.g. Mays & Pope, 2000; Long & Johnson, 2000). 
These strategies, and a description of how they have been incorporated into the 
design of the current study, are outlined below: 
 Respondent validation or member checking – the participants were given a 
summary of the findings of the study, and asked to comment on the 
summary. 
 Clear exposition of methods of data collection and analysis – the framework 
approach to data analysis was used in this study. The steps taken in the 
analysis process have been documented, and quotations from participants 
are given in the Results section of this study to illustrate how interpretation 
is supported by raw data. 
 Reflexivity – reflection on the impact of the researcher’s own beliefs and 
experience on the research process is considered to be an important part of 
qualitative research (Long & Johnson, 2000). The researcher (MC) was 32 at 
the time the interviews were conducted, and is a psychology doctoral 
student with no previous experience of working with people with IC. The 
researcher’s ideological perspective is of a biopsychosocial model of health 
i.e. that health and illness should be considered in terms of biological, 
psychological and social factors. Although the ‘distance’ (Mays & Pope, 2000) 
between the researcher and participants was quite large in terms of age and 
educational qualifications, there were other factors which reduced the 
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distance between the researcher and the participants, including, the 
researcher is Scottish and lives locally and so could discuss local issues with 
participants, the researcher is a similar age to the children of participants, 
and the researcher has children of a similar age to the grandchildren of 
participants, enabling social discussion on areas of common ground. 
  Peer debriefing – Long & Johnson (2000) suggest that presenting methods 
and findings at national research conferences increases credibility of the 
research because it opens the design and analysis of the research to criticism 
from other researchers, and allows an evaluation of the relevance of the 
study by people who are knowledgeable in the field. This study has been 
presented at the East of Scotland Vascular Research Day (2008), the British 
Psychological Society Division of Health Psychology Annual Conference 
(2009) and the Vascular Society Annual Meeting (2009). 
 Inter-rater reliability/peer debriefing – Long & Johnson (2000) suggest that 
involving knowledgeable colleagues in key parts of the analysis process 
enables the consideration of other points of view and provides a check on 
premature ending of the data collection or analysis phases of the study. In 
this study, Maggie Cunningham typed up the transcripts and carried out the 
initial framework analysis. A Vascular Consultant and a Vascular Assessment 
Nurse were given copies of the transcripts and the thematic framework and 
asked to independently review the transcripts and check (i) if they agreed 
with the coding of the themes and (ii) if they could identify other themes 
from a clinical perspective which they felt might be important to the 
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analysis. Discussion of the transcripts with RH and VS then fed back into the 
interpretation stage of the analysis.  
 
Ethics 
Fife and Forth Valley Research Ethics Committee approved this study. The letter of 
invitation, participant information sheet and consent form are included in Appendix 1. 
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Results 
Table 3.3 sets out the a-priori themes which were sought in the data based on the 
research questions, and other themes which emerged during the analysis process. 
 
Table 3.3  Final themes 
 Theme Summary of theme 
A Priori Themes Identity Current symptoms that patient sees as being 
part of their illness 
 Cause Things the patient attributes to causing the 
illness 
 Timeline Length of time the patient believes the illness 
will last 
 Consequences Patient’s beliefs about the severity of the 
condition, and the consequences the illness has 
on the patient’s life. Including: 
- Sense of loss 
- Concerns about future health 
 Cure/Control What the patient believes can be done or has 
been done to improve the illness. 
 Health behaviour Past, current and intended behaviour 
 Treatment Including: 
- Beliefs about vascular treatment 
- Beliefs about walking 
- Confidence in walking 
Emergent Themes Doctor Patient 
Communication 
Patient’s account of interaction with health 
service / patient’s understanding of the illness 
 Coping Including: 
- Adapting to limited mobility 
- Accepting limitations as due to age 
- Making downward comparisons with others 
 
Identity 
All participants reported having current symptoms of IC, although symptoms varied 
greatly in severity. Eight (40%) participants felt that they had the same symptoms as 
they had had prior to revascularisation. Seven (35%) participants felt that the 
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procedure had made a difference and had reduced their symptoms but they still had 
problems with their leg. Five (25%) felt that their leg was much improved, symptoms 
were dramatically reduced and they only had occasional leg pain after walking a long 
distance.  
 
The main symptom of Stage II PAD is intermittent claudication, leg pain which comes 
on while walking and disappears soon after stopping to rest. However, in this study, all 
participants described currently having some or all of the following symptoms - 
swelling in the legs, pain in the scar, tightness, throbbing, numbness, cramps at night, 
problems bending the knee, and pain when kneeling, which they attributed to their 
circulation problems. Participants had not expected to have these symptoms after 
treatment. While some of these symptoms are attributable to PAD, others occur as a 
result of surgery, and this reporting of symptoms indicates unrealistic expectations 
about revascularisation, and lack of knowledge about the consequences of surgery. 
 
Participant 4 Swelling, a lot of swelling, especially in this one… But in my bed, I get 
quite a lot of pain up here where the operation was. 
 
Participant 21 (talking about gardening) I’ve got to come in and sit down. I 
have to. I take a cushion out with me and I kneel down, 
because kneeling is worse. In fact it’s sore, I’ve got to get up 
and sit down. I know how far I can go. 
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Most participants noted that they could only manage a slow pace when walking on 
the flat, and that hills and stairs still caused them problems. However, most 
participants were happy that they could walk around the ground floor of their house 
pain free. 
 
Several participants felt that their legs had lost their power, and that they felt tired 
very quickly when they tried to walk. Almost all participants were limited in how far 
they could walk on the flat. Only 2 participants felt they could walk more than a few 
hundred yards. 
 
Participant 11 I walk very, very slowly... Hills are very, very difficult, even 
now. I can tell you when there’s an incline, where you 
wouldn’t even notice that there’s an incline. It’s not so much 
the cramp, but just, as if my muscles, because I’ve had this 
for so long and I wasn’t using my muscles, my muscles I think 
have wasted a bit. I haven’t the power I used to have. 
 
Participant 18 I was in the forces for 16 year, so I used to be quite fit, you know? But 
now I just feel, I’m getting awful tired easy. I don’t know whether 
that’s something to do with the legs, I should imagine so. 
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Cause 
Participants cited a wide variety of factors which they felt may have caused their PAD. 
The main cause mentioned by participants was smoking, 14 of the 17 (82%) 
participants who either are current or past smokers, mentioned smoking as a possible 
cause of their disease. However, several participants mentioned that they were 
reporting this as a cause because their doctor had said smoking was a cause, but 
indicated through body language and tone of voice that they did not necessarily 
believe this: 
 
Participant 19 It’s cos of this (waves cigarette). Well, that’s what they said anyway. 
 
Participant 14 Well, they say the smoking. I mean, I don’t know. 
 
Several participants said that they had no idea what had caused their disease. Of this 
group, some were or had been smokers, and some were diabetics – therefore they 
had risk factors for the disease but were not aware of this:  
 
Participant 12 I’ve no idea, that’s what I’m saying I just wondered if the metformin 
for the diabetes had anything to do with it, I don’t know. But eh, just 
maybe like an oil change in a car, the older you get it’s maybe needing 
renewed ken, like your blood supply, ken? I don’t know. I don’t know. 
As I say, I thought maybe the medication had something to do with it. 
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Five (25%) participants suggested that the disease may be due to old age. Only three 
(15%) participants mentioned diet as a possible cause of the disease. 
 
Other causes mentioned by participants included Crohn’s disease, a hernia, air travel, 
hard physical work, carrying twins in pregnancy, walking dogs in damp weather, stress, 
standing for long stretches of time, an ‘emotional stroke’ and walking gait. It is 
interesting that several perceived causes included physical activity, as lack of physical 
activity is a risk factor for developing IC.  
 
Participant 22 Right, I had two dogs, three actually, and I used to take them a walk 
every day and every night, I always walked them. So I don’t know 
whether that could have been it, maybe going out in the damp 
weather, I used to go out in all weather, you know? And I don’t know 
whether that caused it, you know? 
 
Later in the interview, this participant went on to describe how he had given up his 
dog because he didn’t feel able to take it for walks due to the leg pain. The 
participant’s model of his illness was logical and coherent (to him) and clearly led to 
his choice of behaviour – non-adherence to walking advice. 
 
Participant 22 I had to give my wee Yorkshire terrier away because I wasnae able to 
take him a walk, and I was breaking my heart, I was breaking my heart. 
And eh, it was beautiful tae, but I had to get rid of it, it was a shame, 
he was always wanting oot, and I couldnae. 
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Timeline 
Participants discussed their illness as acute and treatable, rather than a chronic 
condition, focusing on the symptom (IC) rather than the disease (PAD). Surgery was 
therefore deemed successful if the symptom of IC was relieved, and participants didn’t 
think about the ongoing implications of atherosclerosis to their legs or general health. 
Those participants who still experienced IC symptoms generally viewed the disease as 
something which they hoped could be treated by further surgical interventions, 
although participants accepted that without further surgical intervention they would 
continue to have symptoms - the symptoms would not just disappear or 
spontaneously resolve. 
 
Participant 2 If it’s no going to get any worse, ten year down the line if it was to get 
really bad then I’d say OK lets see what we can do, but it’s no that bad 
at the moment. I mean, I wanted the operation thinking obviously this 
was going to cure it. As it turned out, it’s no, in my case it’s no exactly 
worked. 
 
Some participants were gradually coming to realise that they may always have some 
symptoms, although they had a lack of knowledge and understanding about the 
timeline and likely outcomes of the disease. 
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Participant  9  In fact I was thinking the other day, I must say to my own doctor, is 
this likely to get even worse or what? You know I don’t know what the 
outcome is.  
 
Participant 14 I felt a wee bit disappointed on Monday because I just felt “Well, is 
this me? Am I just going to be stuck with this? Am I going to have to 
say well I’ve walked far enough, I’ll have to rest?” And I don’t feel like 
being an old wifey.  
 
Consequences 
Participants felt that intermittent claudication had an enormous impact on how they 
led their day to day lives, describing at length their experience of loss due to IC. 
Participants missed being able to walk, and felt curtailed and restricted. All 
participants talked about not being able to do the things they wanted to do, and many 
felt trapped and lonely. Loneliness was highlighted by the fact that they couldn’t join 
in normal activities with others, for example at parties, or playing with grandchildren. 
 
Participant 6 Now that I cannae walk, I want to walk. You don’t realize 
how much your legs mean to you, till you cannae use 
them. Then you find oot. 
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Participant 23 You cannae walk so far. I dinnae get out so much. And you’re no 
prepared to go out so much when your legs are like that. I’m stuck 
here. 
 
Despite this restriction in daily activities, participants did not appear to view the long-
term consequences of having PAD as life-threatening. No participants mentioned any 
concern or awareness about their risk of stroke or heart trouble. Concerns for future 
health were around whether or not participants would be offered or would require 
further vascular intervention on their legs. For those who had not been offered further 
vascular intervention, there was concern about what would happen to their mobility 
in the future. Most participants felt that they were dependent on their family to some extent 
for help with transport, shopping and housework. Several participants expressed their fear 
of increased need of care in the future. They felt that they may become a burden to 
their family, and didn’t want to be troublesome or hold their families back. 
 
Participant 18 Well, I’m not getting any younger, I’m 63 year old. I hate to think my 
legs would ever get that bad, and my son, would have to look after 
me, I don’t want that, you know what I mean? Sometimes I think my 
whole life’s went, I cannae walk, I just sit in the house.  
 
Cure/control 
As previously mentioned in the Timeline theme, participants viewed their illness as an 
acute, potentially treatable condition, rather than as a chronic disease. Whether the 
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illness was ‘cured’ or not was seen by participants as being entirely the responsibility 
and under the control of the surgeons. ‘Cure’ was defined by participants as an 
eradication of leg pain symptoms, rather than treatment of atherosclerosis. 
 
Participant 22 So I’m hoping and praying that (the surgeon) will be able to cure me. 
 
Participants tended to control their symptoms by slowing down, and reducing their 
walking. Most participants talked about how they planned excursions from the home, 
thinking about where they would park, and where they could sit down to stop and 
rest. Several participants said that they avoided physical activities and had reduced 
the amount they went out because of their IC. 
 
Participant 25 And you’re just uncomfortable, cos you’re having to sit down in the 
centre (Thistle Centre) in every seat, just like an old wife… I don’t go 
out much at all... As you can see I’m needing to decorate, and I just 
cannae be bothered. I just cannae be bothered. 
 
Participants had come up with a variety of practical aides to help control their 
claudication, for example using a stick to help with balance, having a banister on both 
sides of the stairs to pull themselves up, carrying a walking stick with a seat, rubbing 
cream or olive oil on the legs, putting feet up on a stool when sitting, having a walk-in 
shower, buying a special bed which tilts, and having an electric mobility scooter. 
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Health behaviour 
Most participants said they were aware that they should be trying to exercise, 
because their doctor had told them to. However, they did not have a clear 
understanding of how much walking they should be doing, the recommended 
intensity of walking, or the mechanism by which walking would improve their health. 
Most participants felt they couldn’t exercise because of the pain they experienced 
when walking. As a result of claudication pain, most participants had given up trying to 
exercise. 
 
Participant 1 Again it just comes down to the walking, so you can’t 
exercise as much. I mean even going round the shopping 
centre, you cannae, I mean you’ve jut got to stop and rest. 
 
Several participants mentioned that they had gained weight, or that they felt very 
overweight as a result of not being able to exercise. 
 
Participant 19 I’m no exercising. As I say to my lassies, I’d like to get rid of 
that (shakes tummy). That’s frae sitting here, ken? 
 
Participants were divided over changes to eating habits – half the sample had made 
no changes to their eating habits, half had made some changes, although not 
necessarily as a result of IC. Changes to diet included cutting down sugar and salt 
intake, reducing fat intake, eating anti-cholesterol products and eating more fruit.  
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12 (60%) participants had been smokers but had given up smoking. Of these 
participants, only one had given up as a result of being diagnosed and treated for PAD. 
The other 11 participants who had given up smoking had generally given up due to 
other health events or health scares, for example stroke, heart disease, lung collapse 
and suspected heart problems. In a number of cases, these other health events took 
place after diagnosis with IC. 
 
Most participants talked about looking after their health in terms of their medication 
regime, for example taking statins to lower their cholesterol and taking aspirin to thin 
their blood. When asked whether she had made any changes to her health behaviours 
since being diagnosed with IC, one lady answered: 
 
Participant 21 Not really, no. They keep a watch on my blood pressure. I 
take quinine for my legs. I don’t know if it helps. They say it’s 
supposed to help. And I take an aspirin a day.  
 
Many participants also talked about a heavy use of and reliance on painkillers. 
Participants seemed to feel that taking medication was the way they could contribute 
to improving their health, rather than making dramatic changes to health behaviours. 
This may be linked to their lack of knowledge of risk factors for developing PAD (see 
Causes theme). 
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Treatment 
Only one participant felt that the surgical treatment they had received was not 
worthwhile: 
 
Participant 4 Personally, no really (worthwhile). Then again, I don’t know what like 
it would have been without. 
 
All other participants felt that vascular intervention had been worthwhile, whether it 
had reduced their leg pain symptoms or not. Reasons given for this were because the 
treatment was worth a try, and because the treatment was possibly preventing 
further decline in the legs. However, despite feeling that treatment had been 
worthwhile, several participants mentioned their disappointment with the outcome. 
There was clearly a gap for many participants between their expectations of treatment 
and the outcome – with participants expecting vascular intervention to completely 
eradicate claudication symptoms, and not being aware of potential side-effects of 
surgery like swelling and nerve damage (see Identity theme). This was particularly the 
case for patients who had undergone angioplasty, with many participants noting that 
although it had made a tremendous difference at the time, the effects hadn’t lasted 
long. As one man said of angioplasty: 
 
Participant 5 It worked for a wee while. I was delighted at first. I didnae go out and 
start running on it, but after a couple of days it was brilliant. With 
walking it never came on, I could walk as far as I wanted to and as 
quick as I wanted. It never bothered me. I think it was up till about 6 
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weeks ago… So it lasted quite a while. But I could just feel the calf 
muscles started to get sore. It came on gradually and then it got worse 
very quickly, I thought. I don’t know whether something’s come to 
block the artery or what. 
 
Most participants did not view walking as a treatment for IC, although two 
participants talked about trying to keep walking to help with their circulation: 
 
Participant 9 I don’t stop the minute it gets sore, I keep trying to go, 
because I feel I’ve probably got to try and make it, make the 
blood go through. To be honest I don’t know if that helps 
though. 
 
Participant 5 The only reason I don’t slow down is walking’s supposed to 
be good for it, to try and alleviate it, the blood tries to find 
other ways. 
 
Many participants wanted to be able to walk more, and missed going out 
walking, but felt they couldn’t walk more because of leg pain. Some 
participants had lost confidence in their walking abilities, not trusting their 
balance, or feeling a loss of strength and power in their legs. Participants also 
mentioned avoiding walking into the claudication pain in case the pain was 
an indication of damage to the leg. 
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Participant 2 I’m also a wee bit more careful cos I don’t want to damage 
anything. 
 
Doctor patient communication 
A theme which emerged from the interviews was the communication between 
participants and medical staff during the course of treatment for PAD. A number of 
participants commented that they did not understand the vascular surgeons, and that 
they used complicated, technical language. Some participants felt that they did not 
have much time with the surgeons, and consultations were rushed. These factors 
contributed to make several participants feel that they were unable to question the 
doctors, and that they were not clear why decisions had been made. This was 
especially the case for participants who were suffering claudication pain, but had had 
no further procedures offered - they didn’t understand why. One lady mentioned her 
lack of understanding about surgical decisions several times in the interview - at 
diagnosis: 
 
Participant 9 At that point he said he didn’t think there was really too much they 
could do, where it was or something. He showed me all the x-rays, I 
tried to look intelligent (laughs). I said “oh well, you know, fair 
enough”. 
 
At a follow-up to angioplasty: 
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Participant 9 On Monday when I saw them, I don’t know what tests the sister was 
taking but she wrote them on the end of the bed, and I saw him look 
at one of them, because he was sitting right at the end of the bed, so I 
saw him sort of making a face, so I thought “Oh oh, something’s not 
right.” 
 
And in relation to further vascular intervention: 
 
Participant 9 And in fact, well he doesn’t advise it again, so that’s OK, and 
maybe you don’t do it a second time, I don’t know, but I 
thought well if he suggested it, I was saying to the girls, I said 
“Well if they suggest doing it again, I’d be happy after the 
last time” but then maybe that’s not wise, I don’t know. 
 
Several participants spoke about the lack of information they were given about their 
post-operative health, especially nerve damage and swelling after surgery. 
 
Participant 8 So, after I was out my leg swelled up. I had to go and buy size 10 
slippers cos I couldn’t get my shoes on, they were two sizes too big. 
So, it was painful, I had to wear the slippers for a long, long time, 
weeks and weeks and weeks, and I went to the doctor (GP) and he 
said “You’ve got an infection, you’ll need to take antibiotics” Didnae 
work, I was back 2 or 3 weeks later, I said to him “This leg’s no getting 
any better”, I think this was 12 or 13 or 14 weeks after the operation 
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and I was still swelled up. He said “I’ll send you back to see the 
specialist”. So I went to see the specialist, he says “Oh this could 
happen, this is not unusual, go and get an elastic stocking”. Anyway – I 
got an elastic stocking and after a week it was a lot better, and after a 
fortnight it was OK, I could put my shoe back on again. I think maybe I 
should have had an elastic stocking when they threw me out, and a 
wee bit more kind of instructions. 
 
The above quote also highlights the lack of knowledge about PAD outwith the vascular 
specialism. A number of participants spoke about the length of time they had 
claudication symptoms, and the number of times they visited their GPs about leg pains 
before they were referred to the vascular clinic. Participants described being given 
conflicting messages from GPs about the cause of their leg pains and possible 
treatments, which added to their confusion about what was actually wrong with them, 
and what they should do about it. 
 
Participant 12 Anyway, I kept mentioning it to him (GP), and he’d give me pain 
killers, different drugs… Anyway, I read in a magazine one time aboot 
intermittent claudication, the next time I was there, I mentioned it to 
him, I says “And that’s exactly the same symptoms that I’ve got”. 
 
Participant 18 When I first went to the doctors my arteries were 
actually sticking out, and they gave me cream for it. Then 
the new doctor, he took one look at it, he felt the pulses 
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in my foot and he says “there’s nae pulse in there”, so 
there’s no enough blood getting through “You’ll need to 
see a specialist”. 6 year. It just shows you. A different 
doctor – right away! He says “there’s something wrong 
there”, and that was it. 
 
Coping 
Participants described three ways in which they coped with their illness - adapting to 
limited mobility, accepting limitations as being due to age, and making downward 
comparisons with others. 
 
Participants adapted to having limited mobility by changing the way they spent their 
leisure time, giving up hobbies which involved physical activity like golf, dancing and 
fishing, and instead finding hobbies where they didn’t need to walk, for example 
sewing, knitting, growing bonsai trees and collecting things. Several participants had 
given up their dogs, or had not got a new dog when their old dog died. By reducing 
their physical activity levels, participants were less likely to experience claudication 
pain. 
 
Participant 23 I never got another dog, because I wasnae fit to take him walks, wi’ 
my legs. I never got another dog. That’s the first time I’ve been 
without a dog all my life…. I’m quite content. I collect models, of 
tractors and dumpers and things like that. I’ve got quite a lot. 
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Many participants seemed to rationalise their limited mobility by accepting it as part 
of the ageing process.  
 
Participant 3 What could ye dae at my age? I’m 82. 
 
Participant 16 I can still get aboot, like ken. I used to go fishing, I used to 
play golf. I couldnae dae that now, ken? Nuh. I stop for 
rests now, at times, aye. I’m 73 you see. 
 
Another common way that participants coped with their illness was to make 
downward comparisons with people who they perceived as being worse off than 
themselves. The majority of participants mentioned that they felt lucky that they 
didn’t have a different disease, for example comparing themselves to people with 
cancer, or to people in wheelchairs.  
 
Participant 24 I keep saying to myself there’s worse than me… I would say it’s 
affected my life, but no as extreme as whit some people have. I mean, 
I’m no in a wheelchair.  
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Discussion 
The aim of this study was to explore the illness and treatment representations and 
health behaviour of patients who had received a vascular intervention to treat their 
claudication symptoms. 
 
In general, participants in this study continued to experience a debilitating level of 
symptoms, including claudication pain, after receiving vascular intervention. These 
symptoms led to restrictions in activities outside the home and often led to feelings of 
frustration. However, while participants felt the consequences of PAD were severe in 
terms of everyday life, they did not appreciate the long-term health implications of 
PAD. Participants appeared to view their illness as an acute, rather than chronic 
condition; and those who were still experiencing symptoms generally viewed the 
disease as something which could be successfully ‘cured’ by further vascular 
interventions. This perception of the illness as acute rather than chronic has been 
found in other samples of patients with PAD, Gibson & Kenrick (1998) suggested that 
the acute medical style of treating PAD led to patients having unrealistic expectations 
about the disease and their recovery, and ultimately contributed to patients’ feelings 
of powerlessness. In the present study, patients viewed the management of their 
disease as being controlled by the surgeons, and did not take steps to alter their own 
health behaviours. However, the present study recruited patients who had received 
either angioplasty or surgery as treatment for IC, and these patients may have had a 
‘medical model’ of their illness due to their experience of surgical treatment for their 
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symptoms. Further research could investigate the beliefs of patients who have been 
diagnosed with IC but who have not yet received treatment.   
 
Some of the symptoms which participants reported in their legs were a result of the 
vascular intervention they had received, and were unexpected. However, vascular 
intervention was generally regarded by participants as being worthwhile. This mirrors 
findings from a study of patients with limb threatening ischemia following 
revascularisation (Seabrook, Cambria, Freischlag & Towne, 1999) – 53% of the sample 
reported problems with their revascularised limb despite successful surgery, however 
91% reported that they were glad they had had the surgery. In the present study, 
participants felt treatment had been worthwhile because it was ‘worth a try’. 
However, participants did report a gap between their expectations prior to treatment 
and the reality of their condition after treatment, this was particularly marked for 
participants who had had angioplasty. Both Cook & Galland (1997) and Chetter et al 
(1998) also found a decline in perceived health state and quality of life scores between 
the period immediately after angioplasty and at 6 month and 1 year follow up, despite 
no change in walking distance scores. They suggested this perceived drop in quality of 
life may be due to the development of co morbidities, or that participants’ 
expectations had increased as their activity levels increased. However, in the present 
study there was no evidence that participants’ activity levels had increased after 
vascular intervention, in fact, many participants spoke about their reduced activity 
levels. 
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Many of the causes of PAD are behavioural and therefore modifiable, for example 
smoking, high cholesterol, obesity, and lack of exercise. Many participants were either 
unaware of the causes of the disease, or had misattributed causality. The most 
common cause cited in this study was smoking, but several participants indicated they 
stated this as a cause because they had been told this by their doctor, not because 
they necessarily believed it. Participants did not understand the way that risk factors 
acted on the body to progress disease, and appeared unaware of future health risks as 
a result of continuing unhealthy behaviours. Some participants had changed health 
behaviours due to other more acute health crises, for example heart problems and 
stroke; however, very few had made any changes to their health behaviours as a result 
of IC. This is a concern because continuation of health risk behaviours could lead to re-
stenosis of the arteries and long term cardiovascular problems. 
 
Some participants thought different kinds of physical activity may have caused their 
PAD, for example walking dogs in the rain, standing for long periods of time, hard 
physical work and walking gait. This is particularly interesting as walking has been 
found to improve the symptoms of IC (Leng et al, 2000), however, beliefs that physical 
activity caused PAD may lead participants to avoid physical activity. Although many 
participants were aware they should be exercising, they felt that walking was too 
painful, may damage their legs, and they lacked confidence in their ability to walk, 
therefore they slowed down and avoided exercise.  Galea et al (2008) also found that 
there were many barriers to walking for people with IC. Giving information may 
therefore not be enough to elicit behaviour change, patients may also need some 
assistance with how to overcome barriers and turn knowledge into action. 
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Participants may have been given information about the causes and consequences of 
their disease and the need to change health behaviours in their consultations with 
medical staff, however, they don’t appear to have integrated this information into 
their cognitive framework of how they view the illness. Several participants 
commented that they did not understand the language the surgeons used, felt 
consultations were rushed, and felt they were unable to question the surgeon – these 
factors may affect how well patients process the information given to them during a 
consultation. Ley (1985) found that communication between doctors and patients is 
often not understood by patients and results in non-compliance with health advice. 
Collins et al (2006) suggested that improving patient-physician communication may be 
an important factor in increasing the exercise behaviour of patients with PAD. The 
results from the present study suggest that it may be useful to look at alternative ways 
of imparting important information about PAD to patients, to improve their 
understanding of the disease and enable them to make informed decisions about their 
health behaviours.  
 
Participants were found to have different ways of coping with their illness. Some 
participants had accepted the reality of their illness and had adapted their lives to 
accommodate any limitations, changing hobbies to more sedentary activities so they 
could keep busy. Some participants rationalised the effects of PAD as a part of the 
ageing process. That said, most participants felt curtailed to some extent by their 
current symptoms, and felt that the pain in their legs negatively affected their quality 
of life. Almost all participants made downward comparisons, comparing their health 
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and situation with those who they perceived to be physically worse off. Making 
downward comparisons appeared to provide some comfort to participants. Wann-
Hansson et al (2005) also found that PAD patients awaiting surgery made downward 
comparisons, and concluded this helped them to accept their illness and reduce its 
impact. 
 
Previous questionnaire based studies into the effect of revascularisation on patients 
with IC have found significant improvements in self reported physical functioning, 
walking distance, bodily pain, ABPI and leg symptoms for patients with IC who 
underwent surgery and angioplasty (e.g. Feinglass, McCarthy, Slavensky, Manheim & 
Martin, 2000; Currie, Wilson, Baird & Lamont, 1995; Chetter et al, 1998; Pell & Lee, 
1997). No significant improvement was found in the social and emotional domains as 
measured by the SF-36 in these studies. In the present study participants were found 
to be negatively affected socially and emotionally by their IC, reporting frustration, 
loneliness and a sense of loss, indicating that current questionnaire based methods of 
analysing the success of revascularisation do not sufficiently illustrate the overall 
quality of life of these patients. 
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Summary and implications 
This study found that most participants had not changed their health behaviours as a 
result of being diagnosed with IC, viewing the disease as an acute condition over 
which they had little control. Control was primarily achieved through avoiding walking, 
and slowing walking pace, to avoid pain. Many participants felt they could not 
increase their walking distance without further surgical intervention. Participants were 
largely unaware of the causes of the disease, or of their increased risk of future health 
problems.  
 
The findings of this study indicate that patients with IC have dysfunctional illness and 
treatment representations of PAD. These dysfunctional representations appear to lead 
to sub-optimal coping actions, including reducing walking and slowing pace. An 
intervention aimed at increasing the walking behaviour of patients with IC, based on 
the CSM, would need to modify illness representations, and representations of 
walking behaviour. However, patients with PAD who have already received a vascular 
intervention have a strongly held view that the disease is curable by surgery, possibly 
because of the acute manner in which the disease is managed in the hospital system. 
Therefore an intervention aimed at changing walking behaviour may be more 
successful if targeted at patients who have just been diagnosed with PAD, and are not 
entrenched in the acute management style of the hospital system. 
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GENERAL METHODS 
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Overview 
This chapter aims to describe the measures used in the subsequent two empirical 
studies – the cross-sectional questionnaire (Chapter 5) and the randomised controlled 
trial (Chapter 6); and the design of the brief psychological intervention used in the 
randomised controlled trial.  
 
The cross-sectional questionnaire study (Chapter 5) aimed to examine whether the 
CSM was a useful model for understanding the walking behaviour and health-related 
quality of life of patients with IC, by measuring the illness and walking representations 
of participants and testing how these related to walking behaviour and quality of life. 
 
The randomised controlled trial (Chapter 6) was carried out to test whether a brief 
psychological intervention based on the CSM would modify participants’ illness and 
walking representations and lead to an increase in physical activity and an 
improvement in quality of life.   
 
A summary of the measures used in the individual studies is provided in Table 4.1. As 
Study One used a qualitative methodology, it will not be considered in this chapter, 
and is discussed in detail in Chapter 3. 
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Table 4.1  Summary of measures used in each study 
Measures Study 2 – Cross-
sectional 
questionnaire 
Study 3 - Intervention 
Illness representations     
Treatment Representation – 
Consequences 
    
Treatment Representation – 
Personal Control 
    
Intention to walk     
Health Behaviours      
Health related quality of life     
Walking behaviour - IC     
Walkingbehaviour – pedometer    
Walking behaviour - IPAQ    
 
Illness Representations 
The Brief Illness Perception Questionnaire (BIPQ) developed by Broadbent, Petrie, 
Main & Weinman (2006) provides a measure of both cognitive and emotional illness 
representations (see Appendix 2). The 9-item questionnaire has five items assessing 
cognitive illness representations including consequences (‘How much does the illness 
affect your life?’); timeline (‘How long do you think the illness will continue?’); 
personal control (‘How much control do you feel you have over your illness?’); 
treatment control (‘How much do you think your treatment can help your illness?’); 
and identity (‘How much do you experience symptoms from your illness?’). Two items 
in the questionnaire assess emotional representations including concern (‘How 
concerned are you about your illness?’) and emotions (‘How much does your illness 
affect you emotionally?’). One item in the questionnaire assesses illness 
comprehensibility (‘How well do you feel you understand your illness?’). Causal 
representation is assessed by participants listing the three most important factors 
which they believe caused their illness. All items other than causal representations are 
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rated using a 0-to-10 response scale. The questionnaire can be adapted to a specific 
illness by renaming the word ‘illness’ in each question with the name of a particular 
illness. As participants with IC frequently do not know that they have an underlying 
disease, PAD (see Chapter 3), the word ‘illness’ was replaced with ‘intermittent 
claudication (cramping leg pain)’ in the questionnaires in the subsequent two 
empirical studies. Therefore, in these studies, the BIPQ was used to measure 
symptom, rather than illness, representations. The word ‘treatment’ in the treatment 
control item can also be replaced with the name of a specific treatment, however, as 
participants may have received or be scheduled to receive a range of different 
treatments, it was decided to leave the general word ‘treatment’ in the question.  
 
It has been demonstrated by previous researchers that the questionnaire has good 
test-retest reliability at 6 weeks (personal control: r=0.42, p<0.01; all other items r= 
between 0.61 and 0.75, p<0.001) (Broadbent et al, 2006); good concurrent validity 
with the IPQ-R (Moss-Morris et al, 2002), a longer questionnaire which also measures 
illness representations (r = between 0.32 and 0.63, p<0.001, Broadbent et al, 2006); 
and good predictive validity of outcomes following myocardial infarction, with 
different items in the questionnaire predicting different outcomes related to mental 
and physical functioning (Broadbent et al, 2006). 
 
Treatment Representations – Consequences and Personal Control 
The most effective regime for walking to improve symptoms of IC, involves 
participants walking to near maximal pain, for half an hour at least three times a week 
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(Leng et al, 2000). It is IC patients’ representations of this treatment behaviour which 
this thesis aims to explore. There are no existing measures of IC patients’ treatment 
representations of the consequences of performing this behaviour, or of their 
personal control to perform the behaviour. Elicitation interviews were conducted to 
elicit beliefs to be used in the design of suitable treatment–consequences and 
treatment–personal control scales (Francis et al, 2004). Elicitation interviews were 
conducted with 8 patients recently diagnosed with IC, during a visit to the IC 
Outpatient Clinic. Patients were interviewed individually in a private room at the 
hospital. Treatment-consequences beliefs were elicited by asking participants a range 
of open questions relating to the advantages and disadvantages of walking to near 
maximal pain, for half an hour at least three times a week. Treatment-personal control 
beliefs were elicited by asking participants to describe what makes walking to near 
maximal pain, for half an hour three times a week easier or more difficult (see 
Appendix 2). 
 
The elicitation study was used to develop a measure of treatment-consequences 
beliefs (see Appendix 2) based on methods described in Schwarzer et al (2003). Items 
were designed using if/then statements with the common stem specifying the target 
behaviour - ‘If I walk for at least 30 minutes, at least 3 times a week until the 
claudication pain is almost unbearable before stopping for a rest then…’. The thirteen 
‘then’ statements specify possible positive or negative consequences of performing 
the behaviour, taken from the most common responses in the elicitation interviews. 
The measure consists of eight positive consequences (e.g. ‘it will be good for my 
heart’) and five negative consequences (e.g. ‘I will be embarrassed because I have to 
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stop regularly’). There are four possible answers for each item on a Likert scale from 
(1) not at all true to (4) exactly true. The measure is scored by calculating the mean 
positive treatment-consequences and the mean negative treatment-consequences. 
 
The elicitation interviews were also used to develop a measure of treatment-personal 
control (see Appendix 2) using methods described in Francis et al (2004). Answers to 
the questions about what makes walking easier and harder were used to create a 9-
item measure of confidence in completing the target behaviour in a series of graded 
scenarios. A common stem was used to specify the target behaviour - ‘How confident 
are you that you can do a walk of at least 30 minutes, at least 3 times a week, walking 
until the claudication pain is almost unbearable before resting, when…’. The nine 
items specified the most common situations described in the elicitation interviews as 
making walking easier or more difficult, for example, ‘the weather is good’, ‘the walk 
is uphill’ and ‘there is nowhere to stop for a rest’. Participants answer each item on a 
scale from 0 (Not at all confident) to 10 (Extremely confident). The measure is scored 
by calculating the overall mean. 
 
Intention to perform the behaviour 
The recommended walking behaviour can be split into two distinct behaviours (i) 
walking to near maximal pain before stopping to rest, and (ii) walking for at least half 
an hour three times a week. The CSM proposes that an individual forms an action plan 
to cope with illness, based on illness and treatment representations. Intention to 
perform each of the recommended behaviours is therefore used as a measure to 
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determine whether the individual has formed a decision to perform the behaviour. A 
measure of intention to perform each of the behaviours was developed (see Appendix 
2) using 3 items, with the stems - ‘I intend to…’, ‘I would like to…’, and ‘It is likely that I 
will…’. These items measure intention to perform the behaviour, desire to perform the 
behaviour and expectation that the individual will perform the behaviour (Schwarzer 
et al, 2003). Participants answer each item on a scale from 0 (Strongly disagree) to 10 
(Strongly agree). The measure is scored by calculating the mean intention to walk to 
near maximal pain before stopping for a rest, and the mean intention to walk for half 
an hour three times a week.  
 
Health Behaviours 
This thesis focuses on the walking behaviour of patients with IC. However, patients 
with IC are routinely recommended to also lose weight and stop smoking as well as 
being recommended to increase their exercise (Cassar, 2006). For this reason, smoking 
and dietary behaviour are also measured in the subsequent empirical studies. 
 
Smoking is measured (see Appendix 2) by asking if the participant is a regular smoker, 
occasional smoker, ex-smoker or non-smoker. If the participant is a smoker they are 
asked how many cigarettes they smoke on an average day. 
 
Dietary behaviour is measured (see Appendix 2) in a 4 item scale consisting of two 
positive dietary behaviours and two negative dietary behaviours. Two items are from 
Toobert, Hampson & Glasgow’s (2000) Summary of Diabetes Self-Care Activities – ‘On 
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how many of the last 7 days did you eat five or more servings of fruit and vegetables?’ 
and ‘On how many of the last 7 days did you eat high fat foods such as red meat or 
full-fat dairy products?’. Two items are adapted from Weinman, Petrie, Sharpe & 
Walker (2000) into a similar format to the Self-Care Activities items – ‘On how many of 
the last 7 days did you eat fried food?’ and ‘On how many of the last 7 days did you 
eat breakfast?’. Items were chosen based on relevance to the IC population. 
Participants circle the number of days from 0 to 7 that they have performed an 
activity. The measure is scored by calculating the mean of the 4 items, reverse scoring 
the negative dietary behaviours. 
 
Health related quality of life 
Quality of life in patients with IC has frequently been measured using generic quality 
of life instruments like the SF-36 (e.g. Dumville et al, 2004), the McMaster Health 
Index (e.g. Barletta et al, 1996) and the Nottingham Health Profile (e.g. Khaira et al, 
1996). In a review of quality of life assessment in patients with IC, Mehta, 
Subramaniam, Chetter & McCollum (2003) concluded that generic quality of life 
measures are not sufficiently sensitive to detect clinically relevant variation in the 
quality of life of patients with IC. Two disease-specific quality of life measures have 
been developed in English for patients with IC, the Claudication Scale (Marquis, Comte 
& Lehert, 2001), a 47-item scale with five domains: daily living, pain, social life, disease 
specific anxiety and mood; and the Intermittent Claudication Questionnaire (ICQ, 
Chong, Garratt, Golledge, Greenhalgh & Davies, 2002), a 16-item scale with a single 
domain. Due to the length of the overall questionnaire, it was decided to use the 
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shorter ICQ (see Appendix 2) as a measure of health-related quality of life in the 
subsequent two empirical studies. The ICQ was developed through semi-structured 
interviews with newly diagnosed patients with IC to identify how IC affected their daily 
lives. The 16-item questionnaire includes one item about pain e.g. ‘During the past 2 
weeks, how severe were your leg pains?’; seven items about ability to perform various 
walking tasks ranging in difficulty from going out of the house to walking more than a 
mile; one item about frequency of stopping for rests when walking; three items about 
how IC affects mood; and four items about how IC affects activities like work and 
shopping. The pain item is scored on a 6-point Likert scale with responses ranging 
from ‘None, I had no leg pain’ to ‘Very severe’. All other items are scored on a 5-point 
Likert scale. The instrument is scored by summing up patient responses to individual 
items and transforming to a 0 to 100 scale, where 0 is the best possible and 100 the 
worst possible health-related quality of life score.  
 
It has been demonstrated by previous researcher that the instrument has good test-
retest reliability at 3 months (r=0.94) (Chong et al, 2002). The instrument has good 
construct validity, significantly (p<0.001) correlating with verbal reports of walking 
ability, treadmill walking results, EuroQol scores, and SF-36 scores (Chong et al, 2002). 
The ICQ has also been found to be responsive at 3 months following angioplasty, 
showing a significant improvement in quality of life scores for patients who received 
successful angioplasty (p<0.01) and no change in quality of life scores for patients 
whose angioplasty was unsuccessful (Chong et al, 2002).  
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General quality of life 
All participants were contacted by telephone at 6 and 12 weeks after recruitment into 
the study. The purpose of the telephone calls was to maintain contact and prompt 
review of behavioural goals for patients in the intervention group, however, the 
telephone calls also provided the opportunity to ask a few questions about each 
participant’s ongoing health. Therefore, a single item question was asked at baseline, 
4 month follow-up and during the two telephone calls about general quality of life, 
taken from the World Health Organisation Quality of Life (WHOQOL)- BREF (Murphy, 
Herman, Hawthorne, Pinzone & Evert, 2000) – ‘How would you rate your quality of 
life’, to which there are five possible responses on a Likert scale ‘Very poor’, ‘Poor’, 
‘Neither poor nor good’, ‘Good’, and ‘Very good’. 
 
Walking behaviour – IC 
As previously stated, the recommended walking behaviour can be split into two 
distinct behaviours (i) walking to near maximal pain before stopping to rest, and (ii) 
walking for at least half an hour three times a week. The behaviour of walking to near 
maximal pain before stopping to rest, is measured in the subsequent studies by the 
question ‘In general, do you carry on walking after the pain has started in your leg?’, 
to which there are three possible responses – ‘never’, ‘for a few steps’ and ‘until the 
pain is nearly unbearable’.  
 
The behaviour of walking for at least half an hour three times as week is measured in 
the subsequent studies by the question ‘How often do you walk for at least 30 
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minutes?’ to which there are 6 possible responses – ‘never’, ‘once or twice a month’, 
‘1-2 times per week’, ‘3 times a week’, ‘4-5 times a week’, and ‘everyday’. 
 
Self-reported walking ability is measured with the question ‘How far can you walk, 
aided or unaided, under normal circumstances before the onset of pain?’ to which 
there are 6 possible responses – ‘0 yards’, ‘up to 100 yards’, ‘up to 250 yards’, ‘up to 
half a mile’, ‘up to 1 mile’, ‘more than a mile’. The question is adapted from Mondillo 
et al’s (2003) Claudication Self-Assessment with the distances being re-formatted from 
metres to yards to reflect the fact that older patients are more likely to be confident 
measuring distance in imperial units. This question was asked at baseline, follow-up 
and in the telephone calls at 6 and 12 weeks. In order to measure frequency of 
walking to the onset of pain, participants are asked ‘In general, how frequently do you 
walk that distance?’ with 6 possible responses – ‘never’, ‘once or twice a month’, 
‘once a week’, ‘2-3 times a week’, ‘4-5 times a week’, and ‘everyday’. 
 
Walking behaviour – pedometer 
Previous studies of walking in patients with intermittent claudication have tended to 
measure maximal walking distance on the treadmill. While this measure gives an 
accurate idea of how far a patient can walk before they experience claudication pain, 
and before they have to stop, it does not give any idea of how much walking the 
patient does in their day to day life, and therefore lacks ecological validity. For this 
reason, day-to-day walking in the intervention study is measured using pedometers. 
The Omron-2 (HJ 113) pedometer was selected as an easy to use mid-price range 
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pedometer with good validity – Sugden et al (2008) found a significant correlation 
between walking as measured by an accelerometer and steps measured by the Omron 
2 pedometer (r = 0.78, p = 0.01). Batteries were checked at each pedometer fitting, 
each participant’s stride length was measured and programmed into the pedometer, 
and participants were shown how to use the pedometer and asked to walk for 50 
steps to check the pedometer was accurately recording their walking. Participants 
were visited one week apart for pedometer drop-offs and pick-ups, meaning that 
information was gathered for six full days at each time point. The measure is 
calculated by averaging the six full day readings. Participants were encouraged to seek 
help from the researcher if they encountered any problems or lost the pedometer.   
 
Walking behaviour - IPAQ 
A self-report measure of walking was also taken in the intervention study, as a 
comparison for walking as measured by pedometer. The International Physical Activity 
Questionnaire (IPAQ, Craig et al, 2003) is a self-report measure of physical activity 
with 4 items measuring time spent in vigorous and moderate activity, time spent 
walking, and time spent sitting. The measure is scored by calculating metabolic fitness 
levels (METs) based on reported activity levels. The MET level for each type of activity 
is multiplied by the number of minutes spent doing that activity per day and the 
number of days that the activity was performed, producing an overall score of MET 
minutes/week for each activity. The sum of these MET minutes/week is then 
calculated to produce an overall score of total activity. MET minute scores are 
equivalent to kilocalories for a 60kg person (IPAQ, 2005). The IPAQ has good test-
CHAPTER FOUR 
 
90 
 
retest reliability at 1 week (r = 0.8) (Craig et al, 2003) and moderate criterion validity 
when compared to maximal oxygen uptake (r = 0.31, p<0.01) (Kurtze, Rangul & 
Hustvedt, 2008). 
 
Design of intervention 
Participants in the intervention study were randomly allocated to two groups, a 
control group who received usual care, and a treatment group who received usual 
care and a brief psychological intervention. The process of randomisation is described 
in Chapter 6. The techniques used in the brief psychological intervention are described 
below. 
 
Description of techniques used in the brief psychological intervention 
Hrisos et al (2008) recommend six steps in developing a theory based behavioural 
intervention, summarised in Table 4.2. These steps were followed in designing the 
intervention study in this thesis. 
CHAPTER FOUR 
 
91 
 
 
 
Table 4.2  Steps in developing a theory based behavioural intervention 
1. Specify target behaviour(s). 
2. Select theoretical framework. 
3. Conduct a study with a sample drawn from the population of interest, to 
identify modifiable variables that predict the target behaviour(s). Based on the 
findings of this study, choose which variables to target. These variables are the 
proposed mediators of behaviour change. 
4. Map targeted variables onto behaviour change techniques and select 
techniques that (a) are likely to change the mediator variables and (b) it is 
feasible to operationalise. 
5. Choose appropriate method(s) of delivery of the techniques. 
6. Operationalise intervention components (techniques) in appropriate 
combination and order. 
Adapted from Hrisos et al (2008) 
 
Specification of the target behaviours 
As previously outlined in Chapter 2, this thesis focuses on walking behaviour of 
patients with IC. Recommended walking levels for patients with IC (Leng et al, 2000) 
can be split into two distinct behaviours which are the target behaviours for the 
intervention (i) walking to near maximal pain before stopping to rest, and (ii) walking 
for at least half an hour three times a week. 
 
Select theoretical framework. 
As previously outlined in Chapter 2, the theoretical framework for the intervention is 
Leventhal et al’s (1998) Common-sense model of self-regulation of health and illness 
(CSM). This choice of theoretical framework was guided by findings from qualitative 
studies into the experiences and behaviour of patients with IC (e.g. Gibson & Kenrick, 
1998; Wann-Hansson et al, 2005; Crosby et al, 1993; Leavitt, 1990; Treat-Jacobsen et 
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al, 2002), and by findings from a previous qualitative study (Chapter 3) which explored 
the illness representations and walking behaviour of patients with IC. The CSM 
explains behaviour in terms of modifiable cognitions about the illness and about 
potential treatments, and is self-regulatory in that it proposes that individuals 
constantly monitor their symptoms and the success of their coping actions (behaviour) 
to achieve their goals, and adjust their behaviour in light of this monitoring. Cognitions 
about illness have been found to be modifiable, and changes in illness representations 
have led to changes in behaviour (Petrie et al, 2002; Broadbent, Ellis, Thomas, Gamble 
& Petrie, 2009). 
 
Conduct a study to identify modifiable variables that predict the target behaviour. 
Results from the qualitative study (Chapter3) indicate that patients with IC have poor 
understanding about the causes of the disease, the timeline of the disease, and 
consequences of the disease. Participants interpreted symptoms (identity) as negative 
i.e. walking causes me pain; rather than positive i.e. walking when in pain will help my 
circulation and will ultimately improve the symptoms in my legs. In addition, 
participants tended to express scepticism about the benefits of walking and had low 
confidence in their ability to go out and walk. Participants also had a poor 
understanding of the timeline of walking in terms of how much to do, and the need to 
walk to near maximal pain. Participants did not intend to increase their walking and 
did not make plans to walk. 
 
The findings from the qualitative study can be summarised as variables which have 
been demonstrated to be modifiable in other studies with other populations. Beliefs 
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about causes, consequences, timeline, and identity fit within the illness representation 
construct of the CSM. Beliefs about the timeline of walking, consequences of walking, 
and personal control of walking fit within the treatment representation construct of 
the CSM. Forming intentions to perform the behaviour and planning to perform the 
behaviour fit within the coping action construct of the CSM.  
 
Map targeted variables onto behaviour change techniques 
Abraham & Michie (2008) documented recognised techniques which have been 
successfully used in a wide range of previous psychological interventions to achieve 
behaviour change. The intervention was designed by mapping the above psychological 
constructs related to walking identified in the qualitative study, to selected 
techniques. This process of mapping psychological constructs onto known behaviour 
change techniques means the brief psychological intervention used in this study is 
evidence-based. 
 
To modify interpretation of symptoms (identity), increase patients’ understanding of 
the disease and the link to walking behaviour, improve patients’ understanding of the 
causes of the disease, and explain the causal mechanism by which walking improves 
symptoms, technique one of Abraham & Michie’s (2008) taxonomy of behaviour 
change techniques was used – ‘provide information about the behaviour-health link’. 
 
To increase patients’ understanding of the consequences of PAD, their perception of 
future health risk, and the chronicity of disease (timeline), technique two of the 
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taxonomy of behaviour change techniques (Abraham & Michie, 2008) was used – 
‘provide information on consequences’. 
 
Technique twenty-five, ‘motivational interviewing’ (Abraham & Michie, 2008), was 
used to operationalise the above techniques, using motivational interviewing 
techniques to evoke change talk. Participants were asked open questions about their 
illness beliefs and then given information about the disease and the disease/behaviour 
link. Participants were prompted to evaluate their own walking behaviour, and to 
consider their motivation to increase their walking. The intention was to move 
participants to a point where they had expressed motivation/intention to change the 
target behaviour (walking). 
 
Reframing treatment representations, including the identity of the treatment 
(walking), the interpretation of pain, and the timeline of the treatment (beliefs about 
the duration and intensity of walking behaviour required; patients’ expectations about 
the time until they will see a difference in symptoms), and modifying action plans to 
include a plan to increase walking, mapped onto technique ten (Abraham & Michie, 
2008) – ‘prompting specific goal setting by defining the behaviour, and specifying 
when, where, how long for and with whom’. 
 
Patients with IC have reported many barriers to increasing walking (Stewart & Lamont, 
2007; Galea et al, 2008). Identification of possible barriers to an activity, and forming 
plans to deal with anticipated barriers is known as coping planning. Sniehotta, Scholz 
& Schwarzer (2006) tested the efficacy of action planning to increase physical activity 
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against combined action and coping planning, with a group of cardiac patients. They 
found that a combination of action and coping planning led to significantly greater 
physical activity levels at 2 months than action planning alone. Coping planning works 
by encouraging the participant to anticipate possible barriers to an activity and pre-
plan coping responses to these barriers. This helps the participant to overcome 
situations where they are more likely to fail at self-regulation. Coping planning 
mapped onto technique five (Abraham & Michie, 2008) – ‘prompting barrier 
identification and planning ways of overcoming them’.   
 
Action planning and coping planning were operationalised by creating a personalised 
action and coping plan with the participant, which was typed up, laminated and 
posted to them. The action plan was adapted from the Improving Health: Changing 
Behaviour – NHS Health Trainer Handbook (Michie et al, 2008). 
 
A key part of the CSM is the dynamic process by which individuals assess their coping 
response against goal achievement. This assessment of goal achievement is proposed 
to take the form of an ongoing process matching experience to illness and treatment 
representations, which Leventhal terms the prototype check (Leventhal et al, 2010). 
Ongoing discussion about the maintenance of behaviour change and whether 
behaviour change was resulting in goal achievement mapped onto technique eleven 
(Abraham & Michie, 2008) – ‘prompting review of behavioural goals’. 
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 Choose appropriate method(s) of delivery of the techniques /Operationalise techniques in 
appropriate combination and order. 
Patients with IC tend to be elderly and experience leg pain when walking. In order to 
make the intervention as acceptable as possible, it was decided to deliver the 
intervention in participants’ homes at a time which suited them. The techniques used 
in the intervention and the order they were operationalised are summarised in Table 
4.3. 
 
Table 4.3 Techniques used in the intervention 
Technique Operation 
Provide information about the behaviour-
health link 
 
Session One 
Provide information on consequences 
Motivational interviewing 
Prompting specific goal setting by 
defining the behaviour, and specifying 
when, where, how long for and with 
whom 
 
 
Session Two 
Prompting barrier identification and 
planning ways of overcoming them 
Prompting review of behavioural goals Telephone calls 
 
The intervention was delivered over two, one-hour sessions, one week apart. The first 
session covered technique one – providing information about the behaviour-health 
link; technique two – providing information on consequences; and was 
operationalised using technique twenty-five – motivational interviewing. The pro-
forma which was used to guide Session 1 can be found in Appendix 3. The information 
sheet used to provide participants with more information about PAD can be found in 
Appendix 4. 
 
CHAPTER FOUR 
 
97 
 
The second session covered technique ten – prompting specific goal setting and 
technique five – prompting barrier identification. A copy of the action plan proforma 
can be found in Appendix 5. 
 
Two telephone calls were conducted with each participant at 6 and 12 weeks after 
recruitment into the study. The purpose of the calls was to prompt review of 
behavioural goals (technique eleven), and give the participant a chance to discuss 
their progress with behaviour change, and make changes to their action or coping 
plans if necessary. Copies of the proforma used to guide the telephone calls can be 
found in Appendix 6. 
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APPLYING LEVENTHAL’S COMMON-SENSE MODEL TO PATIENTS 
WITH INTERMITTENT CLAUDICATION – A CROSS-SECTIONAL 
STUDY 
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Abstract 
Background: 
The qualitative study presented in Chapter 3 indicated that many patients with PAD, 
who had received surgery or angioplasty for IC, still experienced a high level of leg 
pain symptoms, and controlled symptoms by avoiding walking and/or walking at a 
slow pace. The data suggested that participants had a poor understanding of the 
causes of PAD, the benefits of walking, and had low walking confidence. This study 
used measures based on the CSM to examine the walking activity and illness and 
walking representations of a cohort of patients with IC, to quantitatively test the 
relationships identified in the qualitative study. 
Method: 
This was a cross-sectional, correlational study. A cohort of patients diagnosed with IC 
(n=262) were sent a postal questionnaire, and 91 (34.7%) completed questionnaires 
were returned and analysed. The CSM was operationalised as described in Chapter 4; 
measures included walking activity, quality of life, symptom representations and 
walking representations. Outcome measures were adherence to minimum 
recommended walking levels and health-related quality of life.  
Results: 
Illness and walking representations predicted adherence to recommended walking 
levels with 93.4% accuracy (binomial logistic regression) in participants with IC. Illness 
and walking representations explained 69.7% of the variance in health-related quality 
of life of participants with IC. 
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Conclusion: 
Findings support the CSM for predicting walking behaviour and quality of life in 
patients with IC. The results from this study suggest that an intervention to modify 
illness and walking representations may improve walking and health-related quality of 
life in patients with IC.
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Introduction 
The qualitative study (Chapter 3) presented in this thesis examined the illness and 
treatment representations, and walking behaviour of patients with IC, and found that 
post-revascularisation, many patients with IC had dysfunctional illness and treatment 
representations and tended to avoid walking. The next logical step from the 
qualitative study is to examine the illness and walking representations and walking 
behaviour of a cohort of patients with IC, to test whether the findings from the 
smaller-scale qualitative study are valid for a larger sample of participants, before 
developing a psychological intervention to improve walking in patients with IC.  
 
Only two studies have previously been conducted which measure psychological 
variables in relation to physical activity in patients with PAD. Rejeski, Tian, Liao & 
McDermott (2008) developed a questionnaire including measures of depression, 
walking ability, self-efficacy of overcoming barriers to walking, desire for physical 
competence, satisfaction with physical function, acceptance of leg pain and perceived 
control related to walking. Participants also completed a six minute walk test, 
measuring how far they could walk in 6 minutes. Splitting participants into three 
groups based on six minute walking test performance, Rejeski et al (2008) found that 
participants with the poorest walking ability also had significantly poorer acceptance 
of pain, significantly less willingness to walk into the pain, significantly lower self-
efficacy to overcome barriers to walking, significantly lower desire for physical 
competence, significantly lower satisfaction with physical function, and significantly 
poorer perceived control over future walking ability. This study indicates that beliefs 
about walking may play a part in walking behaviour. However, the study did not 
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measure walking behaviour, only walking ability, was not based on a specific theory of 
behaviour change, and included a heterogeneous sample of patients with PAD, of 
whom only 26% had IC. 
  
Galea & Bray (2006) used the Theory of Planned Behaviour to predict walking activity 
in patients with IC. They found that while subjective norms, attitude and perceived 
behavioural control accounted for 67% of the variance in intention to walk; intention 
to walk and perceived behavioural control only accounted for 8% of the variance in 
walking activity. Galea & Bray (2006) suggested that the intention-behaviour gap in 
their study may be due either to floor effects with their measure of walking activity, or 
due to other factors like pain perception, and ability to cope with the pain, which may 
influence walking behaviour. Examining illness cognitions alongside behavioural 
cognitions may provide a better model for understanding walking behaviour in 
patients with IC.   
 
A study which is theory-based and which measures actual walking behaviour rather 
than ability to walk is required to examine the relationship between psychological 
variables and walking behaviour in patients with IC. To this end, a questionnaire was 
developed based on Leventhal et al’s (1998) CSM to investigate the illness and walking 
representations and walking behaviour of patients with IC. The questionnaire design is 
described in detail in Chapter 4.        
 
As the previous qualitative study included a sample of participants who had received 
revascularisation, it was not representative of all patients with IC. Therefore a study to 
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test the generalisability of the findings from the qualitative study for IC patients in 
general should also include patients who have been treated conservatively (i.e. 
without surgical or endovascular intervention). 
 
The main objective of this study is therefore to explore the illness and walking 
representations and walking behaviour of a cohort of patients diagnosed with IC. 
 
Health-related quality of life is considered an important outcome measure in the 
management of patients with IC because treatment aims to improve symptoms rather 
than treating the underlying disease. Therefore, a key aim of treatment for IC is to 
improve quality of life. A secondary objective of this study is to explore how the illness 
and walking representations of patients with IC relate to health-related quality of life. 
 
Research Questions 
The research questions are: 
1. What is the walking behaviour of patients with IC? 
2. What are the symptom and walking representations of patients with IC? 
3. How do the symptom and walking representations of patients with IC relate to 
walking behaviour and quality of life? 
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Method 
Design 
This was a cross-sectional postal questionnaire study designed to analyse the 
relationship of illness and treatment representations with walking behaviour and 
quality of life in a cohort of patients with IC.  
 
Recruitment 
All patients who had attended vascular services in NHS Forth Valley and who met the 
study inclusion criteria were identified and sent a pack containing a covering letter 
from their vascular surgeon inviting them to participate, a participant information 
sheet, a consent form, the questionnaire, and a pre−paid envelope addressed to the 
researcher. Inclusion criteria included a diagnosis of IC between 9 months and 3 years 
prior to recruitment. This time frame was chosen to maximise the chances that 
patients would have received any surgery that would be organised as a result of 
diagnosis, and to ensure a reasonable sample size in the study. A sample size 
calculation carried out using Gpower3 (Faul, Erdfelder, Lang & Buchner, 2007), 
indicated that to carry out a regression to detect a medium effect size (0.15), with an 
alpha of 0.05, a power of 80% and 11 predictor variables, would require a sample of 
123 participants. Assuming a 45% response rate (Iglesias et al, 2000) this would 
require 273 questionnaires to be sent out. Exclusion criteria included any amputations 
since diagnosis with IC. The full list of patients diagnosed with IC between 9 months 
and 3 years prior to recruitment was screened by the researcher using hospital 
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databases for evidence of confirmation of diagnosis, death or amputation. Of the 
original 327 names on the list, 26 patients had died, 26 had been wrongly diagnosed 
as claudicants (no blockage identified by arteriogram), 2 patients had had a lower limb 
amputation, and 1 patient had a diabetic foot (several toes amputated). Therefore 272 
questionnaires were sent out. A reminder letter was sent out 2 months later asking 
patients to complete the questionnaire and encouraging them to call the researcher if 
they required assistance or a new pack.  
 
Participants 
Of the 272 questionnaire packs sent out to patients, a further 2 patients were dead, 5 
people called to say that the patients no longer lived at the address the pack was sent 
to, and 3 participants got in touch to say they had been mis-diagnosed and had never 
had IC. Therefore 262 applicable questionnaires were sent out to patients with IC and 
92 questionnaires were returned to the researcher. Where data was missing from 
questionnaires, the researcher tried to call the participant and complete the 
questionnaire by telephone. However, this was not possible in 1 case where only a 
handful of questions had been completed and the participant was not available by 
phone – this questionnaire was therefore excluded from analysis, giving a 
questionnaire response rate of 34.7%. One blind participant called the researcher and 
asked for a home visit to help complete the questionnaire.  
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Ethical approval 
Fife and Forth Valley Research Ethics Service approved this study. The letter of 
invitation, participant information sheet and consent form are included in Appendix 7. 
 
Measures 
The design of the questionnaire used in this study is described in detail in Chapter 4. 
The questionnaire included measures of IC symptom representations, walking 
personal control, positive and negative walking consequences, disease-specific quality 
of life, intention to walk, and intention to walk through the pain, dietary behaviour 
and walking behaviour. Ankle Brachial Pressure Index (ABPI) at most recent outpatient 
clinic and treatment received since diagnosis were taken from participants’ medical 
records. 
 
Analysis 
Some of the participants in the sample had received successful angioplasty or surgery 
for their PAD and no longer reported any symptoms of IC; also, 3 participants who had 
received conservative treatment no longer experienced any symptoms of IC. 
Therefore, the data was split for analysis of psychological factors related to walking 
and quality of life, to consider two groups, those with IC and those who no longer had 
IC. The internal consistency of multi-item measures was assessed using Cronbach’s 
alpha, using an acceptability criterion of α≥0.7. The distribution of each measure was 
checked for significant skewness and kurtosis by group, and was found to have a 
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normal distribution. The groups were analysed descriptively. Chi-square tests were 
used to test differences in categorical variables. Bivariate correlations were used to 
explore associations between variables within each group. An exploratoryprincipal 
components analysis was conducted to identify a factor structure in the data, to 
provide an understanding of the underlying structure of symptom and treatment 
representations and their relationship with walking behaviour and quality of life 
(research questions 1 & 2). Binomial logistic regressions and multiple regressions were 
carried out with walking behaviour and quality of life as the dependent variables, and 
illness and walking representations as the independent variables to clarify the 
predictive value of the CSM in the outcomes of patients with IC. 
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Results 
Internal consistency of the multi-item measures was satisfactory: Cronbach’s alpha: 
Walking Personal Control (9 items) = 0.97; Intention to walk (3 items) = 0.83; Intention 
to walk through pain (3 items) = 0.90; Positive Walking Consequences (8 items) = 0.82; 
Negative Walking Consequences (5 items) = 0.70; Health-related Quality of Life (16 
items) = 0.79. 
Study population 
Ninety-one patients returned completed questionnaires and consented to take part in 
the study. Mean time between diagnosis and return of questionnaire was 25.5 months 
(sd=12.3). Table 5.1 presents the characteristics of the sample split into two groups, 
reflecting the presence or absence of IC pain. There was a significant difference 
between the two groups in the number of people who had diabetes, 2(1)=3.894, 
p=.048, with more participants with diabetes in the pain than no pain group; and a 
significant difference between the groups in the number of current smokers 
2(2)=8.424, p=.015, with a greater proportion of current smokers in the pain than no 
pain group. There was also a significant difference in dietary behaviour between the 
two groups, with participants in the group with no claudication pain having better 
dietary behaviour than participants in the group with claudication pain, t(87)=3.483, 
p=.001. ABPI in the no pain group was significantly higher (i.e. better) than ABPI in the 
group who still had claudication pain, U=457.0, p=.032, r=.23. 
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Table 5.1 Characteristics of the sample by group 
 
 
Walking behaviour 
Overall, 54 (61.4%) respondents did not recall receiving medical advice on how far or 
how long to walk because of IC.  
 
Fifty-nine (67.8%) respondents had attempted to increase the amount they walked 
since diagnosis with IC, and of these 36 (61%) reported maintaining this increased 
walking behaviour. Therefore 41.4% of overall respondents claimed to have both 
increased walking behaviour and maintained this increase since diagnosis with IC.  
 
 IC  
(n = 71) 
No IC symptoms 
(n = 20) 
Demographics   
Age, mean (SD) 69.48 (10.6) 70.25 (8.2) 
Male, no. (%) 46 (64.8) 12 (60) 
Living alone, no. (%) 20 (28.2) 4 (20) 
Retired, no. (%) 55 (77.5) 15 (75) 
ABPI, mean (SD) .92 (.30) 1.05 (.20) 
Risk Factors    
Diabetes, no. (%) 12 (16.9) 0 (0) 
Smoker, no. (%)   
- Yes 30 (42.3) 4 (20) 
- Never 10 (14.1) 0 (0) 
- Given Up 31 (43.6) 16 (80) 
Dietary behaviour, mean (SD) 4.66 (1.23) 5.73 (1.02) 
Co morbidities   
Heart Disease, no. (%) 32 (45) 10 (50) 
Stroke, no. (%) 10 (14.1) 2 (10) 
Treatment   
Conservative, no. (%) 18 (25.4) 3 (15) 
Angioplasty, no. (%) 16 (22.5) 10 (50) 
Bypass surgery, no. (%) 37 (52.1) 7 (35) 
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Significantly more participants who had attempted and maintained increased walking 
levels were walking at least the minimum recommended amount for patients with IC 
(at least half an hour three times a week) than participants who had never attempted 
to increase their walking, or had not maintained increased walking levels, 
2(2)=15.309, p<.001. Table 5.2 shows a breakdown of current walking behaviour by 
attempt to increase walking. Four participants in the group who no longer experience 
claudication pain did not give information about whether or not they had attempted 
to increase walking behaviour since diagnosis, all four of these participants did meet 
minimum recommended walking levels. 
 
Participants who increased walking but did not maintain this increase, gave a variety 
of reasons why they could not maintain an increase in walking behaviour, including 
pain (n=20, 86.96%), lack of motivation (n=8, 34.78%), poor weather (n=4, 17.39%), 
having stopped hobbies which required walking (n=4, 17.39%), using the car (n=3, 
13.04%), co-morbidities (n=2, 8.70%) and poor balance (n=2, 8.70%). 
 
Table 5.2 Current walking behaviour by attempt to increase walking (n=87) 
 Do not meet minimum 
walking recommendations 
At least meet minimum 
walking recommendations 
Never attempted to increase 
walking 
20 8 
Attempted to increase 
walking but did not maintain 
20 3 
Maintained increased walking 14 22 
    
Overall, 37 (40.7%) participants reported currently meeting the minimum 
recommended walking levels for patients with IC. Significantly more participants who 
no longer experienced claudication pain met minimum recommended walking levels 
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than participants who still experienced claudication pain, 2(1)=9.146, p=.002. In the 
group of participants who no longer experienced claudication pain, 6 (30%) 
participants did not meet recommended walking levels, and 14 (70%) did meet 
minimum recommended walking levels. In the group of participants who still 
experienced claudication pain, 48 (67.6%) did not meet recommended walking levels, 
and 23 (32.4%) did meet minimum recommended walking levels.  
 
Of those participants who still experienced claudication pain, 10 (14.1%) participants 
reported stopping for a rest as soon as they felt any pain in their leg, 20 (28.2%) 
participants reported continuing for a few steps before stopping for a rest, and 41 
(57.7%) participants reported continuing until the pain was almost unbearable before 
stopping for a rest. 
 
Pain free walking distance 
Pain free walking distance for the group who still experienced claudication pain is 
shown in Figure 5.1. Participants in the group with claudication pain, who met the 
minimum recommended walking levels had significantly longer pain free walking 
distance than those who did not meet minimum recommended walking levels, 
2(5)=13.148, p=.022. Pain free walking distance by recommended walking behaviour 
is shown in Figure 5.1.    
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Care 
Overall, 33 (36.3%) participants reported receiving some level of help or support in the 
home from family, friends or other organisations because of problems with their 
health. Significantly more participants with claudication pain required help or support 
(n=30/71, 42.25%) than participants with no claudication pain (n=3/20, 15.0%), 
2(1)=5.015, p=.025. In the group of participants who reported having claudication 
pain, there was a marginally non-significant trend towards more participants who did 
not meet minimum recommended walking levels requiring care (n=24/48, 50.0%) than 
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participants who did meet the recommended walking levels requiring care (n=6/23, 
26.09%), 2(1)=3.644, p=.056. 
 
Causal beliefs 
Table 5.3 lists factors which participants believed may have caused their illness. 12 
(35.29%) of the 34 current smokers in the sample did not list smoking as a cause of 
PAD. 12 (75.0%) of the participants who believed exercise and strenuous work caused 
PAD did not meet the recommended walking levels for patients with IC. 
 
Table 5.3 Participants’  (n=91) beliefs about the causes of PAD 
Cause n (%) 
Smoking 49 (53.85%) 
Diet 28 (30.77%) 
Exercise and strenuous work 16 (17.58%) 
Hereditary 15 (16.48%) 
Lack of exercise 13 (14.29%) 
Don’t know 8 (8.79%) 
High blood pressure 6 (6.59%) 
Old age 5 (5.49%) 
Stress 4 (4.40%) 
Varicose veins 4 (4.40%) 
Medication 2 (2.20%) 
Dust inhalation 2 (2.20%) 
Diabetes 2 (2.20%) 
Bad chairs 2 (2.20%) 
 
  
Pearson correlations between variables for participants with no pain 
Table 5.4 illustrates the correlations between variables in the group who reported 
having no claudication pain. The sample (n=20) is too small to conduct a Principal 
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Components Analysis. The variables BIPQ Identity (level of symptoms) and intention to 
walk to maximal pain were removed from the correlation analysis as they were not 
relevant for participants who no longer experience leg pain when walking. 
 
A belief in more serious consequences of IC was significantly positively correlated with 
beliefs that PAD would last for a longer time, a greater emotional effect of IC  and 
disease specific quality of life, where higher scores of disease-specific quality of life 
indicate poorer quality of life; and significantly negatively correlated with illness 
comprehensibility. 
 
A belief that PAD would last for a long time was significantly positively correlated with 
poorer disease specific quality of life. 
 
Personal control over the illness was significantly positively correlated with walking 
behaviour. 
 
Beliefs that treatment can help the illness were significantly positively correlated with 
intention to walk for at least half an hour at least three times a week. 
 
Greater concern about the illness was significantly negatively correlated with illness 
comprehensibility. 
 
Illness comprehensibility was significantly negatively correlated with the emotional 
effect of IC and poorer health related quality of life. 
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The emotional effect of IC was significantly positively correlated with poorer health 
related quality of life. 
 
Beliefs in the positive consequences of walking were significantly positively correlated 
with walking personal control, and intention to walk for at least half an hour at least 
three times a week. 
 
Beliefs in the negative consequences of walking were significantly negatively 
correlated with walking personal control. 
 
Walking personal control was significantly positively correlated with intention to walk 
for at least half an hour three times a week and with self-report walking behaviour. 
 
Intention to walk for at least half an hour three times a week was significantly 
positively correlated with walking behaviour. 
 
These correlations suggest that negative symptom representations related to poorer 
quality of life, and positive walking representations were related to increased walking 
behaviour.  
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 Table 5.4  Correlations, means and standard deviations of all variables in the no claudication pain group 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1.BIPQ Consequence -             
2.BIPQ Timeline .61** -            
3.BIPQ Personal Control -.04 .12 -           
4.BIPQ Treatment Control .14 .12 .34 -          
5.BIPQ Concern .398 .40 .07 .21 -         
6.BIPQ Illness 
Comprehensibility 
-.63** -.29 .30 .05 -.53* -        
7.BIPQ Emotions .56* .36 -.39 .14 .40 -.66** -       
8.Positive Walking 
Consequences 
.19 .31 .15 .09 .37 -.07 .08 -      
9.Negative Walking 
Consequences 
.41 .15 -.09 .10 .12 -.09 .22 -.43 -     
10.Walking Personal 
Control 
-.02 -.05 .24 .04 -.08 .03 -.24 .53* -.64** -    
11.Intention to walk -.06 -.09 .43 .60** .08 .12 .12 .59* -.31 .49* -   
12.Walking for ½ hour .14 -.09 .59** .47* .04 -.05 .07 .08 -.15 .49* .56* -  
13.HRQoL .71** .76** -.05 .14 .39 -.64** .56* .12 .16 .05 -.03 .09 - 
Mean Score 1.05 1.05 7.40 9.15 2.05 8.95 1.25 3.42 1.13 8.39 8.53 3.75 3.15 
SD 1.67 3.07 4.01 2.43 3.09 1.79 2.36 .50 .24 2.54 2.49 1.45 6.89 
 
* Correlation is significant at the .05 level, ** Correlation is significant at the .01 level 
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Pearson correlations between variables for participants with pain 
Table 5.5 illustrates the correlations between variables in the group who reported 
having claudication pain (n=71). 
 
Consequences of IC was significantly positively correlated with beliefs that the illness 
would last for a longer time, illness identity, concern about IC, the emotional effect of 
IC, and poorer disease specific quality of life; and significantly negatively correlated 
with personal control over the illness and walking personal control. 
 
A belief that IC would last for a long time was significantly positively correlated with 
illness identity, concern about IC, the emotional effect of IC, beliefs about the negative 
consequences of walking  and poorer health related quality of life; and significantly 
negatively correlated with treatment control. 
 
Personal control over IC was not significantly correlated with any other variable. 
 
Treatment control (belief that treatment can help IC) was significantly positively 
correlated with illness comprehensibility, intention to walk to maximal pain before 
stopping for a rest, walking behaviour; and significantly negatively correlated with 
poorer health related quality of life. 
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Illness identity was significantly positively correlated with concern about IC, the 
emotional effect of IC, and poorer health related quality of life; and significantly 
negatively correlated with walking personal control. 
 
 
Concern about IC was significantly positively correlated with the emotional effect of IC  
and poorer health related quality of life. Illness comprehensibility was significantly 
negatively correlated with beliefs about the negative consequences of walking, and 
poorer health related quality of life. 
 
The emotional effect of IC was significantly positively correlated with poorer health 
related quality of life. 
 
Beliefs in the positive consequences of walking were positively correlated with walking 
personal control, intention to walk for at least half an hour three times a week, 
intention to walk to maximal pain before resting, and walking behaviour; and 
significantly negatively correlated with poorer quality of life. 
 
Beliefs in the negative consequences of walking were significantly positively correlated 
with poorer health related quality of life; and significantly negatively correlated with 
walking personal control, intention to walk for at least half an hour three times a 
week, and intention to walk to maximal pain before resting. 
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Table 5.5 Correlations, means and standard deviations of all variables in the claudication pain group 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1.BIPQ Consequence -               
2.BIPQ Timeline .63** -              
3.BIPQ Personal Control -.27* -.08 -             
4.BIPQ Treatment Control -.23 -.37** .12 -            
5.BIPQ Identity .71** .56** -.02 -.14 -           
6.BIPQ Concern .65** .40** -.07 -.05 .66** -          
7.BIPQ Illness 
Comprehensibility 
-.04 -.09 .22 .28* .02 .04 -         
8.BIPQ Emotions .64** .30* -.12 -.18 .49** .59** -.07 -        
9.Positive Walking 
Consequences 
-.16 -.16 .22 .19 -.23 -.22 .14 -.09 -       
10.Negative Walking 
Consequences 
.16 .28* -.07 -.31 .14 .05 -.25* .14 -.14 -      
11.Walking Personal 
Control 
-.31** -.17 .06 .22 -.24* -.04 .07 -.24 .46** -.43** -     
12.Intention to walk -.13 -.05 .11 .24 -.08 .03 .11 -.17 .50** -.33** .80** -    
13.Intention to walk 
 through pain 
-.13 -.12 .07 .40** -.11 -.04 .20 .01 .38** -.33** .45** .66** -   
14.Walking for ½ hour -.22 -.09 .01 .28* -.11 -.09 .03 -.19 .37** .11 .71** .74** .44** -  
15.HRQoL .68** .49** -.18 -.33** .61** .47** -.23* .50** -.37** .43** -.56** -.40** -.33** -.36** - 
Mean Score 6.80 7.42 4.55 6.71 6.32 6.62 6.85 5.35 2.85 2.03 3.21 5.46 6.41 1.83 46.44 
SD 2.48 2.98 2.92 3.09 2.78 3.17 3.14 3.25 .67 .62 2.87 2.91 3.35 1.81 21.79 
 
* Correlation is significant at the .05 level, ** Correlation is significant at the .01 level
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Walking personal control was significantly positively correlated with intention to walk 
for at least half an hour three times a week, intention to walk to maximal pain before 
stopping for a rest, and walking behaviour; and significantly negatively correlated with 
poorer health related quality of life. 
 
Intention to walk for at least half an hour three times a week was significantly 
positively correlated with intention to walk to maximal pain before resting and 
walking behaviour; and significantly negatively correlated with poorer health related 
quality of life. 
 
Intention to walk to maximal pain before resting was significantly positively correlated 
with walking behaviour; and significantly negatively correlated with poorer health 
related quality of life. 
 
Walking behaviour was significantly negatively correlated with poorer health related 
quality of life. 
 
Principal components analysis was conducted with the 15 variables listed, to identify 
clusters of variables which correlated highly with each other.  The Kaiser-Meyer-Olkin 
measure of sampling adequacy was .734, and Bartlett’s test of sphericity was 
significant (2 (105) = 462.209, p < .001), indicating suitability of the data for principal 
components analysis. The initial eigenvalues showed that the first factor explained 
33.86% of the variance, the second factor 18.18% of the variance, a third factor 9.20% 
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of the variance, and a fourth factor 7.11% of the variance. None of the other factors 
had an eigenvalue over 1. 
 
The two factor structure, explaining 52.04% of the variance was examined using a 
varimax rotation and results are shown in Figure 5.2. This principal components 
analysis revealed two clusters - illness personal control, walking personal control, 
treatment control, intention to walk, intention to walk through the pain, beliefs about 
positive walking consequences, illness comprehensibility, and walking behaviour were 
all positively loaded onto the first cluster, and beliefs about negative walking 
consequences and quality of life (where lower scores indicate better quality of life) 
were negatively loaded onto the first cluster. Illness consequences, timeline, concern 
about the illness, emotional effect of the illness, illness symptoms and quality of life 
(where higher scores indicate worse quality of life) were all positively loaded onto the 
second cluster. This principal components analysis indicates that negative symptom 
representations are negatively related to quality of life, and positive illness and 
walking representations are positively related to walking and quality of life.  
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---- Cluster 1 
___ Cluster 2 
 
Regression analyses 
The sample size of the group of participants who no longer had claudication pain was 
too small to perform regression analysis, therefore the following analyses only apply 
to the group (n=71) who still had claudication pain. 
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Adherence to minimum walking recommendations 
Separate binomial logistic regression analyses were conducted with adherence to 
minimum recommended walking levels as the dependent variable and firstly symptom 
representations as the independent variables; secondly walking representations as the 
independent variables; and thirdly the full model of illness and walking 
representations as the independent variables. The dependent variable was 
dichotomous – participants either walked the minimum recommended amount of at 
least half an hour three times a week (n=23), or they did not (n=48).  
 
Results of the first logistic regression with symptom representations as the 
independent variables showed that prediction success of the full model was 75.4% 
(91.5% for non-adherence to recommended walking levels and 40.9% for adherence 
to recommended walking levels), whereas the prediction success of the constant only 
model was 68.1%. This improvement in prediction of the full model against the 
constant only model was not significant, 2 (8) = 14.37, p=.073. 
 
Results of the second logistic regression with walking representations as the 
independent variables showed that the prediction success of the full model was 84.1% 
(90.2% for non-adherence to recommended walking levels and 72.7% for adherence 
to recommended walking levels), whereas the prediction success of the constant only 
model was 65.1%. This improvement in prediction was significant, 2 (3) = 39.765, 
p<.001. Nagelkerke’s R2 of .645 indicated a moderate relationship between prediction 
and grouping. The Wald criterion demonstrated that only walking personal control 
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made a significant contribution to prediction, B=1.106, SE=.314, Wald (1)=12.453, 
p<.001. The other walking representations were not significant predictors.  
 
To test whether symptom representations added to the predictive value of walking 
representations in predicting whether participants would meet minimum 
recommended walking levels, a final logistic regression was conducted entering 
walking representations in the first block and symptom representations in the second 
block. Results are shown in Table 5.6. The addition of symptom representations to the 
walking representations only model, was statistically significant, 2 (8) = 18.657, 
p=.017. The full model indicated that illness and walking representations as a set 
reliably distinguished between adherers and non-adherers to recommended walking 
levels, 2 (11) = 57.503, p<.001. Nagelkerke’s R2 of .843 indicated a strong relationship 
between prediction and grouping. Prediction success overall was 93.4% (95% for non-
adherence to recommended walking levels, and 90.5% for adherence to 
recommended walking levels). The Wald criterion demonstrated that only walking 
personal control, made a significant contribution to prediction, B=3.102, SE=1.434, 
Wald(1)=4.683, p=.030. The other variables were not significant predictors. Exp(B) 
value indicates that an increase in walking personal control by one unit makes the 
odds ratio 22 times as large and therefore participants are 22 times more likely to 
adhere to walking recommendations.  
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Table 5.6 Logistic regression to predict adherence to recommended walking levels 
  95% CI for exp(B) 
 B (SE) Lower exp(B) Upper 
Included     
Constant -29.81 (13.81)    
Walking personal control 3.10 (1.43) 1.34 22.30 369.50 
Positive Walking Beliefs 4.95 (2.93) .00 .01 2.21 
Negative Walking Beliefs -4.50 (2.46) .74 90.39 1103.74 
Timeline 1.24 (.81) .70 3.45 16.95 
Consequences -.001(.50) .38 1.00 2.64 
Illness Personal Control -.45 (.38) .30 .64 1.33 
Identity .47 (.37) .77 1.60 3.31 
Concern -.26 (.27) .46 .78 1.30 
Illness Comprehensibility .35 (.32) .76 1.41 2.64 
Emotional Effect -.71 (.47) .20 .49 1.24 
Illness Treatment Control 2.06 (1.09) .93 7.83 66.08 
 
Health-related quality of life 
A series of multiple regression analyses were conducted with health-related quality of 
life as the dependent variable and firstly symptom representations as the independent 
variables; secondly walking representations as the independent variables; and thirdly 
the full model of illness and walking representations as the independent variables.  
 
Results of the first multiple regression with symptom representations as the 
independent variables showed that the model provided a significant fit of the data, 
F(8,60)=9.698, p<.001. The R for the model was .749, and the R2 was .561 (adjusted 
R2=.503), indicating that the model accounted for 56.1% of the variability in health-
related quality of life in this sample. Consequences (B=3.90, SE=1.46, t(8)=2.672, 
p=.010) and Identity (B=2.26, SE=1.06. t(8)=2.137, p=.037) had significant regression 
coefficients in the model. No other symptom representations were significant 
predictors in the model. 
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Results of the second multiple regression with walking representations as the 
independent variables showed that the model provided a significant fit of the data, 
F(3,59)=14.267, p<.001. The R for the model was .648, and the R2 was .420 (adjusted 
R2=.391), indicating that the model accounted for 42% of the variability in health-
related quality of life in this sample. Walking personal control (B=-3.52, SE=.92, t(3)=-
3.810, p<.001) had a significant regression coefficient; neither positive nor negative 
walking beliefs were significant predictors in the model.   
 
To test whether walking representations explained variation in health-related quality 
of life beyond that explained by symptom representations, a final multiple regression 
was conducted with symptom representations entered in the first block and walking 
representations entered in the second block. Results are shown in Table 5.7. The 
addition of treatment representations significantly improved the fit of the model, 
compared to symptom representations alone (R2=.56), F(3,49)=7.358, p<.001. The full 
model provided a significant fit of the data, F(11,49)=10.225, p<.001. The R for the 
model was .835, and the R2 was .697 (adjusted R2=.628) indicating that the model 
accounted for 69.7% of the variability in health-related quality of life in this sample. 
Only Illness Consequences and Walking Personal Control had significant regression 
coefficients in the model.
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Table 5.7 Multiple regression of illness and walking representations on health-
related quality of life in participants who have claudication pain 
  B SE B β 
Constant 22.12 13.81  
Consequences 3.71 1.45 .41* 
Timeline -.21 .93 -.03 
Illness Personal Control .34 .73 .04 
Treatment Personal Control -.45 .70 -.06 
Identity 1.26 1.04 .15 
Concern .09 .91 .01 
Illness Comprehensibility -.72 .59 -.11 
Emotional Effect .37 .79 .05 
Positive Walking 
Consequences 
-.37 3.15 -.11 
Negative Walking 
Consequences 
6.64 3.44 .18 
Walking Personal Control -1.94 .84 -.26* 
*p<.05    
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Discussion 
The aim of this study was to investigate the walking behaviour and illness and walking 
representations of a cohort of patients diagnosed with IC. 
 
 Seventy-one participants in the study (78.0%) continued to experience leg symptoms 
at the time of the postal questionnaire. This reflects the findings of the qualitative 
study, that despite treatment, including revascularisation, many participants continue 
to experience leg pain and other symptoms in the leg.    
 
There was a marked difference in walking behaviour between those participants who 
still experienced leg pain, and those who no longer experienced leg pain – with a 
significantly greater proportion of those who no longer experienced leg pain meeting 
the minimum recommended walking levels for patients with PAD of half an hour, 
three times a week. Only 32.4% of participants who still experienced leg pain reported 
meeting the minimum walking levels, compared to 70% of participants who no longer 
experienced leg pain. As this is a cross-sectional study, it is impossible to determine 
the direction of causality – whether the walking led to the improvement in leg 
symptoms or whether the improvement in leg symptoms led to more walking. 
 
The majority of participants (61.4%) did not recall receiving advice from medical 
professionals about walking, despite all patients being given advice about walking by 
the Vascular Assessment Nurse at the time of diagnosis. Possibly patients are 
overwhelmed with information at diagnosis, which causes to them forget key 
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information about the benefits of walking. However, 59 participants (67.8%) reported 
attempting to increase their walking levels after diagnosis with IC, which suggests that 
participants become aware that walking may be beneficial for them. Ultimately, only 
41.4% of all participants in the study both attempted to increase walking levels after 
diagnosis with IC, and maintained that increase. Reasons given for not maintaining 
increased walking levels included physical barriers such as pain and co-morbidities; 
environmental barriers such as the weather; and personal barriers such as lack of 
motivation, and having given up hobbies which required walking. This reflects Galea et 
al’s (2008) findings that patients with IC have personal, environmental and activity-
related barriers to walking. 
 
Participants in the group who still experienced leg pain, who met the recommended 
walking levels, had significantly greater pain-free walking distance than participants 
who did not adhere to recommended walking levels. This result is to be expected as it 
has been well-documented that increased walking in patients with IC leads to 
improvement in pain-free walking distance (e.g. Leng et al, 2000). However, causality 
and direction of effect cannot be determined from this study. 
 
An interesting finding was the number of participants (36.3%) who reported needing 
some form of care or support because of problems with their health. Significantly 
more participants in the group with leg pain required care than the group with no leg 
pain, which suggests that the need for care may be at least partly related to decreased 
general mobility as a result of IC. This mirrors the finding in the qualitative study that 
many participants with IC feel dependent on their families for help with transport, 
CHAPTER FIVE 
 
130 
 
shopping and housework. However, this need for care and support has not been 
reflected in the literature about PAD and IC to date. It would therefore seem that 
further work would be beneficial in this area.  
 
Participants reported a range of factors as causes of their PAD. Of particular interest is 
the low number of participants with diabetes who recognised their diabetes as a risk 
factor for development of PAD, out of the 12 participants who had diabetes, only 2 
cited diabetes as a cause of PAD. Similarly, 12 of the 34 current smokers did not list 
smoking as a cause of PAD. Also of interest is that more participants believed that 
exercise or strenuous physical work had caused PAD (n=16) than the number of 
people who recognised lack of exercise as a cause of PAD (n=13). Although many 
participants listed genuine risk factors of PAD like smoking, diet, family history, old 
age, high blood pressure and lack of exercise, several participants also listed causal 
beliefs which have nothing to do with the development of PAD, for example exercise 
and strenuous work, medication, stress, varicose veins, bad chairs and dust inhalation. 
Also, 8 participants reported that they had no idea what might have caused their PAD. 
These causal attributions mirror the findings from the qualitative study, that while 
patients with PAD have some idea of causes of their disease, several are unaware of 
behavioural risk factors which are relevant to them and which cause PAD. Some 
participants in both studies believed walking and exercise caused their PAD. This 
dysfunctional causal attribution may lead participants to avoid walking. This 
conclusion is supported by the fact that 75% of participants who believed walking 
caused PAD did not meet the minimum recommended walking levels. 
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Principal components analysis of psychological data from the group who still 
experienced pain revealed two key factors which accounted for over 50% of the 
variance in the data – one factor related to negative illness beliefs and was strongly 
associated with worse quality of life; the other factor related to positive illness and 
walking beliefs and was strongly positively associated with walking behaviour and less 
strongly positively associated with quality of life.  
 
Regression analysis revealed that walking representations were the most significant 
predictors of adherence to recommended walking levels, although the addition of 
symptom representations to the model further significantly improved the accuracy of 
prediction of adherence to recommended walking levels. Although the model as a 
whole accurately predicted walking behaviour 93.4% of the time, the only significant 
predictor within the model was walking personal control. Galea & Bray (2006) found 
that perceived behavioural control, a similar construct to walking personal control, 
was the only significant predictor of walking behaviour when applying the Theory of 
Planned Behaviour to walking activity in participants with IC. Given that patients with 
IC experience a range of barriers to walking, including pain, loss of power in the legs 
and concerns about potentially harming themselves by walking, it makes sense that 
confidence in walking, walking personal control, would play an important part in 
walking behaviour.  
 
Symptom representations as a set accounted for the greatest percentage of variability 
in health-related quality of life scores (56%), however the addition of walking 
representations to the model accounted for a further 13.7% of the variance in health-
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related quality of life. Overall, the psychological variables accounted for 69.7% 
variance in quality of life, however only consequences and walking personal control 
were significant predictors within the model.  
 
Limitations 
There are a number of limitations to this study. The study had a low response rate of 
34.7%. There are a number of possible reasons for this including the fact that this 
cohort of patients are elderly and have poor health, a large proportion of the cohort 
have walking pain and therefore may find posting mail difficult, and the cohort had 
been diagnosed up to 3 years before and therefore addresses may not have been 
current for all patients, it is therefore unknown how many people received the 
questionnaire.    
 
The majority of participants in the study (76.9%) had either received angioplasty 
(n=26) or surgery (n=44); 21 participants in the sample had received conservative 
treatment. The rate of angioplasty/surgery in NHS Forth Valley is around 56%, 
therefore disproportionately more participants who had received angioplasty or 
surgery returned the questionnaire than participants who were treated 
conservatively. This may be because patients who are treated conservatively are 
discharged from the vascular service at 3 month follow-up, therefore a considerable 
amount of time would have passed between discharge and the questionnaire being 
sent out to this group – this may have affected response rate. 
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Although the questionnaire asked a number of questions about walking behaviour, it 
would have benefited from a validated physical activity questionnaire to get a clearer 
idea of the amount and intensity of walking which participants undertake. 
 
Because participants had been diagnosed between 9 months and 3 years previously 
and had then been followed up for varying lengths of time by the vascular service 
depending on treatment, there was no consistent, recent measure of ABPI for this 
sample. A clinical measure of PAD severity would have been useful to control for 
disease severity in the prediction of walking behaviour and quality of life. 
 
Because some participants in the study reported no longer having any claudication 
pain, the overall sample was split into two groups – those with claudication pain, and 
those without. This, combined with a low response rate, meant that the sample sizes 
for statistical analysis were small - resulting in low power, and increasing the risk of a 
Type II error. While the regression analysis found that symptom and walking 
representations as a set reliably distinguished between adherers and non-adherers to 
recommended walking levels, only walking personal control made a significant 
contribution to prediction. It is possible that with a greater sample size, and therefore 
more power, other symptom and treatment representations may also have been 
found to provide a significant contribution to prediction in this analysis. Finally, this 
study is cross-sectional, and as such no conclusions can be drawn about causality or 
direction of effect. 
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Summary and implications 
This study found that the majority of participants still experience leg pain years after 
diagnosis of PAD and treatment of IC, and that the majority of participants who still 
experience leg pain do not meet minimum recommended walking levels. This confirms 
the findings of the qualitative study about the experience and behaviour of PAD 
patients after treatment for IC. Psychological variables from the CSM do appear to be 
related to both walking behaviour and health-related quality of life in patients with IC, 
and are strong predictors of walking behaviour and health-related quality of life. 
Walking personal control has emerged as a particularly important variable in relation 
to both walking behaviour and health-related quality of life in this study.  
 
The findings from this study suggest that while surgery and angioplasty are performed 
for symptom management, many patients still experience leg pain after 
revascularisation, and do not appear to change their walking behaviour to 
recommended levels as a result of revascularisation. The success of psychological 
variables in predicting walking behaviour in this study indicates that a psychological 
intervention to modify these psychological variables may increase walking behaviour 
in patients with IC.   
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MODIFYING ILLNESS AND TREATMENT REPRESENTATIONS TO 
INCREASE WALKING 
IN PATIENTS WITH INTERMITTENT CLAUDICATION 
– A PILOT RANDOMISED CONTROLLED TRIAL 
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Abstract 
Background: Supervised exercise has been shown to increase pain free walking 
distance and reduce symptoms of claudication (Leng et al, 2000). However, supervised 
exercise programmes are not widely available, require patient commitment to attend, 
and may not lead to lasting behaviour change beyond attendance at the programme. 
Psychological variables related to the initiation and maintenance of increased walking 
in claudicants include beliefs about Peripheral Arterial Disease (PAD) and beliefs about 
walking (Chapter 3). This pilot trial (ISRCTN28051878) studied whether a brief theory-
based psychological intervention to modify beliefs about PAD and beliefs about 
walking would lead to increased walking. 
Method: Sixty patients newly diagnosed with claudication were randomised into 2 
conditions. The control condition received usual care, and the treatment condition 
received usual care and a brief psychological intervention to modify illness and 
walking beliefs and develop a walking action plan. Participants were followed up after 
4 months. Daily steps were measured by pedometer. 
Results: There was a significant group*time interaction on mean daily steps (p=.001) 
with participants in the intervention group significantly increasing daily steps from 
baseline to follow-up (Mean=1303.45, SD=1813.00), and participants in the control 
group significantly decreasing daily steps from baseline to follow-up (Mean=-226.53, 
SD=1385.13). At follow-up participants in the intervention group reported significantly 
greater (p=.007) pain free walking distance than participants in the control group. 
Participants in the control group were 4 times more likely (p=.009) to opt for surgery 
at the 3 month meeting with the vascular surgeon than participants in the 
intervention group. 
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Conclusion: This trial demonstrates that a brief psychological intervention for patients 
with claudication can increase daily walking, increase pain free walking distance and 
reduce the demand for surgery at this stage of the disease. This has important 
implications for the design of services to treat patients with intermittent claudication. 
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Introduction 
This introductory section reviews relevant literature on walking in patients with IC. 
 
As outlined in Chapter 1, walking has been found to benefit patients with IC in terms 
of symptom reduction (Leng et al, 2000) and may also reduce cardiovascular morbidity 
and mortality (Khan et al, 2005). Garg et al (2006) found that PAD patients in the 
lowest quartile of levels of physical activity during daily life (as measured by 
accelerometer at baseline) had significantly higher mortality (Hazard ratio = 3.48) at 5 
year follow-up than those PAD patients in the highest quartile of physical activity 
levels during daily life, independent of age, sex, race, body mass index, hypertension, 
smoking, co morbidities, cholesterol levels, leg symptoms and ankle-brachial pressure 
index. In a similar study, Gardner, Montgomery & Parker (2008) classified patients 
with IC as either sedentary if they rated themselves as avoiding physical activity or 
only undertaking light physical activity occasionally; or physically active if they rated 
themselves as undertaking moderate physical activity regularly for a period of less 
than 1 hour per week, up to more than 3 hours per week. The physically active group 
of patients had significantly higher ambulatory function at baseline than the sedentary 
group, as measured by how far they could walk in metres in 6 minutes (Sedentary 
group M=341m (sd=86); Physically active group M=400m (sd=92)). An analysis of 
mortality rates after 5 years found that the risk of mortality in the physically active 
group was 0.51 that of the sedentary group; and 0.693 that of the sedentary group 
when controlling for all confounding variables. This study suggests that even low levels 
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of physical activity performed at a moderate intensity would be beneficial for patients 
with IC in terms of all-cause mortality. 
 
Supervised exercise programmes have been found to be more effective than advice 
alone in improving leg symptoms of patients with IC (Bendermacher et al 2006). 
However, in a recent survey of UK vascular surgeons (Shalhoub et al, 2009), only 24% 
of respondents had access to a supervised exercise programme for patients with PAD, 
with 72% of respondents claiming that they did not have access to a supervised 
exercise programme due to lack of resources. Where no supervised exercise 
programme was available, 63% of respondents gave verbal advice about walking to 
patients with PAD, and 34% offered leaflets. As well as low availability, other problems 
with supervised exercise programmes include the cost to patients, of transport to and 
from hospital several times a week to attend a supervised exercise programme in 
terms of time and money (Bendermacher et al, 2007); patients being too tired by the 
time they have arrived at hospital to comply with the training programme 
(Bendermacher et al, 2007); and high drop-out rates (up to 43%) from supervised 
exercise programmes which have been recorded in a number of studies (e.g. 
Cheetham et al, 2004; Kakkos, Geroulakos & Nickolaides, 2005). It is also unclear 
whether supervised exercise programmes lead to long-term behaviour change beyond 
the end of the training programme, or whether they change daily walking habits. 
Crowther et al (2008) found that while a 12 month supervised exercise programme 
which involved walking on a treadmill for at least 25 minutes three times a week, 
significantly increased the walking capability of patients with IC, the programme had 
no significant effect on physical activity levels as measured by pedometer. 
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It is clear from the qualitative study (Chapter 3) with patients who had already 
received surgical treatment or angioplasty for their IC, that some participants thought 
physical activity may have caused their IC, and most participants were unclear about 
how much walking they should be doing or the mechanism by which walking worked 
to improve their health. Most participants in the qualitative study had stopped 
walking for exercise due to claudication pain, and many expressed a lack of confidence 
in their walking abilities. In addition, participants were not aware of the long-term 
consequences of PAD, or reduced levels of physical activity, in relation to their risk of 
cardiovascular morbidity and mortality. This work has highlighted that many of the 
barriers to walking for patients with IC may be psychological, and indicates that an 
intervention to increase walking for patients could aim to address these maladaptive 
beliefs. 
 
Results from the cross-sectional study (Chapter 5) confirm the findings from the 
qualitative study, and show that psychological variables based on the CSM accurately 
predict walking behaviour in patients with IC. These psychological constructs have 
been found to be modifiable in studies with patients who have had a myocardial 
infarction, and have led to positive changes in health behaviour among those patients 
(Petrie et al, 2002; Broadbent et al, 2009). The findings from the qualitative and cross-
sectional studies in this thesis justify a trial to modify psychological variables based on 
the CSM to increase walking in patients with IC.  
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In a recent cross-sectional study of predictors of walking behaviour in patients with 
PAD and diabetes, Collins, Lunos & Ahluwalia (2010) measured participants’ self-
efficacy to manage a chronic disease, and walking ability on a treadmill walking test. 
There was a significant correlation between self-efficacy and walking ability (r 0.33, 
p=0.0036), and Collins et al (2010) suggested it may be beneficial to target self-efficacy 
in future interventions to increase walking in patients with PAD and diabetes. Bandura 
(1977) defined self-efficacy as an individual’s confidence that they can successfully 
perform a given behaviour to achieve a specified outcome. Bandura (1977) proposed 
that an individual’s level of self-efficacy determines the effort that they will invest in 
performing a given behaviour. In the context of the CSM, Leventhal & Mora (2008, p. 
55) propose that self-efficacy is ‘an indicator of the current status of an underlying 
causal process’ rather than a mechanism which produces health behaviours. Leventhal 
(2010, personal communication) therefore suggests that interventions designed to 
change behaviour should focus on functional variables which cause behaviour, and 
therefore participant self-efficacy should be considered as sitting within the ‘personal 
control’ domain of a treatment representation, alongside the other domains of a 
treatment representation; identity (the treatment label), cause (the causal mechanism 
by which the treatment provides benefit), timeline (ideas about the level of activity 
required, and the timeline for anticipating benefit), and consequences (beliefs about 
the positive and negative consequences of the treatment).  
 
Only two previous studies have been conducted which use psychological techniques to 
increase physical activity in patients with PAD. Collins, Krueger, Kroll & Sharf (2009) 
carried out a randomised controlled trial to compare a face-to-face communication 
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intervention with a video intervention to increase physical activity levels in patients 
with PAD. The communication intervention involved patients completing a 9-item 
survey about their awareness of PAD as a disease, their beliefs about the causes of 
PAD, their beliefs about walking for disease management, and their beliefs about 
factors which facilitate or hinder their walking behaviour; participants then met with a 
doctor for 15 – 20 minutes to discuss their responses to the survey and the doctor 
completed a prescription about walking levels specific to each participant’s ability, 
describing how often and for how long the participant should exercise each week. The 
video intervention involved participants watching a 7 minute video about PAD, which 
gave an overview of PAD and advice to stop smoking and increase exercise levels. 
Participants in both groups were followed-up at 12 weeks to measure changes in self-
reported physical activity. There were no changes in physical activity either between 
or within groups from baseline to follow-up. However, this was not a theory-based 
intervention, patients with both symptomatic and a-symptomatic PAD were included 
in the trial, and self-report measures of physical activity were used as the outcome 
measure rather than an objective measure of physical activity. 
 
Pochstein (2010, personal communication) carried out an intervention based on the 
Health Action Process Approach (Schwarzer, 1999) to increase action and coping 
planning in patients with IC. A secondary outcome of the study was change in physical 
activity, measured by self-report. The purpose of the intervention was to help 
participants who were motivated to walk to translate this motivation into action by 
using a volitional intervention to increase action and coping planning. The control 
group in this study received the standard therapy for PAD, although further details of 
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this are not given. Pochstein & Wegner (2010) found that volitional competence and 
physical activity were significantly higher at follow-up in the intervention group than 
in the control group. This study indicates that a psychological intervention which 
incorporates action and coping planning for patients with IC may increase physical 
activity, however, limitations of this study include lack of information about allocation 
to group, the treatment received by the control group, and the content of the 
intervention, and the lack of objective measurement of physical activity. 
 
A number of randomised controlled trials have tested whether theory-based 
psychological interventions can increase physical activity in a primary care setting, and 
have failed to show an improvement in physical activity in the intervention group 
compared to the control group (Kinmonth et al, 2008; The Writing Group for the 
Activity Counseling Trial Research Group, 2001; van Sluijs et al, 2005). All of these 
studies found that activity levels had increased from baseline to follow-up in both the 
intervention groups and the control groups. Kinmonth et al (2008) suggested that this 
increase in physical activity in the control groups may be due to measurement 
reactivity – the effect of measuring physical activity and its determinants on the 
behaviour of the person being measured.  
 
Implications for the current study 
The current study differs from the primary care studies (Kinmonth et al, 2008; The 
Writing Group for the Activity Counseling Trial Research Group, 2001; van Sluijs et al, 
2005) because  (i) the intervention was designed to address the barriers to walking 
CHAPTER SIX 
 
144 
 
particular to patients with IC, whereas other studies included heterogeneous groups 
of patients facing a wide range of unknown barriers to physical activity; (ii) the 
patients included in this study have sought treatment for their disease and were 
therefore presumably more motivated to adhere to treatment than patients being 
offered unsolicited interventions to increase physical activity; (iii) this study 
objectively directly measured behaviour change, in the form of mean daily steps as 
measured by pedometer, rather than relying on self-report measures of physical 
activity, or objective measures of fitness as a proximal measure of behaviour change. 
 
The present study aimed to assess whether a brief psychological intervention to 
modify illness and walking representations, based on the CSM, would increase 
physical activity in patients with IC.  
 
Participants in the qualitative study (Chapter 3) had already received either 
angioplasty or surgery and tended to view their health in a medical model, believing 
their ability to walk was the responsibility of the surgeon, and believing they 
themselves had little or no control over their health outcomes. Therefore, this study 
focused on patients newly diagnosed with IC, as their beliefs about the outcomes of IC 
were less likely to be influenced by the acute medical style of management of PAD.  
 
In NHS Forth Valley, patients are diagnosed with IC by a Vascular Assessment Nurse at 
an outpatient clinic, attend a further outpatient clinic for an ultrasound scan of their 
legs by a Vascular Technologist approximately 2 weeks later, and then meet with a 
Vascular Surgeon approximately 3 months after diagnosis to discuss possible 
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treatment options. The treatment options suggested by the Vascular Surgeon depend 
on the health of the patient, and the location and size of the narrowing of the artery, 
and are either for conservative management, angioplasty or bypass surgery. 
Regardless of the treatment option chosen, patients are followed up at further 
outpatient clinics for a minimum of 3 months. Symptomatic benefits of physical 
activity for IC have been recorded as early as 6 weeks into an exercise intervention 
(Clifford, Davies, Hayne & Baird, 1980). As the intervention in this chapter would be 
delivered to all participants at diagnosis, and approximately 10 weeks before their 
meeting with a vascular surgeon to decide on surgical treatment, a further aim of this 
study was to determine whether fewer participants in the intervention group would 
opt for surgery for symptom management than participants in the control group. 
 
Trial objectives 
To examine whether: 
 a brief psychological intervention can improve walking and quality of life for 
patients with intermittent claudication; 
 a brief psychological intervention can reduce the demand for surgery for 
symptom management; 
 improvement in walking is mediated by changes in illness and walking beliefs; 
 the brief psychological intervention is acceptable and understandable to 
participants. 
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Method 
Recruitment 
Participants were recruited from the Intermittent Claudication Outpatient Clinic in 
NHS Forth Valley. This is a nurse-led clinic which diagnoses people with IC. People are 
referred from GPs based in Forth Valley. At diagnosis, the Vascular Assessment Nurse 
invited consecutive patients to take part in the trial. The letter of invitation to this 
trial, participant information sheets and consent forms for this study can be found in 
Appendix 8. In order to check representativeness of the participants who agreed to 
take part in the trial, the Vascular Assessment Nurse asked for verbal consent to retain 
all patients’ age, gender and Ankle Brachial Pressure Index (ABPI) information, 
whether they agreed to participate in the trial or not. 
 
Two hundred patients are diagnosed each year in the Forth Valley Intermittent 
Claudication clinic. A sample size calculation carried out using GPower3 (Faul et al, 
2007), indicated that to carry out a (2) group by (2) time mixed ANOVA to detect a 
small group*time interaction effect size (0.2) with an alpha of 0.05, and a power of 
80%, the trial would require 26 participants in each condition. A small effect size of 0.2 
was selected in the sample size calculation based on a previous study of an exercise 
program for physical activity in patients with IC which measured walking outcomes 
using pedometers (Crowther et al, 2008). The sample size calculation was based on 
changes in the primary outcome measure. As this was a pilot study, a further aim was 
to determine the effect sizes achieved in the secondary outcome measures to help 
inform the sample size calculation for a larger, more definitive study. Based on a 
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previous study with patients from this population recruited at outpatient clinic, it was 
estimated that 25% of people may decline to participate in the study. Likely attrition 
rate from the study for this population was unknown, therefore a 10% attrition rate 
was estimated during the trial. The aim was to invite 80 patients to participate in the 
trial, of whom 60 were expected to agree to participate, and a further 6 to drop-out 
during the course of the trial. Based on typical numbers presenting at the clinic who 
are diagnosed with claudication, recruitment was estimated to take place at the rate 
of 2 participants/week.  
 
Inclusion criteria 
Newly diagnosed patients with IC in one or both legs were recruited into the study. 
A diagnosis of lower limb arterial disease causing IC was established by a vascular 
assessment nurse or consultant surgeon. This was based on a combination of 
investigations including post-exercise ABPI of below 0.9 (Cassar, 2006), and duplex 
ultrasound, magnetic resonance angiography (MRA) or computerised 
tomography angiography to provide an anatomic view of the arteries. 
 
Exclusion criteria 
Patients were excluded if they were unable to give informed consent (e.g. due to 
dementia) or if it was medically unadvisable for them to increase their daily walking, 
for example patients with severe cardiac disease, cancer, patients with severe debility 
e.g. who cannot walk unaided, or patients with a history of orthopaedic surgery which 
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affects walking.  Patients with an ABPI of less than 0.35 were also excluded as they 
were likely to be offered emergency surgery. 
 
Participants 
One hundred and nine patients newly diagnosed with IC were assessed for eligibility, 
of whom 35 were excluded from the study by the vascular assessment nurse, and 74 
were invited to take part in the study. Reasons for exclusion included personal 
acquaintance of researcher, dementia, unable to perform exercise test, cancer, critical 
ischemia, severe cardiac disease, severe debility due to arthritis, unable to walk 
unaided, and a history of orthopaedic surgery. Of the 74 who were invited to take part 
in the study, 14 were unwilling to participate, reasons given included didn’t have time 
(n=4), the researcher couldn’t get hold of them (n=4), no reason given (n=1), felt 
unable to contemplate walking (n=2), didn’t want to talk about herself (n=1), felt 
depressed (n=1), worried walking would make legs worse (n=1).    
 
Design 
This was a randomised controlled trial with patients newly diagnosed with IC randomly 
allocated to one of two groups. The protocol of the trial is registered as 
ISRCTN28051878, and is published (Cunningham, Swanson, O’Carroll & Holdsworth, 
2010). Allocation to group was carried out by RO’C, who used a computer generated 
random number table for allocation (http://www.randomizer.org/). The computer 
generated random number table was created at the start of the study by RO’C, who 
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was not involved in participant recruitment. MC assigned consecutive participant 
numbers to patients as their names were sent to her by the Vascular Assessment 
Nurse, each participant number corresponded to a treatment group as established in 
the computer generated random number table. MC assigned participants to groups 
before she had made any contact, and before she had received any information about 
them other than their name and phone number. Participants allocated to the control 
condition received usual care. Participants allocated to the intervention group 
received usual care and a brief, 2-session psychological intervention. The Vascular 
Assessment Nurse who provided usual care at diagnosis, and who recruited 
participants, was blind to participant allocation to groups. Other clinical staff in 
contact with participants during their care, e.g. Vascular Technologists and Vascular 
Surgeons, were also blind to participant allocation to groups. A CONSORT flowchart of 
the trial design is shown in Figure 6.1. 
 
Setting 
This was a single-centre community-based trial based in NHS Forth Valley, Scotland.  
 
Ethical approval 
Ethical approval was obtained from Fife and Forth Valley Research Ethics Committee 
(REC ref. no. 08/S0501/6).  
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Intervention 
Participants in the intervention group received 5 visits from the researcher in their 
own home, including 2 visits to complete questionnaires, 2 one hour intervention 
sessions, and 1 other visit to drop off pedometers. The design of the intervention is 
described in detail in Chapter 4. 
 
Session 1 
The researcher elicited participant beliefs about their illness, or about walking. 
Information was provided about the consequences of the illness, and about the 
behaviour-health link in order to modify illness and walking beliefs. Motivational 
interviewing techniques were used to deliver the intervention, asking open questions, 
prompting the participant to make self-motivating statements and evaluations of their 
own walking behaviour and moving participants to a point where they had expressed 
motivation or intention to change their walking behaviour. The pro-forma which was 
used to guide Session 1 can be found in Appendix 3. The information sheet used to 
provide participants with additional information about PAD can be found in Appendix 
4.  
 
Session 2 
The researcher worked with the participant to draw up an individualised walking 
action plan, based on the recommendation of walking to near maximal pain three 
times a week (Leng et al, 2000). Participants were encouraged to think about how 
they could adapt their daily routines to incorporate a half hour of continuous walking, 
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and were also encouraged to think of possible barriers which may prevent them from 
following their action plan, and strategies to cope with these barriers. Sniehotta et al 
(2006) found that a combination of action planning and coping planning led to much 
greater improvement in physical exercise than action planning alone. Action plans 
were typed up and laminated, and posted out to participants. A copy of the action 
plan proforma can be found in Appendix 5. 
 
Control 
Participants in the control group received 4 visits from the researcher, in their own 
home, including 2 visits to complete questionnaires and a further 2 visits to either 
drop off or pick up the pedometer. This is only 1 less visit from the researcher than 
participants in the intervention group. The researcher engaged control group 
participants in non-walking related conversation in an attempt to control for the 
potentially confounding effects of social contact. 
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Assess for eligibility and receive 
diagnosis/usual care – Vascular 
Assessment Nurse (n=109) 
Included (n=74) 
- Newly diagnosed patient with IC 
-  
Excluded (n=35) 
- Severe cardiac disease 
- Severe debility 
- History of orthopaedic surgery 
- ABPI of less than 0.35 
Invite to take part in intervention – Vascular Assessment Nurse (n=74) 
Randomised (n=60) - 
researcher 
Not randomised: 
-Declined to take part (n=14) 
Brief Intervention (n=30) 
Baseline Assessment 
Week 0 
Control (n=30) 
Baseline Assessment 
Week 0 
Session 1 
Week 1 
Pick up pedometer 
Week 1 
Session 2 
Week 2 
Phone Calls 
Weeks 6 & 12 
Phone Calls 
Weeks 6 & 12 
4 month Assessment 
Week 18 
4 month Assessment 
Week 18 
Analysed 
(n=29) 
Analysed 
(n=30) 
Dropped out of trial 
(n=1) 
Figure 6.1 CONSORT flowchart of trial design 
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Usual care 
Participants in the intervention group and control group received usual care while 
participating in the study. All participants were diagnosed as having IC by the Vascular 
Assessment Nurse, who provided all patients with an information sheet about PAD 
and advised patients to ‘stop smoking and start walking’. All participants then 
attended an outpatient clinic to meet with a Vascular Surgeon, who discussed 
appropriate treatment with the patient. Appropriate treatment depends on the age 
and health of the patient, the size and location of the narrowing of the artery, and on 
the patient’s wishes. If the patient chose surgical intervention they were put on a 
waiting list for surgery or angioplasty. If the patient chose conservative treatment, 
they were invited to attend a further outpatient clinic in 3 months time, and then 
discharged if their claudication symptoms remained stable. Patients who receive 
angioplasty are followed up by the surgeon for 1 year and then discharged; patients 
who receive surgery are followed up by the surgeon for 5 years. Prior to the start of 
this study, approximately 56% of patients diagnosed with IC in NHS Forth Valley went 
on to receive vascular intervention, usually within 6 months of diagnosis. 
 
At the time of 4 month follow-up in the RCT, all patients had attended the outpatient 
clinic to meet the Vascular Surgeon, and a treatment decision had been made. Two 
participants in the control group and one participant in the intervention group had 
received angioplasty before 4 month follow-up; all other participants in this study 
were on a waiting list and had not received treatment. 
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Telephone calls 
MC called participants in both groups, 6 and 12 weeks after recruitment into the 
study. The purpose of the call was to: 
 Intervention group - discuss progress against the action plan with participants 
in the intervention group, paying particular attention to barriers to walking, 
and encouraging participants to use their coping plans, and come up with 
alternative strategies to overcome barriers. Changes to a participant’s action 
plan or coping plan could be agreed with a participant in the phone call. 
 Both groups - ask participants if they had heard from the hospital and what 
treatment, if any, had been agreed upon. 
 Both groups - ask participants to answer 5 standard questions about general 
health, satisfaction with health, quality of life, pain rating, and pain free 
walking distance (see Chapter 4). Copies of the proformas used to guide the 
telephone calls for both groups can be found in Appendix 6. 
 
Outcome measures 
Measures were taken for participants in both arms of the study, at baseline and at 4 
month follow-up. All questionnaires were administered by MC. A copy of the 
questionnaire used in this study can be found in Appendix 2. 
 
The primary outcome measure for this study was walking behaviour as measured by 
pedometer (see Chapter 4). The secondary outcome measure for this study was 
clinical outcome, determined by demand for surgery/angioplasty versus conservative 
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treatment. Other outcome measures for this study included quality of life, symptom 
representations, walking representations, and intention to walk, which are described 
in Chapter 4. 
 
Analysis 
The internal consistency of multi-item measures was assessed using Cronbach’s alpha, 
using an acceptability criterion of α≥0.7. Bivariate correlations were used to explore 
associations between variables at baseline. An exploratory principal components 
analysis was conducted to identify a factor structure in the baseline data, to provide 
an understanding of the underlying structure of symptom and treatment 
representations and their relationship with walking behaviour and quality of life. The 
distribution of each measure was checked for significant skewness and kurtosis, and 
where necessary data was transformed to a normal distribution using logarithmic 
transformations (daily steps, negative walking consequences, positive walking 
consequences, intention to walk and intention to walk through the pain were 
transformed for both time points). Data screening revealed no outliers. Baseline 
demographic measures were compared between the two groups using t-tests and chi-
squared tests, to check that participants in the groups were similar. Data was analysed 
using an intention to treat protocol in a repeated measures mixed design (2 groups*2 
time points), to determine whether there were significant group*time interaction 
effects. Data was missing at 4-month follow-up for 1 participant (intervention group, 
dropped out of study), therefore their baseline data was carried forward to 4-month 
follow-up, assuming that this participant who did not take part in follow-up 
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measurement had no change from baseline values.  The three participants who had 
received angioplasty prior to 4-month follow-up (1 intervention group and 2 control 
group) were analysed according to the group to which they had been assigned. One 
participant in the intervention group lost his pedometer during the baseline 
measurement and refused to wear a pedometer from then on, however he still 
wanted to take part in the study, therefore he was included in the analysis of all 
variables except walking by pedometer. Between-group differences in uptake of 
surgery, and categorical variables measuring walking behaviour were measured using 
a chi-square test. The mediation analysis was conducted using bootstrapping, using a 
script provided by Preacher & Hayes (2008). Data was entered into PASW Statistics 17, 
and all analysis was carried out using this software package. Bonferroni correction was 
not applied to the analysis as all inferential analyses were planned a-priori in line with 
theory. Bonferroni adjustments are considered unnecessary in planned, theory based 
analysis with specific a-priori hypotheses (Perneger, 1998). 
 
Evaluation 
On completion of the study, participants in the intervention group were asked 
additional semi-structured questions about their experience of the intervention 
including what they thought of their action plan, whether they followed their action 
plan, whether the barriers they had predicted prevented them from following their 
action plan, whether they used their coping plan, whether they intend to follow their 
action plan in the future, and whether they thought it was worthwhile to take part in 
the study.
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Results 
Internal consistency of the multi-item measures was satisfactory for most items: 
Cronbach’s alpha: Walking personal control (9 items) = 0.96; Intention to walk (3 
items) = 0.83; Intention to walk through pain (3 items) = 0.93; Positive Walking 
Consequences (8 items) = 0.74; Health-related Quality of Life (16 items) = 0.88.  
 
The Cronbach’s Alpha for Negative Walking Consequences (5 items) = 0.62, below the 
recommended cut-off of 0.70. This statistic could not be improved by removal of items 
from the scale. A Cronbach’s alpha of less than 0.7 implies poor consistency within the 
scale. However, the calculation of Cronbach’s alpha is affected by the number of items 
in the scale – with scales with less items (e.g. 5) having a greater chance of having a 
lower alpha score. While higher alpha values indicate more reliable scales, many 
scales measuring psychological constructs use 0.6 as the minimum acceptable alpha 
value (e.g. Baars et al, 2005; Hrisos et al, 2009).    
Study population 
Of 74 invited patients, 60 (81%) consented to take part in the study. Gender, age and 
ABPI data were collected for the 14 participants who were invited but declined to take 
part in the study, in order to check representativeness of the study population. There 
were no significant differences in age, gender or ABPI in the worst leg between the 
patients who declined to take part in the study and those who agreed to take part in 
the study.  
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Table 6.1 presents the characteristics of the study population at baseline. There were 
no statistically significant differences between the intervention group and the control 
group on the demographic or risk factor variables assessed, however significantly 
more participants in the intervention group reported having heart disease than in the 
control group (2 (1) = 5.08, p = 0.024). Heart disease (yes/no) was therefore entered 
as a covariate into the analysis of group differences.  
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Table 6.1  Baseline Characteristics: Control Group, Intervention Group and 
Overall Study Population 
 
 
 Correlations between variables at baseline 
Table 6.2 illustrates the correlations between all variables at baseline.  
 
A belief in more negative consequences of IC was significantly positively correlated 
with reporting a greater number of symptoms in the leg (BIPQ Identity), having higher 
levels of concern about IC, feeling more affected emotionally by IC, having poorer 
health-related quality of life, and reporting  a better understanding of IC (BIPQ Illness 
Comprehensibility); and significantly negatively correlated with personal control over 
IC. 
 
 Control Group 
(n=30) 
Intervention 
Group (n=30) 
Total  
(n=60) 
Demographics    
Age, mean (SD) 64.50 (10.19) 66.07 (6.30) 65.28 (8.44) 
Male, no. (%) 21 (70) 19 (63.3) 40 (66.7) 
Living alone, no. (%) 5 (16.7) 3 (10) 8 (13.3) 
Retired, no. (%) 21 (70) 26 (86.7) 47 (78.3) 
ABPI, mean (SD) 0.74 (0.22) 0.75 (0.17) 0.75 (0.19) 
Risk Factors     
Daily Steps, mean (SD) 3826.0(2312.8) 4095.1(2316.9) 3958.3(2299.0) 
Diabetes, no. (%) 8 (26.7) 5 (16.7) 13 (21.7) 
Smoker, no. (%)    
- Yes 11 (36.7) 10 (33.3) 21 (35) 
- Never 3 (10) 2 (6.7) 5 (8.3) 
- Given Up 16 (53.3) 18 (60) 34 (56.7) 
Dietary behaviour, mean (SD) 4.97 (1.31) 4.90 (1.35) 4.93 (1.32) 
Co morbidities    
Heart Disease, no. (%) 5 (16.7) 13 (43.3) 18 (30) 
Stroke, no. (%) 5 (16.7) 5 (16.7) 10 (16.7) 
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A belief that IC would last for a long time (IPQ Timeline) was not significantly 
correlated with any other variable. 
 
Personal control over IC was significantly positively correlated with beliefs in positive 
walking consequences, and walking personal control; and significantly negatively 
correlated with beliefs in negative walking consequences, and having poorer health 
related quality of life. 
 
The level of symptoms experienced as a result of IC was significantly positively 
correlated with concern about IC, emotional effect of IC, poorer health related quality 
of life and beliefs in negative walking consequences. 
 
Concern about IC was significantly positively correlated with emotional effect of IC and 
poorer health related quality of life. 
 
Emotional effect of IC was significantly positively correlated with beliefs in negative 
walking consequences and poorer health related quality of life. 
 
A better understanding of IC was significantly positively correlated with walking 
personal control, intention to walk for at least half an hour at least 3 times a week, 
and intention to carry on walking until the pain is almost unbearable before stopping 
for a rest; and significantly negatively correlated with beliefs in negative walking 
consequences. 
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Belief in positive walking consequences was significantly positively correlated with 
walking personal control, intention to walk for at least half an hour at least 3 times a 
week, intention to carry on walking until the pain is almost unbearable before 
stopping for a rest, and mean daily steps; and significantly negatively correlated with 
beliefs in negative walking consequences and having poorer health related quality of 
life. 
 
Belief in negative walking consequences was significantly negatively correlated with 
walking personal control, intention to walk and intention to walk through the pain; 
and significantly positively correlated with having poorer health related quality of life. 
 
Walking personal control was significantly positively correlated with intention to walk, 
intention to walk through the pain and mean daily steps; and significantly negatively 
correlated with poorer health related quality of life. 
 
Intention to walk was significantly positively correlated with intention to walk through 
the pain and mean daily steps.  
 
Intention to walk through the pain was significantly positively correlated with mean 
daily steps. 
 
Mean daily steps was significantly negatively correlated with poorer health related 
quality of life.  
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Table 6.2  Correlations, means and standard deviations of all variables at baseline 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1.BIPQ 
Consequence 
-              
2.BIPQ Timeline .155 -             
3.BIPQ Personal 
Control 
-.317* -.152 -            
4.BIPQ Identity .571** .115 -.189 -           
5.BIPQ Concern .575** .012 -.158 .359** -          
6.BIPQ Emotions .590** .096 -.237 .403** .496** -         
7.BIPQ Illness 
Comprehensibility 
.284* .000 .018 .099 .156 .217 -        
8.Positive Walking 
Consequences 
.004 -.074 .453** -.088 .066 -.085 .196 -       
9.Negative Walking 
Consequences 
.119 .010 -.258* .299* .093 .297* -.288* -.370** -      
10.Walking 
Personal Control 
-.141 .004 .364** -.069 -.106 -.218 .381** .473** -.409** -     
11.Intention to 
walk 
.149 .130 .207 .106 .160 -.053 .427** .370** -.286* .650** -    
12.Intention to 
walk 
 through pain 
.111 .012 .156 .062 .041 -.074 .292* .280* -.372** .618** .592** -   
13.Mean daily 
steps 
-.168 .181 .188 .032 -.137 -.073 .177 .324* -.247 .509** .282* .379** -  
14.HRQoL .593** .045 -.402** .468** .482** .521** .049 .335** .485** -.378** -.047 -.213 -.339** - 
Mean Score 6.25 6.78 4.22 7.13 7.52 5.23 6.83 3.02 1.71 5.57 7.44 7.26 3958.27 35.62 
SD 2.61 2.73 3.12 2.09 2.43 3.35 3.45 .60 .64 3.3 3.0 3.69 2298.76 17.23 
 
* Correlation is significant at the .05 level, ** Correlation is significant at the .01 level
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Principal components analysis was conducted with 13 of the 14 variables listed 
(excluding symptom representation Timeline as it did not correlate significantly with 
any other variable and was therefore not suitable for inclusion in a components 
analysis) to identify clusters of variables which correlated highly with each other.  The 
Kaiser-Meyer-Olkin measure of sampling adequacy was .799, and Bartlett’s test of 
sphericity was significant (2 (78) = 297.64, p < .001), indicating suitability of the data 
for principal components analysis. The initial eigenvalues showed that the first factor 
explained 30.5% of the variance, the second factor 23.6% of the variance and a third 
factor 8% of the variance. None of the other factors had an eigenvalue over 1.  
 
The two factor structure, explaining 54.1% of the variance was examined using a 
varimax rotation and results are shown in Table 6.3. This principal components 
analysis revealed two clusters: 
- Walking personal control, intention to walk, intention to walk through the pain, 
beliefs about positive walking consequences, illness comprehensibility, personal 
control of the illness, and daily steps were all positively loaded onto the first cluster, 
and beliefs about negative walking consequences was negatively loaded onto the first 
cluster. 
- Illness consequences, concern about the illness, emotional effect of the illness, and 
illness symptoms were all positively loaded onto the second cluster, and disease 
specific quality of life was negatively loaded onto the second cluster (because on this 
scale lower scores indicate better quality of life).  
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This principal components analysis broadly supports the theory that participants hold 
separate beliefs about walking (cluster 1) and about their illness (cluster 2). 
 
Table 6.3 Factor loadings based on principal components analysis with varimax 
rotation for baseline variables 
 Cluster 1 Cluster 2 
Walking personal control .853  
Intention to walk .777  
Intention to walk through pain .747  
Positive walking consequences .637  
BIPQ - Illness comprehensibility .613  
Negative walking consequences -.576  
Daily steps .567  
BIPQ – personal control .403  
BIPQ – consequences  .873 
Disease specific quality of life  .782 
BIPQ – concern  .744 
BIPQ – emotions  .740 
BIPQ – identity  .696 
   
 
Outcomes 
The primary outcome for this trial was walking behaviour as measured by pedometer. 
This is presented alongside other measures of behaviour change – self-report walking, 
pain free walking distance, clinical outcome, and dietary behaviour. Secondary 
outcomes included quality of life and the psychological variables, these are presented 
after the behavioural measures. Finally, multi-variable mediation analysis is presented 
to identify psychological variables which mediate the relationship between trial group 
and walking behaviour. 
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Physical activity - pedometer 
Results for mean daily steps at baseline and 4 month follow-up are shown in Figure 6.2 
and Table 6.4. Analyses were carried out after controlling for baseline differences in 
heart disease and walking by entering baseline values as a covariate. There was a 
significant group*time interaction effect on mean daily steps F(1,55)=12.284, p=.001, 
partial η2=.183. Specifically, although both groups had similar walking levels at 
baseline, the intervention group had significantly increased walking levels at 4-month 
follow-up, t(28)=2.859, p=.008, 95% Confidence Interval (CI) -.158 to -.026; whereas 
the control group had a significant decline in walking levels at 4-month follow-up, 
t(29)=-2.268, p=.031, 95% CI .008 to .154. Mean daily steps at baseline were entered 
as a covariate into the model since participants with diabetes, in both groups, had 
significantly lower levels of walking (Mean daily steps at baseline = 2607.67, SD = 
1505.4) than participants without diabetes (Mean daily steps at baseline = 4339.96, SD 
= 2351.73), t(30.404)=3.192, p=.003. Lower walking levels in patients with diabetes 
may be due to peripheral neuropathy.  
 
Contact time 
A possible limitation of this study was the extra time which the researcher spent with 
participants in the intervention group, compared to time spent with participants in the 
control group. Total time spent with each participant and on the phone to participants 
was recorded during the trial. There was a non-significant correlation between time 
spent with participants in the intervention group and change in walking, r=.082, n=29, 
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p=.673, which provides some evidence that contact time was not an influential factor 
in whether participants increased their walking behaviour. 
 
Physical activity – IPAQ 
Total activity score, and amount of time sitting, were calculated for participants using 
the IPAQ. Median scores, and interquartile ranges for activity and time sitting are 
presented in Table 6.5. There was no significant change in activity between the two 
groups from baseline to follow-up, U=382.0, ns. However, there was a significant 
difference between the two groups in change in time spent sitting, U=301.0, p=.026.  
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Table 6.4  Outcome variable scores in the intervention and control groups at 
baseline and 4 month follow-up (intention-to-treat data) 
 
 Control Intervention  
 Baseline Follow-up t Baseline Follow-up t F 
PA - ped 3826.0 
(2312.8) 
3599.4 
(2850.3) 
-2.27* 4095.1 
(2316.9) 
5398.6 
(3196.9) 
2.86** 12.28** 
QoL 40.36 
(18.54) 
35.03 
(22.79) 
-1.61 30.87 
(14.62) 
19.95 
(18.10) 
-3.47** 2.45 
WPersControl 5.29 
(3.55) 
4.43 
(4.08) 
-1.61 5.85 
(3.03) 
7.49 
(2.85) 
4.05*** 12.22** 
WPosCons 2.98 
(.58) 
2.81 
(.80) 
-.82 3.06 
(.63) 
3.50 
(.56) 
3.13** 7.07* 
WNegCons 1.69 
(.70) 
1.87 
(.81) 
1.12 1.73 
(.58) 
1.25 
(.50) 
-5.46*** 11.44** 
IntWalk 7.49 
(3.17) 
5.74 
(3.21) 
-2.89** 7.40 
(2.89) 
8.42 
(2.44) 
1.74 8.38** 
IntPain 7.14 
(3.99) 
6.87 
(3.93) 
-.60 7.38 
(3.43) 
9.29 
(1.68) 
3.21** 6.53* 
BIPQCons 6.63 
(2.48) 
6.20 
(2.72) 
.98 5.87 
(2.71) 
5.20 
(2.68) 
-1.13 1.40 
BIPQTime 7.37 
(2.87) 
5.97 
(3.62) 
-1.87 6.20 
(2.50) 
6.17 
(3.07) 
-.07 .23 
BIPQPersCont 3.87 
(3.07) 
4.43 
(3.17) 
.98 4.57 
(3.18) 
6.47 
(3.38) 
2.36* 5.02* 
BIPQID 7.20 
(2.20) 
6.80 
(2.38) 
-.83 7.07 
(2.02) 
5.43 
(2.57) 
-2.98** 5.00* 
BIPQConcern 7.63 
(2.61) 
6.90 
(3.34) 
-1.35 7.40 
(2.28) 
6.23 
(3.22) 
-1.76 .42 
BIPQComp 7.87 
(3.10) 
8.60 
(2.34) 
1.18 5.80 
(3.52) 
8.27 
(2.77) 
3.46** .02 
BIPQEmotion 6.17 
(3.13) 
4.93 
(3.48) 
-2.43* 4.30 
(3.35) 
3.20 
(3.03) 
-1.95 .59 
Diet 4.97 
(1.31) 
4.68 
(1.46) 
-1.53 4.90 
(1.35) 
5.27 
(1.09) 
1.71 8.46** 
PA – ped, Physical activity measured by pedometer; QoL, Quality of Life measured by 
the Intermittent Claudication Questionnaire; WPersControl, Walking Personal Control; 
WPosCons, Positive Walking Consequences; WNegCons, Walking Negative 
Consequences; IntWalk, Intention to walk for at least half an hour at least 3 times a 
week; IntPain, Intention to walk through the pain until it is unbearable before stopping 
for a rest; BIPQCons, symptom representation Consequences; BIPQTime, symptom 
representation Timeline; BIPQPersCont, symptom representation Personal Control; 
BIPQID, symptom representation Identity; BIPQConcern, symptom representation 
Concern; BIPQComp, symptom representation Illness Comprehensibility; BIPQ 
Emotion, symptom representation Emotion. 
Values given are unadjusted means (standard deviation) 
‘F’ is the F statistic for the ANOVA test of the Null Hypothesis - no significant 
time*group interaction 
*p<.05; **p<.01;***p<.001 
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Specifically, participants in the intervention group reported significantly less time 
sitting/day at follow-up compared to at baseline, z=-3.166, p=.002; while participants 
in the control group reported no significant change in the amount of time they spent 
sitting/day.   
 
Table 6.5 IPAQ scores at baseline and follow-up 
 Control Intervention 
 Baseline Follow-up Baseline Follow-up 
Total Activity(METmins/week)     
Median 1141.50 599.75 1135.50 1359.50 
Interquartile range 2259.00 2802.75 2943.38 2150.25 
Sitting (mins/day)     
Median 480.00 450.00 480.00 360.00 
Interquartile range 360.00 450.00 360.00 180.00 
 
 
Walking behaviour – Intermittent Claudication 
As discussed in Chapter 4, recommended walking behaviour for patients with IC can 
be split into two distinct behaviours (i) walking to near maximal pain before stopping 
to rest, and (ii) walking for at least half an hour three times a week. 
 
(i) Participants were asked how often they carry on walking after the pain has started 
in their leg, with three possible responses, ‘Never’, ‘For a few steps’ and ‘Until the pain 
is nearly unbearable’. The responses ‘Never’ and ‘For a few steps’ were amalgamated 
in the analysis to form a category ‘Not continuing to maximal pain’, to meet the 
minimum cell count requirements for the chi-square test. Results are shown in Table 
6.6. There was no significant difference between the groups at baseline in walking into 
the pain behaviour, however, there was a significant difference between the groups at 
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4 month follow-up, 2(1)=12.273, p<.001, with more participants in the intervention 
group continuing to walk through the pain to near maximal pain before stopping for a 
rest, than participants in the control group. 
 
Table 6.6 Self-report walking through the pain at baseline and follow-up 
 Not continuing to maximal pain Continuing to maximal pain 
Baseline   
Intervention 11 (36.67%) 19 (63.33%) 
Control 16 (53.33%) 14 (46.67%) 
4 month follow-up   
Intervention 2 (6.67%) 28 (93.33%) 
Control 14 (46.67%) 16 (53.33%) 
 
(ii) Participants were asked how often they walk for at least half an hour, with six 
possible responses. The responses ‘Never’, ‘Once or twice a month’ and ‘1-2 times a 
week’ were amalgamated into one category, ‘Walking less than 3 times a week’; and 
the responses ‘3 times a week’, ‘4-5 times a week’, ‘Everyday’ were amalgamated into 
one category ‘Walking at least 3 times a week’, to meet the minimum cell count 
requirements for the chi-square test. Results are shown in Table 6.7. There was no 
significant difference between the groups at baseline, although there was a trend 
towards more people in the control group walking for at least half an hour at least 
three times a week than in the intervention group. At 4 month follow-up, there was a 
significant difference between the groups, 2(1)=6.667, p=.010, with more participants 
in the intervention group walking for at least half an hour three times a week, and 
more participants in the control group walking for less than half an hour three times a 
week. 
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Table 6.7 Self-report walking for at least half an hour at baseline and follow-up 
 Walking less than 3 
times/week 
Walking at least 3 
times/week 
Baseline   
Intervention 23 (76.67%) 7 (23.33%) 
Control 16 (53.33%) 14 (46.67%) 
4 month follow-up   
Intervention 10 (33.33%) 20 (66.67%) 
Control 20 (66.67%) 10 (33.33%) 
 
Pain free walking distance 
Pain-free walking distance was measured by asking participants how far they could 
walk until the onset of pain, with 6 possible choices from ‘0 yards’ to ‘More than a 
mile’. This question was asked at baseline, follow-up and in the two telephone calls. 
The final three categories, ‘Up to ½ mile’, ‘Up to 1 mile’ and ‘More than 1 mile’ were 
amalgamated to form one category, ‘Over ½ mile’, to meet the minimum cell count 
requirements for a chi-square test.  Results are shown in Table 6.8. There was no 
significant difference in cell counts at baseline, however there were significant 
difference between the observed and expected cell counts between the two groups at 
the first call, 2(3)=8.691, p=.034; at the second call, 2(3)=8.315, p=.040; and at 4 
month follow-up, 2(3)=12.038, p=.007. Specifically, more participants in the 
intervention group reported longer pain free walking distances at all follow-ups than 
participants in the control group. 
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Table 6.8 Pain free walking distance across the trial period 
 0 yards Up to 100 
yards 
Up to 250 
yards 
Over ½ mile 
Intervention     
Baseline (n=30) 5(16.67%) 14(46.67%) 10(33.33%) 1(3.33%) 
Call 1 (n=28) 2(7.14%) 5(17.86%) 15(53.57%) 6(21.43%) 
Call 2 (n=25) 3(12.0%) 6(24.0%) 8(32.0%) 8(32.0%) 
Follow-up (n=30) 2(6.67%) 5(16.67%) 9(30.0%) 14(46.67%) 
Control      
Baseline (n=30) 5(16.67%) 17(56.67%) 4(13.33%) 4(13.33%) 
Call 1 (n=28) 8(28.57%) 9(32.14%) 6(21.43%) 5(17.86%) 
Call 2 (n=22) 7(31.82%) 10(45.45%) 2(9.09%) 3(13.64%) 
Follow-up (n=30) 9(30.0%) 11(36.67%) 3(10.0%) 7(23.33%) 
 
Clinical outcome 
Results for clinical outcome are shown in Table 6.9. Significantly fewer participants in 
the intervention group had opted for either angioplasty or surgery at 4-month follow-
up than participants in the control group, 2(1)=6.787, p=.009. The odds ratio for 
clinical outcome was 4.125, indicating that participants in the control group were 
4.125 times more likely to opt for revascularisation than participants in the 
intervention group.  
 
Table 6.9 Clinical Outcome by Experimental Group 
 Control Group 
(n=30) 
Intervention 
(n=30) 
Revascularisation 18 (60%) 8 (26.67%) 
No revascularisation 12 (40%) 22 (73.33%) 
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Dietary behaviour 
Results for dietary behaviour are shown in Table 6.4, and Figure 6.3. There was a 
significant group*time interaction effect on dietary behaviour, F(1,57)=8.463, p=.005, 
partial η2=.129. Participants in the intervention group showed a non-significant 
improvement in diet from baseline to follow-up, while participants in the control 
group showed a non-significant worsening in dietary behaviour. 
 
Quality of life 
Results for the disease specific measure of quality of life are shown in Table 6.4. There 
was a significant difference between the groups on baseline measures of disease 
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specific quality of life, t(58)=-2.200, p=.032, with the intervention group reporting 
significantly better mean quality of life than the control group. Therefore quality of life 
at baseline was entered as a covariate in the analysis. There was no significant 
group*time interaction effect, and no significant main effects for group or time on 
quality of life after adjustment for baseline values. There was a significant within-
group improvement in disease specific quality of life from baseline to follow-up in the 
intervention group, t(29)=3.474, p=.002, 95% CI 4.49 to 17.35; there was a non-
significant improvement in control group disease specific quality of life.  
 
Quality of life was also measured at baseline, 4 month follow-up and in the two 
telephone calls with the single item question ‘How would you rate your quality of life?’ 
which had five possible responses on a Likert scale, ranging from ‘Very poor’ to ‘Very 
good’. Data was collected at all 4 time points for 25 participants in the intervention 
group and 22 participants in the control group. Results for general quality of life are 
shown in Figure 6.4. There was a significant group*time interaction effect on general 
quality of life, F(3,132)=4.613, p=.004, partial η2=.095. Participants in the intervention 
group reported a significant improvement in general quality of life over time, 
F(3,69)=5.504, p=.002, partial η2=.193; while participants in the control group 
reported a non-significant decrease in general quality of life over time. 
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Walking personal control 
Results for walking personal control are shown in Table 6.4 and Figure 6.5. There was 
a significant group*time interaction effect on walking personal control, 
F(1,57)=12.219, p=.001, partial η2=.177. Specifically, although both groups had similar 
levels of walking personal control at baseline, the intervention group had significantly 
increased levels of walking personal control from baseline to 4 month follow-up, 
t(29)=4.052, p<.001, 95% CI .811 to 2.463; whereas there was a non-significant 
decrease in levels of walking personal control from baseline to follow-up in the control 
group.  
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Positive walking consequences 
Results for beliefs in positive consequences of walking are shown in Table 6.4 and 
Figure 6.6. There was a significant group*time interaction effect on beliefs about 
positive walking consequences, F(1,57)=7.071, p=.010, partial η2=.110. Specifically, 
although both groups had similar levels of beliefs about the positive consequences of 
walking at baseline, beliefs in the positive consequences of walking increased 
significantly from baseline to follow-up in the intervention group, t(29)=3.131, p=.004, 
95% CI .039 to .185; whereas there was a non-significant decrease in beliefs about the 
positive consequences of walking from baseline to follow-up in the control group.  
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Negative walking consequences 
Results for beliefs about the negative consequences of walking are shown in Table 6.4 
and Figure 6.7. There was a significant time*group interaction effect on negative 
beliefs about walking, F(1,57)=11.438, p=.001, partial η2=.167. Post-hoc analysis 
revealed that negative beliefs about the consequences of walking decreased 
significantly from baseline to follow-up in the intervention group t(29)=-5.463, p<.001, 
95% CI -.117 to -.053; whereas there was a non-significant increase in the negative 
beliefs about the consequences of walking from baseline to follow-up in the control 
group. 
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Intention to walk 
Results for intention to walk for at least half an hour at least three times a week are 
shown in Table 6.4 and Figure 6.8. There was a significant group*time interaction 
effect on intention to walk, F(1,57)=8.380, p=.005, partial η2=.128. Post-hoc analysis 
revealed that there was a non-significant rise in intention to walk in the intervention 
group from baseline to follow-up; there was a significant decrease in intention to walk 
in the control group from baseline to follow-up t(29)=-2.885, p=.007, 95% CI -.355 to -
.060. 
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Intention to walk through pain 
Results for participants’ intention to carry on walking through the pain and only stop 
walking when the pain is unbearable are shown in Table 6.4 and Figure 6.9. There was 
a significant time*group interaction effect on intention to walk through the pain, 
F(1,57)=6.529, p=.013, partial η2=.103. Post-hoc analysis revealed that intention to 
walk through the pain increased from baseline to follow-up in the intervention group, 
t(29)=3.207, p=.003, 95% CI .089 to .404; there was a non-significant decrease in 
intention to walk through the pain from baseline to follow-up in the control group. 
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Symptom representations 
Results for symptom representations are shown in Table 6.4. Symptom 
representations data was analysed in a repeated measure ANCOVA with the baseline 
value of symptom representation variables entered as a covariate and change in the 
symptom representation over time as the dependent variable, following the analytic 
methods of Broadbent et al (2009) and Petrie et al (2002) when analysing illness 
representations. 
 
There was a significant group*time interaction for the personal control symptom 
representation, F(1,56)=5.024, p=.029, partial η2=.082, such that participants in the 
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intervention group had significantly increased personal control from baseline to 
follow-up, t(29)=2.358, p=.025, 95% CI .252 to 3.548, whereas the control group did 
not. 
 
There was a significant group*time interaction for the identity symptom 
representation, F(1,56)=5.004, p=.029, partial η2=.082, such that participants in the 
intervention group reported experiencing significantly fewer symptoms from baseline 
to follow-up, t(29)=-2.982, p=.006, 95% CI -2.753 to -.513, whereas the control group 
did not. 
 
There were no significant group*time interactions for the other symptom 
representations. However, there was a significant within group improvement in the 
illness comprehensibility symptom representation from baseline to follow-up in the 
intervention group, t(29)=3.463, p=.002, 95% CI 1.01 to 3.92; while there was a small 
non-significant improvement in illness comprehensibility in the control group. There 
was a significant within group reduction in the emotional effect of IC in the control 
group from baseline to follow-up, t(29)=-2.434, p=.021, 95% CI -2.27 to -.20; while 
there was a non-significant reduction in the emotional effect of IC in the intervention 
group. 
 
Mediation analysis 
A series of regression analyses was conducted to examine mediation effects in a 
multiple mediator model, following the procedure described in Preacher & Hayes 
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(2008). The procedure involves calculating the total effect of an independent variable 
(IV) on a dependent variable (DV), given as a regression coefficient; the direct effect of 
an IV on a DV after factoring out the effect of the mediators on the DV, given as a 
regression coefficient; and then calculating the effect of the mediators on the DV 
(total effect of IV on DV – direct effect of IV on DV). Mediation is considered to have 
occurred when the difference between the total and direct effects is significant.  
 
Illness and walking representations as mediators of the group-walking behaviour 
relationship 
In the first model considered, the IV was treatment group; the DV was walking at 4 
month follow-up measured by pedometer; and the mediators were the illness and 
walking representations at 4 month follow-up (ten mediator variables). Baseline 
measures for all variables were entered as covariates in the model. Bootstrapping 
techniques were used to estimate the indirect effect of the IV on the DV, based on 
5000 bootstrap samples. Bootstrapping is recommended when using small samples in 
multiple mediator models, as the assumption of normality of the sampling distribution 
of the total and specific indirect effects may not be met (Preacher & Hayes, 2008).  
 
The results of the mediation analysis show that taken as a complete set, symptom 
representations and walking representations do not mediate the relationship between 
group and walking. The total effect of group on walking was .1906, p=.0012, and the 
direct effect of group on walking was .1134, p=.1608. The difference between the total 
and direct effects - the total indirect effect through the ten mediators (7 symptom 
representations and 3 treatment representations), had a point estimate of -.0772 and 
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a 95% bootstrap CI of -.2874 to .1196 (therefore the difference between the total and 
the direct effect of group on walking was not different from zero). 
 
Illness and walking representations as mediators of the group-intention to walk relationship 
In the second mediation model tested, the IV was group, the mediators were illness 
and walking representations and the DV was intention to walk. Baseline values for all 
variables were entered as covariates in the model. The results of the mediation 
analysis show that symptom representations and walking representations do mediate 
the relationship between group and intention to walk for at least half an hour at least 
three times a week. The total effect of group on intention to walk was .3706, p=.0006, 
and the direct effect of group on intention to walk was .1174, p=.2508. The total 
indirect effect through the ten mediators had a point estimate of .2532, and a 95% 
bootstrap CI of .0084 to .5383. Examination of the specific indirect effects indicates 
that only walking personal control was a mediator, 95% bootstrap CI .0995 to .5203; 
the 95% bootstrap CI’s for all other mediators contain zero. Pairwise contrasts 
revealed that the indirect effect of walking personal control differed significantly from 
the indirect effect of the consequences symptom representation, 95% bootstrap CI -
.4872 to -.0706; the timeline symptom representation, 95% bootstrap CI -.5288 to -
.1202; the personal control symptom representation, 95% bootstrap CI -.5375 to -
.0751; the identity symptom representation, 95% bootstrap CI -.5967 to -.1092; the 
concern symptom representation, 95% bootstrap CI -.5076 to -.0765; the illness 
comprehensibility symptom representation, 95% bootstrap CI -.5376 to -.0997; and 
the emotions symptom representations, 95% bootstrap CI -.5624 to -.1025. Pairwise 
contrasts revealed that the indirect effect of walking personal control did not 
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significantly differ from the indirect effects of beliefs in the positive consequences of 
walking or beliefs in the negative consequences of walking. 
 
Walking personal control as a sole mediator of the group-intention to walk relationship 
Testing the third model, effect of walking personal control as a sole mediator between 
group and intention to walk, revealed a total effect of group on intention to walk of 
.3037, p=.0009; and a direct effect of group on intention to walk of .0864, p=.2601. 
The total indirect effect through the mediator, walking personal control, was .2174, 
95% bootstrap CI .1121 to .3368. Therefore walking personal control does mediate the 
relationship between group and intention to walk for at least half an hour at least 
three times a week. 
 
Illness and walking representations as mediators of the group-intention to walk through the 
pain relationship 
The fourth model tested whether illness and walking representations mediated the 
relationship between group and intention to walk through the pain. The results of the 
mediation analysis show that illness and walking representations do not mediate the 
relationship between group and intention to walk through the pain. The total effect of 
group on intention to walk through the pain was .2090, p=.0525, and the direct effect 
of group on intention to walk was .1455, p=.2999. The total indirect effect through the 
ten mediators had a point estimate of .0636, 95% bootstrap CI -.2465 to .3984. 
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Intention to walk as a sole mediator of the walking personal control-walking behaviour 
relationship 
The CSM proposes that illness and treatment representations influence coping plans 
which in turn influence behaviour (Leventhal et al, 1998). Intention to walk was 
measured as a proximal measure of formation of a coping procedure which involved 
increasing walking levels, in this study. Therefore, the final mediation model tested 
whether intention to walk for at least half an hour at least three times a week 
mediated the relationship between walking personal control (the only representation 
which significantly mediated the relationship between group and intention to walk) 
and daily steps as measured by pedometer. The results of the mediation analysis show 
that intention to walk does mediate this relationship. The total effect of walking 
personal control on walking was .0338, p=.003, and the direct effect of walking 
personal control on walking was .0100, p=.3501. The total indirect effect through the 
mediator, intention to walk, was .0238, 95% bootstrap CI .0090 to .0436.  
 
As a result of these mediation analyses a mediation model is proposed for this data as 
shown in Figure 6.10. A two stage model is proposed, in line with the CSM, with 
walking personal control mediating the relationship between group and intention to 
walk; and intention to walk mediating the relationship between walking personal 
control and walking behaviour. Figure 6.10 shows the coefficients for the total effect 
of each relationship. 
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*p<.05, **p<.01, ***p<.001 
Figure 6.10 The mediating effect of walking personal control and intention to walk 
on the relationship between group and walking behaviour 
 
 
Evaluation of intervention 
Evaluation of the intervention included consideration of the feasibility and 
acceptability of the intervention, and examination of participant feedback on the 
intervention. 
 
The intervention was feasible, it was possible to recruit participants at diagnosis, visit 
them in their own homes, and conduct the intervention over two, one-hour sessions. 
Participants understood the information about IC and walking, and were able to 
create action plans to increase walking, with the help of the researcher. Participants 
were happy to wear a pedometer, and although there were a few instances where the 
pedometer was lost, these were resolved without any problems, by the participants 
calling the researcher. 
 
Group 
Walking 
Personal Control 
Intention 
to Walk 
Walking 
Behaviour 
2.55*** 
.08*** 
.30*** 
.29** 
.03*** 
.17** 
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There was an extremely high retention rate of participants in the study (98.3%) 
indicating acceptability of the research. One participant dropped out of the 
intervention group, however the reason she gave for withdrawing from the study was 
that she had increased her walking, was getting about ‘fine’ now with little pain, and 
didn’t see the point of seeing the researcher as she was much better. 
 
Participants in the intervention group were asked a series of questions about the 
acceptability of the intervention at the end of the 4 month follow-up meeting. Of the 
29 participants interviewed at follow-up, 25 reported trying to follow the action and 
coping plan, and 4 reported not following the action and coping plan. Reasons for not 
following the action and coping plan were – ‘walking too painful’ (n=2), ‘couldn’t be 
bothered’ (n=1) and ‘I don’t like to be pinned down to a plan’ (n=1). Both participants 
who found walking too painful were female, and both had low ABPIs (.57, and .62), 
although these ABPIs were not significantly different from the overall mean ABPI (.75, 
sd=.19). All four participants who reported not following the action plan also had a 
drop in mean daily steps from baseline to follow-up (Mean drop = -433.80, sd = 
341.18). Removing these four non-adherers from the overall between group analysis 
of walking at baseline and follow-up reveals a more significant group*time interaction, 
F(1,52)=19.365, p<.001, partial η2=.271. 
 
All participants in the intervention group felt that it had been worthwhile to take part 
in the intervention, reasons given included the extra encouragement and motivation 
from the intervention, receiving extra information about their illness and about 
walking, having a personalised plan, being clear on what they needed to do, 
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understanding why walking was important and how it would help. Participants 
reported barriers which they had to overcome in order to follow their action plans 
including the weather, family members not wanting to walk, and other health 
problems (e.g. back pain, arthritis and a sprained ankle). Participants reported more 
use of their action plans than their coping plans. Several participants reported that as 
they increased their walking, they could see that their leg symptoms were reducing 
and this provided them with a strong motivation to stick to the action plan. All 
adherers reported that they intended to continue using their action plan in the future. 
Table 6.10 provides comments from a selection of participants about their action 
plans. 
 
Table 6.10 Comments about the action plan by participants in the intervention group  
Participant 57 It was worthwhile to take part because it has encouraged 
me. The doctor said ‘keep walking’ but I never did. But 
with this plan I’ve done it. I like to see the calories I’ve 
been burning on the pedometer. 
Participant 20 It was an incentive to go out and walk. I liked the sheet 
(action plan), I passed it around my neighbours. 
Participant 32 The action plan is great. It focused what was in my mind 
and it was in black and white. I made the change because I 
had to for my health, and then I found that I enjoy it. 
We’re finding brilliant walks in places we’ve never heard 
of before. When we’re driving about we scan for green 
signs that indicate country walks. I started to use walking 
as a tool to try and help my leg, and now we go out as 
often as we can. 
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Discussion 
This study demonstrates that a brief psychological intervention significantly improves 
walking in patients with IC when compared to usual care. The intervention also 
significantly increased the number of participants who carried on walking through 
pain, and improved dietary behaviour in the intervention group compared to the 
control group. The intervention group had significant symptomatic improvement, with 
participants reporting an increase in pain-free walking distance compared to controls. 
Participants in the intervention group were also 4 times less likely to opt for surgery 
for symptom management than participants in the control group.  
 
A previous review of walking for IC demonstrated that supervised exercise 
programmes led to greater symptomatic improvement in the leg than unsupervised 
exercise programmes (Bendermacher et al, 2006). This is thought to be because of the 
greater level of intensity of exercise in supervised walking programmes 
(Bendermacher et al, 2006). However, supervised exercise programmes measure 
walking ability rather than day-to-day walking behaviour, and little is known about 
whether supervised exercise programmes lead to long-term behaviour change beyond 
the end of the programme. The current study demonstrates that a home-based, 
unsupervised psychological intervention to increase walking, changes day-to-day 
walking behaviour, and leads to significant symptomatic improvement.  
 
A further issue with supervised exercise programmes is the high drop-out rate from 
the programmes, of up to 43% (e.g. Cheetham et al, 2004; Kakkos et al, 2005). The 
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current study had a low drop-out rate (1.7%), and high reported adherence to the 
action plans (86%) indicating that this type of intervention was acceptable to 
participants.  
 
Although the current study reports an improvement in walking behaviour at 4 month 
follow-up, it is unknown whether this increase in physical activity levels will be 
maintained, or have an impact on 5 year mortality risk. However, Gardener et al’s 
(2008) analysis of mortality and physical activity levels in patients with IC indicates 
that even a small increase in physical activity levels may benefit the health of patients 
with IC and reduce their mortality risk.  
 
There may be a number of reasons why participants in the intervention group were 
less likely to opt for surgery than participants in the control group. Participants in the 
intervention group had increased walking levels and greater pain free walking distance 
at follow-up, and they may have judged their new level of physical activity sufficient 
for their needs. Surgery is solely for symptom management and participants in the 
intervention group may have felt surgery was more risky than symptom management 
by walking, once they saw that walking did reduce their leg pain. The reduced demand 
for surgery may also have been due to changes in psychological variables – 
participants in the intervention group reported higher levels of walking personal 
control and illness personal control compared to the control group at follow-up. This 
increased confidence that they could walk and that they were in control of their illness 
may have reduced their need to be managed surgically.       
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The intervention did not significantly improve disease-specific quality of life compared 
to the control group, although there was a significant improvement in disease-specific 
quality of life in the intervention group from baseline to follow-up, representing a 35% 
improvement. The control group also had a non-significant 13% improvement in 
disease-specific quality of life from baseline to follow-up. This improvement in 
disease-specific quality of life in the control group may be due to a decrease in 
anxiety, possibly due to having received a surgical consultation and treatment 
decision; it may also be due to a reduction in symptoms experienced as a result of 
decreased walking, as several questions in the ICQ relate to symptoms. Two previous 
studies of supervised exercise therapy for IC have used the ICQ as an outcome 
measure of quality of life (Cheetham et al, 2004; Kakkos et al, 2005). Cheetham et al 
(2004) found a 43% improvement in quality of life in the exercise group at 6 months, 
compared to a 16% improvement in quality of life in the exercise advice alone group. 
The exercise group received exercise advice plus weekly exercise classes and 
motivation classes. Kakkos et al (2005) compared exercise advice with supervised 
treadmill walking three times a week for six months, and found a 17% improvement in 
quality of life in the supervised exercise group compared to no change in the advice 
alone group at 6 months. Neither of these studies had a usual care control group, and 
the sample size in the Kakkos et al (2005) study was small (n=21). However, they do 
show that the improvement in disease-specific quality of life in the current study was 
greater than improvements due to advice alone, indicating that the intervention in the 
current study did more than simply providing information on the benefits of walking.   
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There was a significant improvement in general quality of life in the intervention 
group compared to the control group, with the intervention group reporting no 
change in general quality of life at the first phone call (6 weeks), but then an increase 
in general quality of life at the second phone call (12 weeks) and again at the 4 month 
follow-up. The timing of the improvement in general quality of life gives some 
indication of the length of time it takes for patients to maintain increased walking 
levels before they notice the benefits. This is important information to feed back to 
patients to ensure they have realistic expectations of outcome. 
 
The intervention was based on the Leventhal et al’s (1998) CSM and aimed to modify 
participants’ illness and walking representations. Changes in psychological variables 
from baseline to follow-up indicate that the intervention did change participants’ 
illness and walking representations. In terms of treatment representations, the 
intervention significantly increased walking personal control and beliefs in the positive 
consequences of walking, and significantly decreased beliefs in the negative 
consequences of walking compared to usual care. In terms of symptom 
representations, the intervention significantly increased illness personal control and 
decreased illness identity compared to usual care.  
 
The CSM proposes that an individual forms illness representations about a health 
threat which influence the efforts the individual makes to cope with the health threat. 
Modifying the illness and treatment representations of participants in the intervention 
group should therefore lead to changes in the way participants intend to cope with 
the health threat. Intention to cope with IC by walking, was measured in this study by 
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questions about intention to walk and intention to walk through the pain. Participants 
in the intervention group had significantly higher intention to walk for at least half an 
hour three times a week, and significantly higher intention to walk to maximal pain 
before stopping for a rest than control group participants at follow-up.  
 
Mediation analysis indicated a possible two stage model, with walking personal 
control mediating the relationship between group and intention to walk, and intention 
to walk mediating the relationship between walking personal control and walking 
behaviour. However, this is a very tentative analysis, and the results of all the 
mediation analyses should be interpreted with caution. Mediation analysis with ten 
mediators would require a large sample of data to have sufficient power to reduce the 
risk of Type II error. A sample size of 60 will have had low power in these analyses. In 
addition, the mediators will be influenced by group and will therefore be highly 
correlated with the IV - this will have resulted in poor precision in estimation of the 
coefficients and may have increased the risk of Type I error. Also the follow-up data 
was all gathered at one time point, making it impossible to draw conclusions about 
the direction of effect. A larger sample and further follow-ups would help to shed light 
on the mediation analysis. 
 
Limitations 
There are a number of possible limitations to this study. Firstly, the intervention group 
spent more time overall with the researcher than the control group (approximately 
110 mins), including one extra visit from the researcher. This extra interaction with the 
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researcher may have led to social contact effects in the intervention group. Analysis of 
data for the intervention group indicated no significant association between contact 
time with the researcher and improvement in walking, however, future research 
should include a control group with the same amount of researcher contact as the 
intervention group to properly control for social contact effects.  
 
The current study used a number of measures which specify the ideal walking 
behaviour of patients with IC (walking for at least half an hour, at least three times a 
week), and used pedometers to measure physical activity, therefore it is possible that 
participants in this study may also have been affected by measurement reactivity. In a 
recent review of reactivity of measurement in health psychology, French & Sutton 
(2010) concluded that measurement reactivity may affect self-report measures of 
walking but does not seem to affect objectively measured physical activity. As the 
control group in the present study was measured in the same way as the intervention 
group, any measurement reactivity would have caused a systematic change to results 
in both groups, rather than a treatment group bias.  
 
Pedometers were used at baseline and follow-up to measure daily walking. The 
screens of the pedometers were not covered, which means that participants’ walking 
behaviour could have been affected by feedback from pedometer readings. This could 
have affected the two groups differentially, as the intervention group were aware they 
should be increasing their walking levels due to the action planning session. However, 
although providing feedback on performance is a recognised behaviour change 
technique (Abraham & Michie, 2008), pedometers were only used in the first and last 
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weeks of the study. Participants did not know which group they were in during the 
first week of wearing pedometers, therefore pedometer use should not have caused a 
bias between the groups at this time point. The intervention group showed changes in 
pain-free walking distance and general quality of life during the 6 and 12 week 
telephone calls, which confirms that they had increased walking behaviour prior to 4 
month follow-up. 
 
Kinmonth et al (2008) suggested that improvement in control group physical activity 
levels in their study may have been due to measurement reactivity, with all 
participants in the study increasing their physical activity levels because it was being 
measured. As there were several measures in the current study which specified 
desired walking behaviour and focused on walking, it is possible that either control 
group participants would also increase their walking, or that they would self-report an 
increase in walking at follow-up. As there was a significant drop in mean daily steps in 
the control group from baseline to follow-up it seems that control group participants 
did not actually increase their walking levels as a result of measurement, or may have 
initially increased walking levels but did not maintain this increase to follow-up. The 
self-report IPAQ results of physical activity were not as sensitive to changes in physical 
activity between the two groups as the pedometer data, although the IPAQ scores 
showed a similar decrease in physical activity in the control group over time, and an 
increase in physical activity in the intervention group. Despite having been used as the 
primary measure of physical activity in another intervention to increase walking in 
patients with IC (Pochstein & Wegner, 2010), the IPAQ is not particularly suitable for 
use with patients with IC because it asks the participants to judge the amount of time 
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they spent walking for at least ten minutes at a time. As many participants with IC can 
barely manage to walk for ten minutes at a time, there is the potential for floor effects 
with this scale. Also, as many patients with IC stop for a rest whenever they 
experience leg pain, it is difficult for them to judge how much time they actually spend 
walking e.g. they may be out of the house walking the dog for 20 minutes but only 
actually walk for 12 minutes of that time.  
 
A further limitation of this study was that fidelity checks of the intervention were not 
carried out. However, all participants in the intervention group received the same 
information sheet about IC from the researcher, and the topics discussed and 
questions asked in both sessions was guided by detailed proformas. All sessions were 
conducted by the same researcher which will also have increased the fidelity of the 
intervention. 
 
That said, using a single researcher to conduct the intervention can also be seen as a 
limitation of the study, as it is impossible to determine whether it was the 
intervention itself or a therapist effect of that particular researcher which led to 
changes in the intervention group. This is a pilot study, however future studies should 
include more than one therapist to enable comparison of effect between therapists. 
 
The researcher conducting this trial was not blinded to group allocation. This was 
inevitable in this study, as the study formed part of a body of PhD research, was not 
funded, and was conducted by a single researcher. However, non-blinded assessment 
introduces the risk of conscious and un-conscious bias into the trial. The researcher 
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knew group allocation at baseline, and may have treated participants in the two 
groups differently; the researcher may also have asked questions differently when 
completing questionnaire measures. The researcher tried to minimise the risk of bias 
due to lack of blinding by following the exact wording of questionnaires, however, any 
future trial should be blinded, with different researchers delivering the intervention 
and gathering measurements. 
 
This was a single-centre RCT and therefore results describing the uptake of 
revascularisation are specific to the NHS Board in which the research took place. The 
practice in this NHS Board is to offer revascularisation if the patient is sufficiently fit, 
and the location of the narrowing of the artery is amenable to surgical intervention. 
Other NHS Boards have different practices, offering e.g. supervised exercise 
programmes, angioplasty alone, exercise advice alone, or pharmacological 
management of symptoms, suggesting the study should be replicated in other NHS 
areas with different approaches to IC management. 
 
This trial demonstrated initiation of behaviour change at 4 month follow-up. However, 
further follow-ups would be necessary to determine whether behaviour change is 
maintained in the long-run, and whether these changes lead to improved general 
health. 
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Summary and implications 
This is the first study to use a brief psychological intervention based on the CSM to 
increase walking in patients with IC. The intervention is patient-centred, can be 
tailored to the specific needs of each individual, and has directly measured behaviour 
change as the primary outcome. Usual care for patients with IC usually involves either 
supervised exercise programmes or revascularisation for symptom management. 
Neither of the current treatment options are ideal – supervised exercise programmes 
are not widely available, require a large time and effort commitment from patients 
and have high drop-out rates; surgery is inherently risky for the patient, and is 
expensive for the NHS. A brief psychological intervention which increases walking and 
reduces leg pain symptoms may therefore provide a cheaper, safer and more 
accessible means of treatment of patients with IC. 
 
The exclusion criteria for the RCT were not conservative, and no differences were 
found between participants and patients who did not agree to participate. There was 
also a very low drop-out rate from the study. Therefore, although this was a pilot RCT 
with a small sample size, the results provide preliminary evidence that a two hour 
psychological intervention delivered over two sessions in the participant’s own home 
can increase intention to walk and day to day walking behaviour. 
 
Further research should examine the effectiveness of the intervention in a multi-
centre RCT, using a greater number of therapists to deliver the intervention, including 
nursing staff. A health economic evaluation should also be central to any further large-
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scale trial of this intervention. Finally, dosage effects (length of intervention) and 
delivery effects (face-to-face, DVD or computer aided) should be considered in future 
studies. 
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GENERAL DISCUSSION 
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Overview 
This final chapter aims to summarise the findings of the studies described in this 
thesis, considering theoretical implications of the research. Limitations of the thesis 
are discussed, with suggestions for possible directions for further research. What 
these findings add to the body of knowledge about PAD is then highlighted.   
 
Summary of findings 
The aim of this thesis was to explore the relationship between beliefs about PAD and 
health behaviour within the framework of the CSM. To this end, the three studies that 
comprise this thesis had the following aims (i) to qualitatively explore the relationship 
between the walking behaviour of patients with IC, and their illness and treatment 
representations; (ii) to model key psychological constructs with walking behaviour in a 
cohort of IC patients; (iii) to modify illness and treatment representations in order to 
change walking behaviour in a sample of patients newly diagnosed with IC. The 
findings of this research with regard to each of these aims is summarised below. 
 
The relationship between walking behaviour and illness and treatment 
representations 
The results of this thesis indicate that many patients with IC have dysfunctional illness 
and treatment representations of PAD, and that patients who had received 
revascularisation to treat symptoms of PAD did not tend to change health behaviours 
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as a result of diagnosis or treatment of IC (Chapter 3). Patients who had received 
revascularisation reported a high number of ongoing leg symptoms, which affected 
their hobbies, social life and general physical activity. Symptom control was achieved 
by avoiding walking and walking at a slow pace. Participants were largely unaware of 
the causes of the disease, or of their increased risk of future cardiovascular health 
problems. Participants believed they had an acute condition, curable with surgical 
intervention, rather than a long-term chronic condition which they could self-manage. 
Participants appeared to lack knowledge of how they could self-manage their 
condition. 
 
Modelling key psychological constructs with walking behaviour 
Findings from the cross-sectional questionnaire (Chapter 5) confirmed the results of 
the qualitative analysis in Chapter 3. Despite revascularisation treatment, the majority 
of participants reported leg pain when walking, and of those, the majority did not 
meet recommended minimum walking levels. Psychological constructs based on the 
CSM were strongly associated with both walking behaviour and health-related quality 
of life in patients with IC. Symptom and walking representations as a set were strong 
predictors of both walking behaviour and health-related quality of life. Walking 
personal control was found to be a particularly important predictor of walking 
behaviour and health-related quality of life. 
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Modifying illness and treatment representations in order to change walking 
behaviour 
Results from the randomised controlled trial of the brief psychological intervention 
designed to modify illness and walking representations in patients newly diagnosed 
with IC (Chapter 6), showed that the intervention improved both walking behaviour 
and quality of life. Daily steps increased significantly over time in the intervention 
group, compared to a significant decrease in daily steps over time in the control 
group. The number of participants in the intervention group who walked through pain 
increased over time, as did the number of participants in the intervention group who 
met the minimum recommended walking levels, compared to those in the control 
group. Participants in the intervention group also reported an increase in pain-free 
walking distance over time. Participants in the control group were 4 times more likely 
to opt for surgery at the 3 month vascular outpatient clinic than participants in the 
intervention group. Most psychological variables improved significantly in the 
intervention group from baseline to follow-up, in comparison to the control group – 
walking personal control, positive walking consequences, negative walking 
consequences, intention to walk, intention to walk through the pain, symptom 
personal control and symptom identity changed as a result of intervention. The high 
(98.3%) retention rate in the trial, along with positive participant feedback, indicated 
that the intervention was acceptable. Self-reported adherence to the intervention was 
also high (86%) again indicating acceptability of the intervention. 
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Theoretical implications 
Leventhal et al’s (1998) CSM provided the underlying theoretical framework for this 
thesis. The CSM proposes that an individual’s illness and treatment representations 
will influence the actions they undertake to cope with illness and return to a normal 
health state. Leventhal et al (1998) proposed that illness and treatment 
representations have similar content including an identity, timeline, beliefs about 
cause, consequences, and cure/control.  
 
Coherence between an individual’s illness representation and their representation of 
possible treatment is thought to be a key issue in self-regulation (Leventhal et al, 
2008). Weinman et al (2000) found that when patients did not have congruence 
between their illness and treatment representations, they did not undertake that 
treatment. The intervention in this thesis was designed to modify illness and walking 
(treatment) representations, based on findings from the qualitative and cross-
sectional studies. A goal of the intervention was to increase congruence between 
participants’ representations of the illness, and their beliefs about walking. The 
intervention was therefore designed to elicit illness representations, and walking 
representations, and to modify dysfunctional representations by providing 
information about the behaviour-health link and providing information on the 
consequences of the illness and of low levels of walking. The success of the 
intervention in terms of its impact on walking behaviour and quality of life, lends 
support to the CSM. 
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Illness representations 
The importance of illness representations to the walking behaviour and quality of life 
of patients with IC emerged in the qualitative study, and was confirmed in the cross-
sectional study in this thesis. In the qualitative study, patients with IC were found to 
have dysfunctional illness representations in terms of the causes and consequences of 
IC. They tended to believe that treatment for IC was under the control of medical staff, 
rather than themselves; and they tended to view the disease as an acute symptom 
which could be cured by revascularisation, rather than a chronic condition to be 
managed. Symptom representations were found to significantly add to the predictive 
value of walking representations in predicting whether or not participants would meet 
minimum recommended walking levels. Symptom representations were also found to 
explain a significant proportion of health-related quality of life in patients with IC. The 
intervention aimed to modify illness representations by eliciting causal beliefs from 
participants and providing information about the true causes of PAD, providing 
information on the consequences of PAD, and increasing participants’ understanding 
of what they could do to control their condition (walking). 
 
Symptom representations were measured in the cross-sectional study and the trial 
with the Brief IPQ (Broadbent et al, 2006). Significant improvements in personal 
control and identity were found in the intervention group compared to the control 
group over time. The increase in personal control possibly reflects an increase in 
participants’ understanding that there are treatment options (walking) which they can 
undertake to control the symptoms of IC. The significant reduction in identity score 
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over time in the intervention group reflects a reduction in leg pain symptoms as a 
result of increased walking. 
 
There were no significant group*time interactions for the other symptom 
representations (consequences, timeline, concern, illness comprehensibility, 
emotional effect), although there was a significant within group improvement in 
illness comprehensibility over time in the intervention group. The lack of significant 
results in the other symptom representations could be interpreted in a number of 
ways (i) the intervention did not modify the other symptom representations; (ii) the 
scale used to measure symptom representations was not sensitive enough to detect 
change; (iii) the scale used to measure symptom representations did not measure the 
same representations that were changed by the intervention. Observations from the 
questionnaire sessions suggest that participants struggled to interpret and answer 
some of the questions in the Brief IPQ. For example, baseline data was gathered one 
week after diagnosis with PAD, and participants struggled to answer the timeline 
question ‘How long do you think the intermittent claudication will continue?’, 
frequently commenting that they had ‘absolutely no idea’. Also, participants’ frame of 
reference changed over time, possibly changing the meaning ascribed to numbers on 
the 0 to 10 response scale. Participants’ comments when answering Brief IPQ 
questions indicated that they were taking different things into account when 
answering the questions at each timepoint, e.g. ‘How much does the intermittent 
claudication affect your life?’ was frequently answered in terms of pain at baseline, 
but was often answered in terms of time - ‘I have to get out and walk, so I’m very 
busy’, or surgery - ‘I’m going in to hospital, and then I don’t know what affect it will 
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have’, at 4 month follow-up. This suggests that while the numbers that participants 
gave in answer to Brief IPQ questions may not have changed dramatically over time or 
between groups, the scale may not have captured the complex cognitive symptom 
representations of participants. This is important as it is these complex cognitive 
representations, and their congruence with treatment representations which 
determine coping actions. Leventhal et al (2010) suggests that IPQ instruments may 
not capture the perceptual-behavioural level of representations. This is a disadvantage 
common to most survey instruments used in Health Psychology, but is possibly more 
of a problem when attempting to measure multi-factorial illness cognitions, than 
specific behavioural beliefs.  
 
In a recent randomised controlled trial to modify illness perceptions of patients 
following a myocardial infarction, Broadbent et al (2009) measured illness 
representations using the Brief IPQ and only found a significant group*time 
interaction for one illness representation – illness comprehensibility. In a very similar 
intervention with a similar patient group, Petrie et al (2002) measured illness 
representations using the IPQ (Weinman et al, 1996) and found significant group*time 
interactions for several illness representations – consequences, timeline, control/cure 
and symptom distress. The IPQ is a longer scale which asks several specific questions 
about illness perceptions, it includes 50 questions about illness beliefs plus detailed 
cause and identity sub-scales. A further illness perception questionnaire, the IPQ-R 
(Moss-Morris et al, 2002) was developed to measure emotional representations and 
illness coherence along with illness representations. The IPQ-R has 38 questions plus 
cause and identity sub-scales. It would have been interesting to measure participant 
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illness representations with the IPQ-R in this thesis, however, the questionnaire used 
in this thesis was already very long, and the need for detailed measurement had to be 
balanced with the need to retain participant commitment to the study. A shorter 
questionnaire was therefore judged to be more appropriate for use in the studies in 
this thesis.  
 
Finally, it was decided to measure symptom, rather than illness representations in the 
studies in Chapter 5 and 6, as it emerged from the qualitative study in Chapter 3 that 
participants did not have a clear understanding of their illness, Peripheral Arterial 
Disease, and were very focused on their symptom, Intermittent Claudication. It would 
be interesting in future research to measure participants’ symptom and illness 
representations as separate constructs. This is especially important in terms of 
measuring outcomes from a trial of the intervention, as the intervention is designed to 
modify both illness and symptom representations.    
 
Walking representations 
The intervention aimed to change participants’ walking representations by firstly 
introducing the idea of walking as a possible treatment of PAD (identity), and then 
giving information about the benefits of walking to health in general, and specifically 
giving information about how walking could help to improve symptoms of IC (causal 
mechanism). Beliefs in the positive consequences of walking increased significantly, 
and beliefs in the negative consequences of walking decreased significantly in the 
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intervention group compared to the control group over time, indicating that the 
intervention did successfully modify walking (consequences) representations. 
 
The intervention aimed to make participants aware of the temporal issues related to 
walking for IC (timeline), including the amount of walking recommended to achieve 
symptomatic improvement (dosage) and the length of time increased walking would 
have to be maintained before an effect was evident (response to treatment). It was an 
important part of the intervention to set participants’ expectations about the length 
of time it would take for leg symptoms to reduce as a result of increased walking 
(around six weeks) as this delay between behaviour and positive feedback may affect 
motivation to perform the behaviour. Leventhal et al (2010) suggest that while illness 
and treatment representations ‘create the context for management’, change in an 
individual’s behaviour is dependent on the creation of an action plan to change that 
behaviour. Therefore, temporal issues related to walking were addressed in both parts 
of the intervention, in Session One by giving information about the behaviour, and in 
Session Two, by embedding temporal issues into the action plan. 
 
The intervention aimed to increase participants’ sense of walking control, or self-
efficacy by altering the participants’ interpretation of physiological signals. 
Participants in the intervention group were given information that leg pain as a result 
of IC would not harm them, and were encouraged to re-frame their interpretation of 
walking while in pain as something which could be beneficial to them – through the 
growth of a collateral blood supply. Bandura (1977) suggests that four factors 
influence self-efficacy – performance accomplishments, vicarious experience, verbal 
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persuasion and physiological states. The intervention aimed to change participants’ 
interpretation of pain (physiological state) and provided verbal persuasion to increase 
walking. Mastery of particular steps in the action plan would also lead to feelings of 
performance accomplishment. Walking personal control increased significantly in the 
intervention group compared to the control group over time, and was the only 
psychological variable which emerged as a significant mediator between group and 
intention to walk. The importance of walking personal control in the walking 
behaviour of patients with IC was also highlighted in findings from the qualitative and 
cross-sectional studies.          
 
Intention  
The intervention was designed to change attitudes and intentions towards two 
distinct behaviours: (i) walking for at least half an hour at least three times a week; (ii) 
walking until the pain is nearly unbearable before stopping for a rest. Intention to 
perform each of these behaviours was measured as an indicator of the individual’s 
readiness to act, and as a measure of the individual having made a decision to act. 
Leventhal et al (2008, p.488) state that ‘intentions…are at home in any theory that 
conceptualizes action readiness at implicit and explicit levels.’ The results from the 
randomised controlled trial show a significant change in intention to perform both 
behaviours in the intervention group compared to the control group. Interestingly, the 
significant interaction in intention to walk for at least half an hour three times a week 
consisted of a non-significant increase in intention to walk in the intervention group, 
and a significant decline in intention to walk in the control group. The findings from 
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the qualitative study indicated that participants had a medical model of their illness, 
believing that the management and outcomes of their disease were controlled by the 
surgeons, and as a result not taking steps to alter their own health behaviours. This 
may explain the significant decline in intention to walk among control group 
participants in the trial – they may have had a decline in intention to walk because 
they believed that the medical system would cure/control their disease, rather than 
their own actions (walking) controlling or curing their disease. Participants in the 
intervention group had a significantly greater intention to walk than participants in the 
control group suggesting that the intervention had counter-acted beliefs in the 
medical model of PAD, and increased beliefs in walking as an appropriate behaviour to 
manage the disease. 
 
Implications for clinical practice 
Existing treatment to reduce the symptoms of IC involves drug therapy, exercise, 
percutaneous transluminal angioplasty and bypass surgery (Cassar, 2006). Exercise 
treatment usually takes the form of advice to exercise (Shalhoub et al, 2009), however 
supervised exercise programmes are recommended because of the impact they have 
on walking capability (Bendermacher et al, 2006). Unsupervised exercise advice has 
been criticised for failing to address the barriers to walking faced by patients with IC 
(Stewart & Lamont, 2007). At present in the UK, supervised exercise programmes for 
IC are relatively uncommon (Shalhoub et al, 2009), have limited capacity, are 
dependent on patients’ regular attendance, and may not lead to behaviour change. 
The findings from the qualitative and cross-sectional studies in this thesis show that 
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psychological variables, based on the CSM are strong predictors of walking behaviour 
in patients with IC. The brief psychological intervention which was tested in this thesis, 
was designed to modify these psychological variables, and could provide an 
alternative or supplementary exercise treatment. It was designed to overcome many 
of the barriers to walking identified by Stewart & Lamont (2007) and Galea et al 
(2008), and achieved a significant improvement in walking behaviour and significant 
symptom reduction in the intervention group. These improvements are not only 
statistically significant, they are also clinically significant as evidenced by the smaller 
number of participants who opted for surgery in the intervention group compared to 
the control group. 
 
This thesis researched the outcomes of revascularisation treatment for patients with 
IC, studying outcomes of both angioplasty and surgery. SIGN (2006, p.18) guidelines 
state ‘endovascular and surgical intervention are not recommended for the majority 
of patients with intermittent claudication.’ However, rates of angioplasty to treat IC 
have increased in recent years (Vogel et al, 2007). This thesis has demonstrated in 
both the qualitative and cross-sectional studies, that many patients still experience 
high levels of symptoms in their legs after receiving revascularisation, which has an 
ongoing impact on their levels of physical activity and quality of life. In addition, many 
patients with IC report a continuing need for some level of care or support, despite 
having received revascularisation. These findings indicate that current measurement 
of outcomes following revascularisation may not adequately capture the experience of 
patients with IC post-revascularisation.  
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 Many participants did not understand the causes or health consequences of PAD, did 
not recall receiving specific advice from medical staff about walking, and found 
communication with vascular surgical staff complicated. Collins et al (2006) found 
poor doctor-patient communication an issue for patients with IC, and suggested that 
improving patient-physician communication may be an important factor in increasing 
the exercise behaviour of patients with PAD. Participants in the studies in this thesis 
tended to have a medical model of their illness, and viewed surgical staff as having the 
power to cure the illness, rather than the illness being a chronic condition which could 
be managed with changes in health behaviour. This finding mirrors other studies into 
patients with IC (Gibson & Kenrick, 1998; Leavitt, 1990). These findings suggest that 
the current system in the NHS, of diagnosing and treating patients within a specialist 
surgical clinic leads patients to a surgical view of their illness, and possibly reduces 
their willingness to engage in self-care activities. A different structure of services in 
the NHS for diagnosing and treating individuals with PAD, with less focus on surgical 
and endovascular treatment of IC may lead to greater levels of behaviour change in IC 
patients. This would be a worthwhile area for future research.         
 
Key drivers of the NHSScotland Healthcare Quality Strategy include person-
centredness and clinical effectiveness; and priority areas for action within the strategy 
include supporting staff and patients in shared decision-making, informing and 
supporting patients to manage ill-health, and increasing the focus on preventative and 
anticipatory care and intervention (NHSScotland, 2010). These healthcare concepts 
also translate to other healthcare regions in the UK. The findings from this thesis begin 
to address these quality ambitions for patients with IC. The intervention is patient-
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centred, can be tailored to the specific needs of each individual, and is capable of 
being delivered by trained non-specialist health workers in an NHS setting. 
 
Limitations 
The main limitations of this thesis are that all the studies were conducted in a single 
NHS centre, and that a single researcher designed and delivered the intervention and 
analysed the results. This reduces the generalisability of findings from the studies in 
this thesis. However, wherever possible, findings have been compared to other 
studies conducted with patients with PAD or with IC. There has been a high level of 
congruence between the findings about the beliefs and behaviour of patients with IC 
in this thesis, and the conclusions drawn from other research with patients from the 
same disease population. 
 
A further limitation of this thesis was that the intervention was designed to be 
delivered to patients newly diagnosed with IC, based on the results of the qualitative 
and cross-sectional studies which had samples of patients who had been diagnosed a 
long time ago, and many of whom had received revascularisation. Ideally, the 
qualitative and cross-sectional studies conducted in this thesis would have had 
samples of patients newly diagnosed with IC; or the intervention would have been 
designed to modify the beliefs and behaviours of patients post-revascularisation. The 
time constraints of the PhD meant that the rate of recruitment of people at diagnosis 
into the qualitative and cross-sectional studies would have been too slow to analyse 
results in time to then design and deliver an intervention. The intervention was 
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designed to modify the illness and walking representations of patients at diagnosis, 
because it was evident as a result of the qualitative study that patients have a very 
medical model of their illness post-revascularisation which affects their attitude 
towards self-management of their disease. Therefore, a pragmatic decision was taken 
to design the intervention for patients at diagnosis, to alter their illness and walking 
representations before their thinking became embedded in a medical model. 
 
Another limitation of this research was the power of the statistical analyses in the 
cross-sectional study (Chapter 5) and the mediation analysis (Chapter 6). The sample 
size of the cross-sectional study was affected by both a low response rate to the 
questionnaire, and the division of the sample into two groups to reflect the presence 
or absence of claudication symptoms. The resulting low sample size meant that the 
statistical analyses conducted in the study had low power, increasing the risk of Type II 
error. While the overall regressions had significant results, it is possible that some 
psychological variables were not identified as significant predictors in the regression 
analyses due to low power. Further, the mediation analysis conducted to identify 
significant process variables in the intervention study, only identified walking personal 
control as a significant mediator between group and intention to walk. Again, this may 
be due to the small sample size and resulting low power of this mediation analysis. 
This was a pilot trial, however, the sample size of any future trial to test the brief 
psychological intervention should be sufficiently powered to conduct the mediation 
analysis with confidence.     
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Direction for future research 
This thesis has highlighted a number of issues in the study of PAD which warrant 
further research.  
 
This thesis has presented initial findings from a pilot randomised controlled trial to 
modify illness and walking representations and increase walking behaviour in patients 
with IC. While the initial results from this trial are very positive, further research could: 
 test whether behaviour change is maintained over a longer time period by 
following participants up at 1 year and 2 years; 
 test whether quality of life is improved in the longer term in the intervention 
group; 
 test whether the intervention reduces the surgical intervention rate in the 
longer term; 
 test whether participation in the intervention improves surgical outcomes (e.g. 
walking behaviour and quality of life post-surgery) for participants who go on 
to have surgery. 
 
The pilot trial presented in this thesis was conducted in a single NHS centre, and the 
intervention was delivered by one therapist, who also analysed results. These factors 
reduce the generalisability of the research therefore a larger, blinded, multi-centre 
trial of the intervention could be conducted in future to test whether the results from 
the successful pilot can be replicated. Several nurses could be trained to deliver the 
intervention to participants.  This would provide valuable information about the 
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feasibility of translating the intervention into the general healthcare system. In 
addition, dosage effects (length of intervention) and delivery effects (face-to-face, 
DVD or computer-aided) could be considered in future trials. 
 
Treatment for IC should both reduce the symptoms of claudication, and improve 
cardiovascular health. Future research could consider whether the brief psychological 
intervention improves the cardiovascular fitness or participants, and whether it 
impacts on cardiovascular morbidity and mortality. 
 
The pilot trial presented in this thesis compared a brief psychological intervention to 
usual care. Further research could compare the brief psychological intervention to 
supervised exercise programmes, to explore how each treatment changes walking 
capability and walking behaviour, and to compare the acceptability to patients of each 
type of treatment. 
 
Any future comparison of the brief psychological intervention described in this thesis 
to either usual care, or to supervised exercise should include a full health economic 
analysis, to consider whether the intervention represents a cost-effective use of NHS 
resources. 
 
This intervention measured day-to-day walking behaviour with a pedometer. 
Pedometers were found to be acceptable to participants. However, pedometers only 
give an overall daily step count, and provide no more detailed information about e.g. 
length of time sitting, and type of walking behaviour. The recommended minimum 
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walking levels for patients with IC are to walk for at least half an hour three times a 
week, and to continue walking into the pain until it is almost unbearable before 
stopping for a rest. Future studies into the walking behaviour of patients with IC could 
use a more sophisticated measurement device to give information about the pattern 
of walking activity within the day. Analysis could compare this activity to the action 
plans set in the intervention. 
 
An unexpected finding in this thesis was the large number of patients with IC who 
reported requiring some level of care because of their health. Further research could 
confirm this finding, and explore the nature of the care required by patients with IC. 
 
This thesis suggests that the current procedure within the NHS, of diagnosing and 
treating patients with IC in surgical clinics, leads patients to have a medical model of 
their illness. Further research could explore this issue in more detail, and test whether 
alternative structures have a different impact on the illness representations of 
patients with IC. In addition, further research could design and test an intervention to 
modify the illness and walking representations of IC patients who are already ‘in the 
system’, and who have already received surgical or endovascular treatment for IC. 
 
This thesis questioned the sensitivity of the Brief IPQ for measuring the symptom 
representations of patients with IC. Further research could look into alternative 
measurements of illness representations for patients with IC, for example using longer 
questionnaires like the IPQ-R, or using open questions to elicit more detailed 
responses from participants about their illness perceptions. In addition, questions 
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were designed in this thesis to capture participants’ walking consequences, and 
walking personal control representations. Further work could validate these 
questions, and develop further questions to measure all walking representations of 
patients with IC (cause, timeline and identity). 
 
Finally, the mediation analysis in the trial was tentative, due to small sample size and 
follow-up data being gathered at one time point. Future research could measure 
changes in psychological variables and behaviour at a number of time points to 
measure how changes in psychological variables change behaviour, and vice-versa. 
This could be modelled in a large trial with multiple follow-up points. Multiple follow-
ups would also enable analysis of measurement reactivity effects, where participants 
were randomly allocated to groups with different numbers of follow-up sessions (van 
Sluijs, 2005). Alternatively a series of n of 1 trials could be analysed using time-series 
analysis to tease apart the dynamic relationship between illness and walking 
representations and walking behaviour.  
 
What does this thesis add? 
1. A brief psychological intervention to modify illness and walking representations 
increases the daily walking behaviour of patients newly diagnosed with IC. 
2. Patients receiving usual care were 4 times more likely to opt for surgical or 
endovascular intervention to treat leg pain, than patients who received the brief 
psychological intervention. 
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3. Illness and walking representations accurately predict adherence to minimum 
recommended walking guidelines in patients with IC. 
4. This thesis was the first to use the CSM to understand the beliefs and health 
behaviours of patients with PAD. 
5. This thesis was the first to explore the treatment representations of the CSM in a 
context other than medication taking, and demonstrated that treatment 
representations add to the usefulness of the CSM as a model to understand 
health and illness behaviour. 
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Appendix 1:  Example of letter of invitation, information sheet and consent form 
given to participants (Chapter 3) 
 
 
DEPARTMENT OF 
PSYCHOLOGY 
 
University of Stirling 
Stirling FK9 4LA Scotland 
 
 
Dear  
 
Experience of Peripheral Arterial Disease After Revascularization. 
 
I am a postgraduate student from the Psychology Department of the University of 
Stirling.  
 
As part of my course, I am conducting a research project into the experiences of 
people who have intermittent claudication and have undergone surgery to improve 
the blood flow in their legs. The study is being carried out in conjunction with Mr 
Holdsworth from the Stirling Royal Infirmary Vascular Surgery ward. 
 
As you have previously undergone a surgical procedure for your intermittent 
claudication, your help in this research would be very valuable.  
 
If you would like to take part in this study, details of which are given on the 
information leaflet enclosed, please let me know. You can either return the enclosed 
card to me with your details and I will contact you, or you can call me on the number 
below. I will then arrange a convenient time and venue with you to obtain your 
consent and conduct a short interview, which should last no more than one hour. 
 
I would like to thank you for taking time to read this letter and hope to hear from you 
soon.  If you have any queries, please feel free to contact me, on the telephone 
number below. 
 
Yours sincerely, 
 
 
 
Margaret Cunningham 
 
Telephone : 01786 466 845 
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Experience of Peripheral Arterial Disease After Revascularization. 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it 
with others if you wish.  Ask us if there is anything that is not clear or if you would like 
more information.  Take time to decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
This study aims to understand the experience of patients with intermittent 
claudication who previously underwent a procedure in the hospital to improve the 
blood flow in their legs. This study involves a short interview of no more than an hour. 
The researcher will ask questions about how satisfied you were with the 
revascularization procedure, whether you have any symptoms at the moment, how 
you cope with these, and what your life is like now that you’ve had the procedure. 
 
You have been chosen for this study because you had intermittent claudication, and 
you came into hospital to have a procedure carried out to improve the blood flow in 
your leg about a year ago. Twenty participants will be interviewed for this study. 
 
It is up to you to decide whether or not to take part.  If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a 
reason.  A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
 
If you decide to take part in this study, you will be scheduled to attend one interview, 
which should last no more than an hour. The interview can be carried out at a place 
and time that suits you, for example the researcher can come to your home if this is 
more convenient for you; alternatively, the interview can be carried out in a private 
interview room in Stirling Royal Infirmary. This research is being carried out as part of 
a PhD by a student at the University of Stirling, and there are no funds available to re-
imburse your travel expenses. The researcher will ask you some questions about the 
procedure you had in hospital, and how you have been since then. The researcher will 
use a tape recorder to tape your responses, so that they can be analysed once the 
interview is over.  
 
Your participation in this study will not affect the clinical care you receive.  
 
All information which is collected about you during the course of the research will be 
kept strictly confidential.  Any information about you which leaves the hospital will 
have your name and address removed so that you cannot be recognised from it. All 
information will be stored securely, and only the researcher and the project supervisor 
will have access to the information. 
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This research is important in order to understand how having a revascularization 
procedure affects people’s lives, to understand whether there are continuing 
problems, and how these are dealt with by patients. 
 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action but you may have to pay for it.  Regardless of 
this, if you wish to complain, or have any concerns about any aspect of the way you 
have been approached or treated during the course of this study, the normal NHS 
Complaints Procedure will be available to you (details are in the attached leaflet). 
 
The results of this study will be summarised and given to you. You will be given the 
opportunity to discuss the summary of findings with the researcher. The research will 
then be written up in a report that will form part of the researcher’s PhD qualification. 
In addition the research may be published in an academic journal. You will not be 
identified in any report or publication. 
 
This is a PhD research project and is being sponsored by The University of Stirling. The 
research has been reviewed by the Fife and Forth Valley Research Ethics Committee. 
 
If you require any more information about this study, please contact the researcher, 
Maggie Cunningham, on 01786 466 845. 
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CONSENT FORM 
 
 
Title of Project: Experience of Peripheral Arterial Disease After Revascularization. 
 
Name of Researcher: Maggie Cunningham 
 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet     
dated 23/2/6 (version 4) for the above study and have had the opportunity to ask 
questions. 
 
2. I understand that my participation is voluntary and that I am free to                
 withdraw at any time, without giving any reason, without my medical care 
 or legal rights being affected. 
 
3.I understand that sections of any of my clinical records may be looked            
at by the researcher. I give permission for the researcher to have access to my 
records. 
 
4. I agree to the interview being tape recorded and the tapes being destroyed   
 once the interview has been transcribed.   
 
5.  I agree that Forth Valley Acute Operating Division can check my medical        
records for a copy of this consent form if auditing this research project.   
 
6. I agree to take part in the above study.                                                              
 
 
_______________________ ________________ ____________________ 
Name of Patient Date Signature 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consentDate  Signature 
(if different from researcher) 
 
 
_________________________ ________________ ____________________ 
Researcher Date  Signature 
 
 
 
 
 1 for patient;  1 for researcher;  1 to be kept with hospital notes 
 248 
 
1.  Are you?   Male   Female  
2.  How old are you? …………..years old 
5. Do you or have you suffered from any of the following conditions? 
         (please tick one box on each line) 
  
 
    
    
  
 
 
 
 
 
 
 
 
    
    
Please answer the following questions by ticking the answer that most applies to 
you or writing in the answer. 
3. Do you?  Live alone   
 
     Live with somebody else in the house  
  
No 
 
Yes 
a. Chest Trouble   
b. Diabetes   
c. Osteoarthritis   
d. Rheumatic Troubles   
e. Cancer   
f. Heart Troubles   
g. Stroke   
h. Back Trouble   
i. Depression   
j. Other (please specify) __________ ______________ 
4. What is your occupation? If you are retired, please state your occupation before you 
 retired. 
 
 Retired?  Yes  No    
 
 Please specify occupation………..……………………………………………… 
6. Do you receive help or support from family members, friends, neighbours or others 
 because of problems with your health? (for example help with cleaning, or shopping) 
 
No 
 
Yes, 1-4 
hours per 
week 
 
Yes, 5-19 
hours per 
week 
Yes, 20 
hours or 
more per 
week 
 
Continuous 
care 
 
Varies 
 
Don’t know 
       
Appendix 2: Questionnaire (Chapters 4, 5 & 6)  
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7. How would you rate your quality of life? 
 
 Very poor Poor Neither poor 
nor good 
Good Very good 
1 2 3 4 5 
8. How much does the intermittent claudication (cramping leg pain) affect your life? 
0 1 2 3 4 5 6 7 8 9 10 
No 
affect 
at all 
         Severely 
affects 
my life 
BRIEF IPQ -The following questions ask about your intermittent claudication—the 
problems you have had with the blood flow in your legs. Please circle the number that 
best corresponds to your views: 
This part of the questionnaire asks for your views about your health. Answer every 
question by marking the questions as indicated. If you are unsure about how to answer 
a question, please give the best answer you can. 
9. How long do you think the intermittent claudication (cramping leg pain) will continue? 
0 1 2 3 4 5 6 7 8 9 10 
A 
very 
short 
time 
         forever 
10. How much control do you feel you have over your intermittent claudication (cramping 
 leg pain)? 
         0 1 2 3 4 5 6 7 8 9    10 
Absolutely 
no control 
         Extreme amount 
of control 
11. How much do you think your treatment can help the intermittent claudication? 
0 1 2 3 4 5 6 7 8 9    10 
Not at 
all 
         Extremely 
helpful 
12. How much do you experience symptoms from your intermittent claudication? 
             0 1 2 3 4 5 6 7 8 9    10 
No symptoms 
at all 
         Many severe 
symptoms 
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13. How concerned are you about your intermittent claudication? 
         0 1 2 3 4 5 6 7 8 9    10 
Not at all 
concerned 
         Extremely 
concerned 
14. How well do you feel you understand your illness (intermittent claudication)? 
                  0 1 2 3 4 5 6 7 8 9     10 
Don’t understand 
at all 
         Understand 
very clearly 
15. How much does your intermittent claudication affect you emotionally? (e.g. does it 
 make you angry, scared, upset or depressed?) 
                   0 1 2 3 4 5 6 7 8 9    10 
Not at all affected 
emotionally 
         Extremely affected 
emotionally 
16. Please list in rank order the three most important factors that you believe caused your 
 illness (intermittent claudication). The most important causes for me:- 
 
 1. _________________________ 
 
 2.__________________________ 
 
 3.__________________________ 
ICQ -The questions below ask about the problems of pains and cramps patients with  
intermittent claudication get in their calves, thighs or buttocks when walking. The term 
’leg pains’ has been used to describe all of these problems. Please answer every  
question with a tick. If you are unsure about how to answer a question please give the 
best answer you can. Tick only one box per question. 
17. Which of your legs has intermittent claudication?   (Please mark one) 
 
Only Right  Only Left  Both  
18. During the past 2 weeks, how severe were your leg pains? 
None, I had 
no leg pain 
 
Very mild 
 
Mild 
 
Moderate 
 
Severe 
 
Very severe 
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19. The following questions ask about activities you might do during a typical day. Do 
 your leg pains limit you in these activities? If so, how much? 
 
 Totally  
limited 
Very  
limited 
Moderately 
limited 
A little  
limited 
Not limited  
at all 
Crossing the road      
Using the bus or train      
Climbing several 
flights of stairs 
     
Climbing one flight of 
stairs 
     
Walking more than a 
mile 
     
Walking 100 yards      
Going out of the house      
20. During the past 2 weeks, how often have you had to stop walking and rest because of 
 the pains in your leg? 
More than 3 
times a day 
2 to 3  
times a day 
 
Once a day 
Less than  
once a week 
 
Not at all 
     
21. During the past 2 weeks, how much of the time have you spent thinking about your 
 leg pains? 
All of the  
time 
Most of the  
time 
Some of the 
time 
A little of the 
time 
None of the  
time 
     
22. During the past 2 weeks, how much of the time have you felt downhearted and low 
 because of your leg pains? 
All of the  
time 
Most of the  
time 
Some of the 
time 
A little of the 
time 
None of the  
time 
     
23. During the past 2 weeks, how much of the time have you been worried that your leg 
 pains will get worse? 
All of the  
time 
Most of the  
time 
Some of the 
time 
A little of the 
time 
None of the  
time 
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28. How far can you walk, aided or unaided, under normal circumstances before the onset 
 of pain?  
0 yards Up to 100 
yards 
Up to 250 
yards 
Up to 1/2 a 
mile 
Up to 1 
mile 
More than 
a mile 
      
All of the  
time 
Most of the  
time 
Some of the 
time 
A little of the 
time 
None of the  
time 
     
24. During the past 2 weeks, how much did your leg pains interfere with your normal 
 work (including work both outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
     
25. During the past 2 weeks, how much did your leg pains interfere with your hobbies or 
 pastimes? 
Not at all A little bit Moderately Quite a bit Extremely 
     
26. During the past 2 weeks, how much of the time have your leg pains interfered with 
 social activities (like visiting friends and relatives etc)? 
All of the  
time 
Most of the  
time 
Some of the 
time 
A little of the 
time 
None of the  
time 
     
27. During the past 2 weeks, how much of the time have your leg pains interfered with 
 doing errands (like shopping, going to the post office or bank, etc)? 
 
 
29. In general, how frequently do you walk the distance you wrote in question 32? 
 
Never 
Once or 
twice a 
month 
Once per 
week 
2-3 times a 
week 
4-5 days per 
week 
 
Everyday 
      
30. In general, do you carry on walking after the pain has started in your leg? 
Never For a few steps Until the pain is 
nearly unbearable 
   
31. How many steps do you usually take after the onset of claudication pain, before you 
 stop for a rest? …………………………. 
32. How often do you walk for at least 30 minutes? 
Never Once or twice 
a month 
1-2 times per 
week 
3 times a 
week 
4-5 days a 
week 
Everyday 
      
General questions about walking behaviour: 
 253 
 
33. Please indicate the extent to which you agree or disagree with the following statements 
 about you doing a walk of at least 30 minutes. 
         (please circle one number on each line) 
       Strongly disagree   Strongly agree 
a. I intend to walk that distance 3 times a week 0 1 2 3 4 5 6 7 8 9 10 
b. I would like to walk that distance 3 times a week 0 1 2 3 4 5 6 7 8 9 10 
c. It is likely that I will walk that distance 3 times a 
week 
0 1 2 3 4 5 6 7 8 9 10 
34. Please indicate the extent to which you agree or disagree with the following statements 
 about you continuing to walk after the onset of claudication pain until the pain is 
 almost unbearable, before stopping for a rest. 
       Strongly disagree   Strongly agree 
a. I intend to keep walking until the pain is almost 
unbearable 
0 1 2 3 4 5 6 7 8 9 10 
b. I would like to keep walking until the pain is   
almost unbearable 
0 1 2 3 4 5 6 7 8 9 10 
c. It is likely that I will keep walking until the pain 
is almost unbearable 
0 1 2 3 4 5 6 7 8 9 10 
This section asks about your views and opinions of walking at least 30 minutes, at least 
3 times a week, walking until the claudication pain is almost unbearable before resting. 
There are no right or wrong answers. We would like you to think about what it is like 
for you to do a walk of that distance. Please tick the box that describes you or your 
opinion best. (Treatment representations - Personal Control and Consequences) 
35. Do you recall receiving medical advice on how far or how long to walk because of 
 your intermittent claudication? Yes  No 
36a. Since being diagnosed with intermittent claudication, have you attempted to increase 
 the amount that you walk?    Yes  No 
 
b. If yes, has this increase been maintained? Yes  No 
 
c. If the increase has not been maintained, please list the 3 most important reasons why 
 not: 
 
 1.__________________________________ 
 
 2.__________________________________ 
 
 3.__________________________________ 
Questions about intention to walk, and intention to walk through the pain: 
Questions about advice, attempts to increase walking and maintenance of increased 
walking since diagnosis: 
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38. These questions ask about the consequences that walking for at least 30 minutes, at 
 least 3 times a week until the claudication pain is almost unbearable, before stopping 
 for a rest, might have for you. 
 
 If  I walk that distance three times a week… 
 Not at all 
true 
Hardly 
true 
Moderately 
true 
Exactly 
true 
I will feel better afterwards 1 2 3 4 
I’ll be left with bad leg pain 1 2 3 4 
my quality of life will improve 1 2 3 4 
it will be good for my heart 1 2 3 4 
I will miss my television programmes 1 2 3 4 
I can be more independent 1 2 3 4 
I will be embarrassed because I have to 
stop regularly 
1 2 3 4 
the pain in my legs will go away 1 2 3 4 
my legs will suffer from wear and tear 1 2 3 4 
I will keep fit 1 2 3 4 
I will damage my legs 1 2 3 4 
I will be able to control my weight 1 2 3 4 
the blood flow in my legs will improve 1 2 3 4 
37. Where 0 is ‘not at all confident’ and 10 is ‘extremely confident’, how confident are 
 you that you can do a walk at least 30 minutes, at least 3 times a week, walking until 
 the claudication pain is almost unbearable, before resting, when: 
     Not at all               Extremely 
     Confident        Confident 
a. the weather is good 0 1 2 3 4 5 6 7 8 9 10 
b. the walk is flat 0 1 2 3 4 5 6 7 8 9 10 
c. the weather is bad 0 1 2 3 4 5 6 7 8 9 10 
d. the walk is uphill 0 1 2 3 4 5 6 7 8 9 10 
e. you are on your own 0 1 2 3 4 5 6 7 8 9 10 
f. you are with someone who walks 
quickly 
0 1 2 3 4 5 6 7 8 9 10 
g. there is a flight of steps 0 1 2 3 4 5 6 7 8 9 10 
h. you are tired 0 1 2 3 4 5 6 7 8 9 10 
i. there is nowhere to stop for a rest 0 1 2 3 4 5 6 7 8 9 10 
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39. IPAQ—I am going to ask you about the time you spent being physically active in the 
last 7 days.  
Now, think about all the vigorous activities which take hard physical effort that you did in 
the last 7 days. Vigorous activities make you breathe much harder then normal and may in-
clude heavy lifting, digging, aerobics or fast cycling. Think only about those activities that 
you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities? 
 ________________days per week (if 0 skip to Q3) 
 
2. How much time did you usually spend doing vigorous physical activities on one of 
those days? 
 _________ hours/minutes per day 
 
 How much time in total would you spend over the last 7 days doing vigorous physical 
 activities? 
 
 __________ hours per week 
 
3.  During the last 7 days, on how many days did you do moderate physical activities? 
 
 __________ days per week 
 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
 __________hours/minutes per day 
 
 What is the total amount of time you spent over the last 7 days doing moderate  
 physical activities? 
 
 __________ hours per week 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time? 
 
 _____________ days per week 
6. How much time did usually spend walking on one of those days? 
 
 _________hours/mins per day 
 
 What is the total amount of time you spent walking over the last 7 days? 
 
 _________ hours per week 
 
7. During the last 7 days, how much time did you usually spend sitting on a week day? 
 
 __________ hours per weekday 
 
 What is the total amount of time you spent sitting last Wednesday? 
 
 __________ hours on Wednesday 
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This FINAL section asks you about some health related behaviours.  
40. On how many of the last 7 days did you eat five or more servings of fruit and 
 vegetables?         (circle one number only) 
 
0 1 2 3 4 5 6 7 
41. On how many of the last 7 days did you eat high fat foods such as red meat or full-fat 
 dairy products?        (circle one number only) 
0 1 2 3 4 5 6 7 
42. On how many of the last 7 days did you eat fried food? 
           (circle one number only) 
0 1 2 3 4 5 6 7 
43. On how many of the last 7 days did you eat breakfast? 
           (circle one number only) 
 0 1 2 3 4 5 6 7 
44. Do you usually use fat-reduced milk (e.g. skimmed milk)? 
 
Yes  No  
45. What do you normally use as a choice of spread? 
 Butter  Margarine  
46. Are you a… 
 
 
 
 
 
 
 If you are a smoker, how many cigarettes do you smoke on an average day? 
 
 …………………………………………..Number of cigarettes 
...regular smoker?  
...occasional smoker?  
...ex-smoker (I don’t smoke any more but I used to smoke)?  
...non-smoker (I don’t smoke and I have never smoked)?  
THANK YOU VERY MUCH FOR COMPLETING THIS  
QUESTIONNAIRE 
 
 
We are keen to hear you opinions about the questions you have just answered. If you have 
any comments about the questionnaire please share them with us by writing them in the 
space below. 
 
__________________________________________________________________________ 
 
__________________________________________________________________________ 
 
__________________________________________________________________________ 
 
__________________________________________________________________________ 
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Appendix 3: Schedule of questions used in Session One of the RCT (Chapter 6) 
 
 
What is your understanding of intermittent claudication? 
 
 
 
 
(I have some information about intermittent claudication, would you like to hear it?) 
 
Looking at the risk factors, what do you think you can do about your circulation problems? 
 
 
 
What are you thinking about your current walking behaviour at this point? 
 
 
 
 
How would you like to be in 6 months time? 
 
 
 
 
What would be the good things about doing more walking? 
 
 
 
 
Rate on a scale of 0 to 10 (with 10 being the highest) how interested you are in making a 
change to your walking? 
 
(Why did you not choose a higher number?) 
 
 
Rate, again on a scale of 0 to 10, how confident you are that you can make the change? 
 
(What would it take to get you to a higher number?) 
 
 
What personal strengths do you have that will help you succeed? 
 
 
 
Who could offer you support in making this change? 
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Appendix 4: Information sheet used in Session One of the RCT (Chapter 6) 
 
What is Intermittent Claudication? 
 
Your arteries carry blood from your lungs around your body to all your different muscles. 
 
 
 
The blood provides oxygen to the muscles to make them work properly. 
 
If your muscles don’t get enough oxygen they start to hurt. The pain that you feel in your legs 
when you walk is because your leg muscles aren’t getting enough oxygen. This is because you 
have a narrowing in one of the arteries supplying your leg which slows down the flow of blood 
to that part of your leg. 
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What causes intermittent claudication? 
 
Intermittent claudication is usually the result of atherosclerosis, the development over many 
years of fatty plaques in the walls of the arteries. You may have heard of this as “furring up of 
the arteries”. This furring up of the arteries happens over the years in the arteries all over the 
body. When it happens in the legs, it can cause intermittent claudication. 
 
 
 
 
 
There is no one thing which causes atherosclerosis, but there are some things which you can 
tackle to reduce the rate of build-up of fatty plaques in your arteries. 
 
Risk factors you can change: 
 
 Raised blood cholesterol 
 Cigarette smoking 
 Raised blood pressure 
 Lack of physical activity 
 Obesity 
 Diabetes 
 
Stopping smoking, eating a healthy diet, exercising regularly and taking your prescribed 
medications are all important ways to improve your condition. 
 
How does walking help? 
 
You may worry that walking will harm your legs because of the cramping pain you experience 
when you walk. There is no evidence that this is the case, in fact, lots of research has shown 
that walking more will help improve how far you can walk before the pain comes on. 
 
Carrying out regular walking changes the blood flow in the leg, by encouraging the blood to 
find other routes to the muscles. This is known as stimulating collateral blood flow. In 
addition, regular walking can improve glucose metabolism and lower blood pressure. 
 
Walking regularly will help reduce the rate of build-up up atherosclerosis and could therefore 
be beneficial to your heart as well as your legs. 
 
In order for walking to help your intermittent claudication you need to do it regularly and 
consistently, otherwise the benefits will be lost.  
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Appendix 5: Template for action and coping plan used in Session Two of the RCT 
(Chapter 6) 
 
 
The changes I want to make are: 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
 
The most important reasons why I want to make these changes are: 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
 
My general goal is: 
…………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………….. 
 
My first specific action 
 
WHAT am I going to do? 
 
WHERE am I going to do it? 
 
WHEN am I going to do it? 
 
WITH WHOM am I going to do it? 
 
3 possible barriers which might hinder me from doing this activity? 
1. 
2. 
3. 
 
How am I going to overcome these barriers? (substitution of means, increased effort etc) 
 
My second specific action 
 
WHAT am I going to do? 
 
WHERE am I going to do it? 
 
WHEN am I going to do it? 
 
WITH WHOM am I going to do it? 
 
3 possible barriers which might hinder me from doing this activity? 
1. 
2. 
3. 
 
How am I going to overcome these barriers? (substitution of means, increased effort etc) 
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My third specific action 
 
WHAT am I going to do? 
 
WHERE am I going to do it? 
 
WHEN am I going to do it? 
 
WITH WHOM am I going to do it? 
 
3 possible barriers which might hinder me from doing this activity? 
1. 
2. 
3. 
 
How am I going to overcome these barriers? (substitution of means, increased effort etc) 
 
 
 
 
 
I will know my plan is working if: 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
………………………………………………………………………………………….. 
 
 
 
Notes: 
Re barriers, ask: 
 
 Is there anything about the things around you or the places you are in that makes it difficult 
to do this behaviour? What can you do to change this? 
 Are there any people I spend time with who make it difficult to do this behaviour? What can 
I do to change this? 
 Is there anything I am thinking or feeling that makes it difficult to do this behaviour? How 
can I overcome these things? 
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Appendix 6: Schedule of questions used in the telephone calls (Chapter 6) 
 
Follow-Up Phone Call (Control) 
 
Date ________________________ 
 
How are you? 
 
 
 
In general would you say your health is…? 
Excellent Very Good Good Fair Poor 
     
 
How satisfied are you with your health? 
Very Dissatisfied Dissatisfied Neither Satisfied 
nor Dissatisfied 
Satisfied Very Satisfied 
     
 
How would you rate your quality of life? 
Very poor Poor Neither Poor nor 
Good 
Good Very Good 
     
 
How are your legs? 
 
 
During the past 2 weeks, how severe were your leg pains? 
None, I had no 
leg pain 
Very mild Mild Moderate Severe Very severe 
      
 
How far can you walk before the onset of pain? 
0 yards Up to 100 
yards 
Up to 250 
yards 
Up to ½ a mile Up to 1 mile More than a 
mile 
      
 
Have you heard anything from the hospital yet? 
 
 
 
 
 
Duration of call _________________________________ 
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Follow-Up Phone Call (Treatment) 
 
Date ________________________ 
 
How are you? 
 
 
 
In general would you say your health is…? 
Excellent Very Good Good Fair Poor 
     
 
How satisfied are you with your health? 
Very Dissatisfied Dissatisfied Neither Satisfied 
nor Dissatisfied 
Satisfied Very Satisfied 
     
 
How would you rate your quality of life? 
Very poor Poor Neither Poor nor 
Good 
Good Very Good 
     
 
How are your legs? 
 
 
 
 
During the past 2 weeks, how severe were your leg pains? 
None, I had no 
leg pain 
Very mild Mild Moderate Severe Very severe 
      
 
How far can you walk before the onset of pain? 
0 yards Up to 100 
yards 
Up to 250 
yards 
Up to ½ a mile Up to 1 mile More than a 
mile 
      
 
 
 
Have you heard anything from the hospital yet? 
 
 
264 
 
How is it going with your walking action plan? 
 
 
 
Action 1: 
 
 
 
Has anything got in the way of doing that?  
 
 
 
How did you manage that? 
 
 
 
Action 2: 
 
 
 
Has anything got in the way of doing that?  
 
 
 
How did you manage that? 
 
 
 
Action 3: 
 
 
 
Has anything got in the way of doing that?  
 
 
 
How did you manage that? 
 
 
 
 
 
Have you heard anything from the hospital yet? 
 
 
 
 
 
 
Duration of call _________________________________ 
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Investigation of Effect of Intermittent Claudication on Quality of Life 
 
 
We are initiating research into the effect intermittent claudication on quality of life and 
walking behaviour, as part of our ongoing research into the relationship between 
intermittent claudication, quality of life and health behaviours. This work is being co-
ordinated by a postgraduate Psychology student, based in the University of Stirling.  
 
We are approaching patients who have previously been under our care who we feel would 
be appropriate to take part in this study. Your help would be greatly appreciated. 
 
We enclose an information sheet regarding the current study. If you would be willing to 
help us with this study, we would be grateful if you could complete the enclosed consent 
form and questionnaire.  
 
If you have any questions or queries regarding this study please feel free to contact the 
researcher, Maggie Cunningham on 01786 466 845. A postage paid envelope is provided 
for you to send in your completed questionnaires and consent form to the researcher. We 
would appreciate it if you could return the questionnaires as soon as possible if you have 
decided to take part in the study. 
 
We would like to thank you for taking time to read this letter and hope to hear from you 
soon.   
 
Yours, 
 
 
Mr RJ Holdsworth 
Mr M Yapanis 
Appendix 7: Example of letter of 
invitation, information sheet and 
consent form given to participants 
(Chapter 5) 
 
Vascular Surgery 
 
Stirling Royal Infirmary 
Livilands, 
Stirling 
FK8 2AU 
 
 
 
 
   
 
 
   
  
  
  
Enquiries to  Maggie Cunningham 
  
Direct Line 01786 466 845 
Email mac1@stir.ac.uk 
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Investigation of Effect of Intermittent Claudication on Quality of Life 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it 
with others if you wish.  Ask us if there is anything that is not clear or if you would like 
more information.  Take time to decide whether or not you wish to take part. 
 
Thank you for reading this. 
 
This study aims to understand the effect that intermittent claudication has on quality 
of life, and functioning. In addition, this study will investigate whether there are other 
factors, such as people’s thoughts about their illness, and how they cope with their 
illness that influence quality of life and functional outcome. This study will involve you 
filling in a set of questionnaires that will ask you questions about your leg pain and 
what affect it has on you and your life. The set of questionnaires should take about 
half an hour to complete. 
 
You have been chosen for this study because you were diagnosed with intermittent 
claudication within the last 3 years. 
 
It is up to you to decide whether or not to take part.  If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a 
reason.  A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
 
This research will all take place at one time, you will be asked to fill in one set of 
questionnaires, complete these and send them back to the researcher in a pre-paid 
envelope. The questions do not require a lot of thought, however, it is important to fill 
them in as accurately as possible. If you have any questions, please contact the Chief 
Investigator, Maggie Cunningham, who will be happy to help you. 
 
Your participation in this study will not affect the clinical care you receive.  
 
If you consent to take part in the research any of your medical records may be 
inspected by the researcher for purposes of analysing the results. All information 
which is collected about you during the course of the research will be kept strictly 
confidential.  Any information about you which leaves the hospital will have your 
name and address removed so that you cannot be recognised from it. All information 
will be stored securely, and only the researcher and the project supervisor will have 
access to the information. 
 
This research is important in order to understand the impact of intermittent 
claudication on quality of life and functioning; and to understand what psychological 
factors may be involved in coping with intermittent claudication.  
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If you are harmed by taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action but you may have to pay for it.  Regardless of 
this, if you wish to complain, or have any concerns about any aspect of the way you 
have been approached or treated during the course of this study, the normal NHS 
Complaints Procedure will be available to you (details are available in leaflets at 
Stirling Royal Infirmary or your GP clinic). 
 
The findings from this research will be written up in a report that will form part of the 
researcher’s PhD qualification. In addition the research maybe published in an 
academic journal. You will not be identified in any report or publication. 
 
This is a PhD research project and is being sponsored by the University of Stirling. The 
research has been reviewed by the Fife and Forth Valley Research Ethics Committee. If 
you require more information about this study, please contact the researcher, 
Maggie Cunningham, on 01786 466 845. 
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CONSENT FORM 
 
 
Title of Project:  Investigation of Effect of Intermittent Claudication on Quality 
of Life 
 
 
Name of Researcher: Maggie Cunningham 
 
 
 
 
 
 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet     
dated 23/02/2007 (version 4) for the above study and have had the opportunity to 
ask questions. 
 
2. I understand that my participation is voluntary and that I am free to                 
withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected. 
 
3. I understand that sections of any of my clinical records may be looked            
at by the researcher. I give permission for the researcher to have access to my 
records. 
 
4.  I agree that Forth Valley Acute Operating Division can check my medical        
records for a copy of this consent form if auditing this research project. 
 
4. I agree to take part in the above study.                                                              
 
 
 
 
 
 
 
________________________ ________________ ____________________ 
Name of Patient Date Signature 
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Changing illness perceptions of patients with intermittent claudication: 
a pilot randomised controlled trial to increase walking 
 
We are initiating research into the effect of a brief psychological intervention to increase 
walking behaviour in patients newly diagnosed with intermittent claudication, as part of 
our ongoing research into the relationship between intermittent claudication, quality of 
life and walking behaviour. This work is being co-ordinated by a postgraduate Psychology 
student, based in the University of Stirling.  
 
We are approaching patients who have been newly diagnosed with intermittent 
claudication who we feel would be appropriate to take part in this study. Your help would 
be greatly appreciated. 
 
We enclose an information sheet regarding the current study. If you would be willing to 
help us with this study, we would be grateful if you could complete and return the 
enclosed reply paid slip and give your contact details so that the researcher can contact 
you and arrange a suitable time to visit you at home.  
 
If you have any questions or queries regarding this study please feel free to contact the 
researcher, Maggie Cunningham on 01786 466 845.  
 
We would like to thank you for taking time to read this letter and hope to hear from you 
soon.   
 
Yours sincerely, 
 
Val Sinclair 
Vascular Assessment Nurse 
Appendix 8: Example of letter of 
invitation, information sheet and 
consent form given to participants 
(Chapter 6) 
 
Vascular Surgery 
 
Stirling Royal Infirmary 
Livilands, 
Stirling 
FK8 2AU 
 
 
 
 
   
 
 
Date  31
st
 August 2009 
  
  
  
Enquiries to  Maggie Cunningham 
  
Direct Line 01786 466 845 
Email mac1@stir.ac.uk 
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DEPARTMENT OF 
PSYCHOLOGY 
 
University of Stirling 
Stirling FK9 4LA Scotland 
 
Telephone: +44 (0) 1786 467640 
Facsimile:  +44 (0) 1786 467641 
http://www.stir.ac.uk/psychology 
 
 
Information about the research 
 
 
Changing illness perceptions of patients with intermittent claudication: 
a pilot randomised controlled trial to increase walking 
 
We would like to invite you to take part in a research study that is being conducted in part 
fulfilment of a Doctorate in Psychology degree at the University of Stirling.  Before you decide 
it is important for you to understand why the research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if you 
wish.  Ask me if there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part.  
 
Thank you for reading this 
 
What is the purpose of the study? 
 
This study aims to understand the illness beliefs and walking behaviour of patients newly 
diagnosed with intermittent claudication. It involves a brief psychological intervention to 
clarify participants’ beliefs about intermittent claudication and help participants set a walking 
action plan. Your involvement in the study will last for 4 months. The researcher will assign 
you to one of two groups. One group will receive usual care, and the other group will receive a 
brief psychological intervention of two 1 hour sessions. Regardless of which group you are in, 
you will be asked to fill in a set of questionnaires at the start and end of the study, and to wear 
a pedometer for one week at the start and end of the study.  
 
Why have I been invited? 
 
You have been chosen for this study because you have been newly diagnosed with 
intermittent claudication. Eighty participants will be involved in this study. 
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part.  If you do decide to take part you will be 
given this information sheet to keep and a reply paid slip to send to me with your contact 
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details. I will then contact you and arrange a suitable time to visit you at home and ask you to 
sign a consent form. Your Vascular Consultant will also be informed that you are taking part in 
the study. If you decide to take part you are still free to withdraw at any time and without 
giving a reason.  A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
 
What if I do not wish to take part in this study? 
 
It is important to check that there is no bias in this research caused by differences in age, 
gender or severity of intermittent claudication between those patients who decide to take 
part and those who do not wish to take part in the study. Therefore, if you do not wish to take 
part in this study the Vascular Assessment Nurse who approached you will ask for your 
permission to record a note of your age, gender and a clinical measure of your ankle artery 
pulses. This information will be passed to me in an anonymised form so that you cannot later 
be identified from it. Note however that you do not have to agree to this and you still have the 
right to refuse to take part without having to give any reason.  
 
What will happen to me if I take part? 
 
If you decide to take part in this study, please return the reply paid slip with your contact 
details. The researcher will contact you and arrange a suitable time to visit you in your home 
and go through a questionnaire with you. This will take no more than an hour. The researcher 
will also give you a pedometer to wear for one week, which will count the number of steps 
you take. A pedometer is a small, light box which clips onto the waistband of your skirt or 
trousers and counts the number of steps you take. If you are assigned to the usual care group, 
you will not be visited by the researcher again until the end of the study. If you are assigned to 
the intervention group, the researcher will visit your house for two 1 hour sessions to discuss 
your beliefs about intermittent claudication, and about walking, and to help you set a walking 
action plan. Regardless of which group you are in, the researcher will also make a brief 
telephone call to you in weeks 6, 10 and 14 of the study to ask you to rate your leg pain when 
walking. At the end of the study the researcher will visit you and ask you to wear the 
pedometer again for one week, and to complete another set of questionnaires. This visit will 
last no more than an hour. 
 
If you decide to take part in this study, the researcher will need a clinical measure of your 
ankle artery pulses from your first visit to the Vascular Assessment Nurse. This measure gives 
an indication of the severity of your intermittent claudication. The researcher will ask your 
Vascular Consultant for a note of this measure. 
 
The researcher will also ask you to nominate a close friend or relative to be involved with you 
in this study. They will be asked to fill in a questionnaire at the start and end of the study 
which asks what they know about intermittent claudication. If you are in the intervention 
group, your nominated close friend or relative will also be invited to attend the two 1 hour 
meetings to help support you set your walking action plan. 
  
Your participation in this study will not affect the clinical care you receive.  
 
Will my taking part in the study be kept confidential? 
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All information which is collected about you during the course of the research will be kept 
strictly confidential.  Any information about you which leaves the hospital will have your name 
and address removed so that you cannot be recognised from it. All information will be stored 
securely, and only the researcher and the project supervisor will have access to the 
information. Research records will be kept for 5 years. They will be kept in a locked filing 
cabinet in a locked office in the University of Stirling Psychology Department. 
 
Will the sessions be taped? 
 
A randomly selected 50% of intervention sessions will be taped. The tapes will then be 
transcribed, and destroyed. The transcripts will be anonymous and will not have anything 
which could identify you on them. The purpose of taping some sessions is so that the 
researcher’s supervisor can check that the plan for the intervention has been followed, and 
the intervention has been delivered consistently. 
 
What are the possible benefits of taking part? 
 
The research is important in order to understand whether a brief psychological intervention 
can increase the amount that patients with intermittent claudication walk. The results from 
this study will be used to influence the future care of patients diagnosed with intermittent 
claudication.  
 
What if there is a problem? 
 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements.  If you are harmed due to someone’s negligence, then you may have grounds 
for a legal action but you may have to pay for it.  Regardless of this, if you wish to complain, or 
have any concerns about any aspect of the way you have been approached or treated during 
the course of this study, the normal NHS Complaints Procedure will be available to you (details 
are available in Stirling Royal Infirmary or through your GP). 
 
What happens when the research study stops? 
 
The results of this study will be summarised and given to you. You will be given the 
opportunity to discuss the study with the researcher. The research will then be written up in a 
report that will form part of the researcher’s PhD qualification. In addition the research may 
be published in an academic journal. You will not be identified in any report or publication. 
 
This is a PhD research project and is being sponsored by The University of Stirling. The Fife and 
Forth Valley Research Ethics Committee, which has responsibility for scrutinising proposals for 
medical research on humans, has examined this proposal and has raised no objections from 
the point of view of medical ethics. If you require any more information about this study, 
please contact the researcher, Maggie Cunningham, on 01786 466 845. Alternatively, if you 
wish to speak to someone who is independent of the research, please contact Professor 
Ronan O’Carroll on  
01786 467640. 
 
Thank you for reading this Information Sheet and considering taking part in this study. 
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CONSENT FORM 
 
 
 Title of Project:   Changing illness perceptions of patients with intermittent 
claudication: a pilot randomised controlled trial to increase 
walking 
 
 
Name of Researcher: Maggie Cunningham 
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet    
dated 07/04/08 (version 3) for the above study and have had the opportunity to ask 
questions. 
 
2. I understand that my participation is voluntary and that I am free to                  
 withdraw at any time, without giving any reason, without my medical care 
 or legal rights being affected. 
 
3.  I agree that the researcher can ask for a note of my ankle pressure index       
from my Vascular Consultant, as measured at my first visit to the Vascular Assessment 
Nurse. 
 
4.  I agree that NHS Forth Valley can check my medical records for a copy         
 of this consent form if auditing this research project. 
 
1. I agree that the researcher can inform my Vascular Consultant that                 
 I am taking part in this study.  
 
2. I agree that the researcher may tape the intervention sessions and that           
 the tapes will be destroyed after they have been transcribed. 
 
3. I agree to take part in the above study.                                                             
 
________________________ ________________ ____________________ 
Name of Patient Date Signature 
 
_________________________ ________________ ____________________ 
Researcher Date  Signature 
 
 
 1 for patient;  1 for researcher;  1 to be kept with hospital notes 
